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SUMMARY
Recent progresses in pharmaceutics and medicine have identified many intracellular
targets for future pharmaceutics development. Intracellular delivery of large therapeutic
molecules is a major challenge because of the presence of the plasma membrane. While
there are many strategies to load cells with drug, one approach is to use a physical force
to porate the cell membrane, thereby letting therapeutic molecules diffuse into the cell.
These methods, collectively called physical methods of drug delivery, have the advantage
of being generic, fast, and often less cytotoxic compared to the viral and chemical meth-
ods of intracellular drug delivery, but cannot simultaneously sustain high levels of uptake
and cell viability. Our approach to the problem is to induce controlled and reversible
cell damage through pulsed laser irradiation of carbon black (CB) nanoparticles. We first
demonstrated intracellular delivery of calcein and FITC-dextran in human prostate carci-
noma cells (DU145) and rat cardiomyoblasts (H9c2). We found that both the laser and
CB had to be present for the drug delivery to occur significantly. We then characterized
and optimized the system for maximal uptake and minimal loss of viability. We studied the
effect of number of parameters including laser fluence, time of exposure, CB concentration,
and pulsing frequency, and characterized the system efficacy in terms of uptake of marker
molecule and viability. We observed efficient uptake in most cases, however cell death was
also high at higher fluence and longer exposures. We hypothesized that absorption of laser
by CB leads to heating which causes thermal expansion of CB particles followed by vapor
bubble formation and/or initiates a chemical reaction between CB and water, leading to
generation of pressure waves. Then, the pressure waves and/or the vapor bubbles interact
with the cells leading to pore formation from which either the cells recover and drug delivery
is achieved or cell death occurs.
In the second half of this study we worked on understanding the underlying causes of
cell death. We concluded that cell death is caused by either necrotic death or death through
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fragmentation of cells caused by the force generated through laser-carbon interaction. After
concluding that cell death is caused by fast mechanical poration, we added poloxamers to
mitigate the effect with the rationale that it will plug pores as soon as they are formed. The
observed increase in viability through addition of poloxamer leads us to believe that this
process is similar to other physical methods like ultrasound and electroporation in some
regards.
We then proceeded to understand the details of mechanism of force generation. We
devised a technique to measure the acoustic waves generated from the laser-irradiated CB.
We observed that increasing fluence and CB concentration leads to increase of pressure
waves. We also predicted the maximum particle temperature through bulk temperature
measurements and theoretical calculations. Our prediction is that the particle temperature
approaches 1000◦C for 44 mJ/cm2 pulses. Through this we developed the hypothesis that
the laser heats the CB leading to thermal expansion, vapor formation and/or chemical
reaction leading to generation of acoustic waves. We also concluded that the reaction does
not play an important role and that thermal expansion and vapor formation are the two
main reasons for acoustic wave generation. Our experiments also suggested that the effect
is a near-field effect making the cellular and particle microenvironments very important for
successful transient poration of cell membrane..
To demonstrate its potential for medical applications, we applied our technique for
intracellular delivery of a real therapeutic molecule. We chose to deliver anti-EGFR siRNA
to ovarian cancer cells. Cells exposed to a laser at 18.75 mJ/cm2 for 7 minutes resulted in
a 49% knockdown of EGFR compared to negative control. We established an alternative
way to deliver siRNA to knockdown proteins, for the first time using laser CB interaction.
Finally, we demonstrated the technique in-vivo, wherein we showed that about 30%
of the exposed area had uptake compared to non-exposed (sham) controls, but did not
quantitatively assess cell death. We believe further optimization will lead to better efficacy
in vivo.
The method proposed in this study has several advantages: i) it is fast compared to
viral and chemical delivery, ii) it can be applied to a wide variety of cell types and tissue
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types, iii) there is no modification required to nanoparticles used in this study which makes
it a relatively simple procedure, iv) the necessity of both the CB and laser for the effect to
occur results in a localized effect. This technique holds the potential to be an alternative
to chemical and biological methods of intracellular drug delivery and we hope someday it




For most of the industrys existence, pharmaceuticals have primarily consisted of low molec-
ular weight chemical compounds that are dispensed orally (as solid pills and liquids) or as
injectables as a bolus. During the past three decades, however, formulations that control
the rate and period of drug delivery (i.e., time-release medications) and target specific areas
of the body for treatment have become increasingly common [1]. However, this creates a
challenge to not only develop new drugs and treatments but also come up with a way to
effectively deliver them.
Since development of new drug molecules is expensive and time consuming, an alter-
native is to increase the efficacy of old drugs by delivering them at controlled rate, and
targeting them effectively [2]. The goal of many sophisticated drug delivery systems is
to deploy medications intact to specifically targeted parts of the body through a medium
that can control the therapys administration by means of either a physiological or chemical
trigger. Many pharmaceutical agents, including various large molecules (proteins, enzymes,
antibodies) and even drug-loaded pharmaceutical nanocarriers, need to be delivered intra-
cellularly to exert their therapeutic action inside cytoplasm or onto nucleus or other specific
organelles, such as lysosomes, mitochondria, or endoplasmic reticulum. In addition, intro-
cytoplasmic drug delivery in cancer treatment may overcome such important obstacles in
anticancer chemotherapy as multidrug resistance [3].
However, the lipophilic nature of biological membranes restricts the direct intracellular
delivery of such compounds. The cell membrane prevents big molecules, such as peptides,
proteins, and DNA, from spontaneously entering cells unless there is an active transport
mechanism, as in the case of some short peptides. Under certain circumstances, these
molecules or even small particles can be taken from the extracellular space into cells by
the receptor-mediated endocytosis [4]. The problem, however, is that molecules/particles
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entering the cell via the endocytic pathway become entrapped in endosomes and eventually
end up in the lysosomes, where active degradation processes by the lysosomal enzymes
takes place. As a result, only a small fraction of unaffected substance appears in the
cell cytoplasm. This result in the situation where many compounds showing a promising
potential in vitro cannot be applied in vivo owing to bioavailability problems.
So far, multiple and only partially successful attempts have been made to bring various
macromolecular drugs and drug-loaded pharmaceutical carriers directly into the cell cyto-
plasm, bypassing the endocytic pathway, to protect drugs and DNA from the lysosomal
degradation, thus enhancing drug efficiency or DNA incorporation into the cell genome.
Techniques like ultrasound induced intracellular drug delivery, electroporation, microinjec-
tion, etc. collectively called the physical methods of drug delivery are capable of achieving
that, but the primary drawback with these techniques is the tradeoff between high levels of
uptake and high viability.
We propose an alternative technique of achieving intracellular drug delivery through
exposure of dilute carbon black (CB) solution to pulsed nanosecond laser in the presence
of cells. The idea to use laser-CB particle interaction for drug delivery came from the work
of Chen and Diebold [5] who demonstrated generation of giant photo-acoustic waves when
dilute CB suspension was exposed to nanosecond pulsed lasers [5]. Our labs experience
with ultrasound mediated intracellular drug delivery, made us aware of the fact that short,
intense pressure fluctuations in a cell system can lead to uptake of molecules. Guided by our
previous experience and intuition, we first demonstrated and optimized intracellular drug
delivery through the use of a femtosecond laser and CB. The system was quite efficient
but femtosecond lasers are expensive and complicated to use, making it less attractive for
applications. Encouraged by the femtosecond laser experiments we decided to try the same
method with much cheaper, widely available nanosecond laser. This thesis represents the
summation of all the effort in that direction. The overall objectives of this thesis can be
broadly classified into two parts: i) to characterize the systems efficacy through uptake
and viability measurements by varying input parameters and understanding the underlying
mechanism of intracellular drug delivery, and ii) applying the system to deliver fluorescent
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molecules in vivo and therapeutic like siRNA in vitro to demonstrate its clinical relevance.
The first part of the study focuses on understanding the bioeffects of the laser particle
interaction. For that, we characterize the viability (i.e. live cells) and uptake (i.e. viable
cells with molecules inside them) by varying a number of parameters like laser fluence,
time of exposure, CB concentration, pulsing frequency, etc. to establish the dominant
parameters that govern the outcome. We also attempt to determine the cause of cell death
post treatment and try to address the issue through the use of various additives. Next, we
study the underlying mechanism of generation and nature of the physical force that results
in membrane poration, by measuring the pressure and temperature of the system. The final
part of this thesis focuses on applying the technique to assess a future medical application.
For that, first the system is used to deliver siRNA in vitro to demonstrate knockdown of
EGFR protein in ovarian cancer cells and finally, we show a proof of principle study of
intracellular delivery of propidium iodide (PI) in murine TA muscles.
In the subsequent chapters we will first ask questions and then formulate hypotheses to
answer them, and then test those hypotheses through experiments and calculations. Each
chapter will describe in detail the questions asked, the hypotheses proposed, experimental
design to test the hypotheses, and interpretation of results followed by a conclusion. We




In the last century significant advancement in pharmaceuticals has resulted in eradication of
deadly diseases like small pox; led to reduction of 99% of the deaths caused by diphtheria,
mumps, pertussis and tetanus in the US [6]. With the advent of new kinds of drugs, it
became equally important to come up with ways to deliver them [7, 8]. Traditionally
the oral route was preferred, owing to its non-invasive nature and ease of delivery, but
unfortunately, adequate peptide or protein drug delivery has not yet been attained via this
route. This is, in part, a consequence of the acidic conditions of the stomach, the first-pass
effect of the liver (i.e. the loss of drug owing to metabolic processes before entering the
systemic circulation) and the resistance exerted by the intestine, which alters, destroys or
reduces absorption of nearly all macromolecules, thereby reducing their bioavailability [9].
There are alternative routes of delivery like nasal, transdermal, intravenous, etc., but they
suffer from drawbacks like whole body exposure and limitations on the types of drugs that
can be used [10]. This, in part, led to discovery of newer techniques to deliver drugs that
are targeted towards the specific sites in the body. At present drug delivery is a vast and
important field in its own [11].
A lack of good drug delivery technique can not only hamper effectiveness of traditional
medication [12, 13] but will lead to further complications to future medication techniques
like gene corrections, RNA interference (RNAi) and cell therapy. With the progress in
biotechnology, it has been possible to identify a lot of intracellular targets that, if treated
will lead to better therapy. Most pharmaceutical agents have primary targets within cells
and tissues; ideally, these agents may be preferentially delivered to these sites of action
within the cell [14]. This group includes preparations for gene and antisense therapy, which
have to reach cell nuclei; proapoptotic drugs, which target mitochondria; lysosomal enzymes,
which have to reach the lysosomal compartment; siRNA and mRNA which needs to reach
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into the cytoplasm [3].
2.1 Current Intracellular Drug Delivery Techniques
In order to deliver drugs to intracellular targets, a strong barrier called cell membrane
must be overcome. Cell membrane is an extremely hard barrier to overcome because it is
made of highly structured lipid bilayer, which regulates the entry and exit of most of the
external molecules. Only a very few small molecules can make it across the cell membrane
through diffusion. Cell membrane being negatively charged does not interact with a lot of
naturally occurring macromolecules. P-glycoprotein pumps push drugs out of the cells [15].
Big molecules can only make it into the cells through a collective process of cells called
endocytosis which eventually leads the drugs to highly acidic endosomes and are subject to
lysosomal degradation [16, 17]. Because of the nature and complexity of intracellular drug
delivery, there are varieties of techniques and approaches that can be used to achieve the
same. Most intracellular drug delivery methods can be classified into 3 kinds of techniques
viz. a) Chemical b) Biological and c) Physical. Each method has its own advantages and
shortcomings which would be discussed in the following section.
2.1.1 Chemical Methods
Chemical methods involve modifying the drug chemically to make the drug more stable,
changing the drug formulation or encapsulating them in a polymeric material to have a
longer circulation in blood or embedding the drug in porous structure to get a sustained
release effect. These techniques also give an either precise targeting effect or a control of
the release profile. In the past few decades there has been a growing interest in deliver-
ing effective drugs, proteins, peptides in specific targets using nanoparticles [12, 18, 19].
Nanoparticles are man-made materials which are in the 5 - 200 nm size range [14]. The use
of nanoparticles in science is called nanotechnology [20]. Due to its small size, it generally
has a higher efficiency of being taken up by cells, and gets cleared more efficiently unlike
microparticles which stay in the body for extended periods of time.
Based on the materials used and the method of preparation various kinds of nanopar-
ticles can be manufactured, like inorganic nanoparticles [21], polymeric nanoparticles [22],
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nanocrystals [23], solid lipid nanoparticles [24], liposomes [25] and dendrimers [26]. These
nanoparticles can be engineered to target various intracellular targets with varying degree
of success. Drugs encapsulated within a shell or adsorbed on a surface provide a protection
of the naked drug from a systemic response. Examples of this technique are nanoshells,
polymeric nanoparticles, solid lipid nanoparticles and liposomes. Among all of these tech-
nologies, the most notable is the use of liposomes, where the drug is encapsulated in a
phospholipid bilayer structure, which prevents immune response and increases the circula-
tion period in the body. They are also amphiphilic and therefore are conducive to surface
modification which can then be used to target specific cells and provide stealth from im-
munity [27, 28]. The protective activity has a special relevance to RNA delivery because of
the presence of RNAase in the tissue of animals. Polymeric nanoparticles can also be used
to provide a sustained release of a drug once they are taken up by cells.
Cell penetrating peptides and cationic lipids are also possible ways of delivering drugs
and nucleic acids into the cell by overcoming the electrostatic force of the cell membrane.
Complexes of polymers with DNA, called polyplexes [29], are used for their high loading and
low toxicity [30]. The general drawbacks associated with chemical methods are associated
with the stability in the systemic circulation, clearance of the nanoparticles, toxicity and
endosomal and lysosomal degradation [31-33].
2.1.2 Biological Methods
Biological methods, also known as viral vector techniques, are methods which use a biolog-
ical carrier mostly viruses to deliver drugs to specific tissues. Virus has been evolutionarily
very good at infecting tissues and therefore serves as a potentially good carrier for targeted
drugs. This technique has been traditionally chosen as a preferred method for gene delivery
because of the ease of design and high efficiency [34]. The use of retroviruses [35] and ade-
noviruses[36] and herpes simplex virus are some examples of the carrier. But because large
scale production of virus based drug is extremely expensive and high host immunogenic-
ity associated with this technique has led to decline of interest in this method [37]. With
the advent of other methods, biological methods are more and more at a disadvantageous
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position in clinical medicine [38].
2.1.3 Physical Methods
An alternative technique to deliver drugs to cells is to use a physical force that temporarily
disrupts the membrane and allows the molecules to either diffuse in or are driven elec-
trophoretically to cause uptake of molecules [39]. Membrane disruptions leads to direct
cytosolic delivery bypassing the endocytotic pathway and the externally controlled field can
be manipulated to change the pore size leading to uptake of different kind of molecules by
the same force [40, 41]. Generally bigger pores and pores that remain open for a longer
duration causes uptake of bigger molecule but there is a potential risk of cell death because
of apoptosis triggered by Ca2+ efflux or necrosis [42]. The primary challenge is to optimize
the conditions to maximize uptake while minimizing cellular deaths. Physical methods
have gained interest in the drug delivery world because of their ease in use, genericity and
targeting properties. Some examples of physical methods are listed as follows:
2.1.3.1 Electroporation
Electroporation or electropermeablization is a process of increasing cellular permeability
caused by an externally applied electrical field. The field causes destabilization of the cell
membrane leading to enhanced permeability. The field then, in some cases of charged
molecules like DNA and protein, drives the molecules across the membrane electrophoreti-
cally achieving drug delivery of big molecules [43, 44]. Gene transfer by electroporation has
been successfully used to deliver genetic materials across broad range of cells both in-vitro
and in-vivo [45, 46]. The approach becomes increasingly invasive, as the tissue becomes
more and more non-accessible. There have been reports of cell death by apoptosis and
long term effects on cells after being subject to electroporation. The efficacy of the method
is highly dependent on the local distribution of electric field in the tissue and therefore
has to be optimized from tissue to tissue [47]. Even though this sensitivity has prevented
commercialization of the technology in the US, electrochemotherapy is approved in Europe.
A more recent approach is a technique termed as electron avalanche transfection which
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involves delivery of DNA using high voltage plasma discharge, following very short (mi-
crosecond) pulses. This technique has been shown to be more efficient in terms of uptake
and viability compared to electroporation [48].
2.1.3.2 Ultrasound
Ultrasound which is primarily used for imaging has also been used to achieve intracellular
drug delivery [49]. Ultrasound-mediated delivery occurs due to the transient mechanical
disruption of the cell membranes by acoustically-induced bubble activity or acoustic cav-
itation [50-52]. Its a relatively fast, non-invasive tool for drug delivery and gene delivery.
This method has been used in conjunction with viral vectors [53] and microbubbles [54]
to obtain targeted and efficient drug delivery. The method involves focusing a beam of
ultrasound into the desired tissue externally. This causes heterogeneous effects because the
sound attenuates and reflects heterogeneously from the body. The underlying mechanism
of membrane disruption by ultrasound might be caused by acoustic cavitation which in in-
trinsically a heterogeneous effect [55]. Cell death through this method either occurs by lysis
(fragmentation), necrosis or apoptosis. If the intensity of ultrasound is increased, it leads
to more cell death by lysis suggesting a mechanical disruption of cell membrane during the
ultrasound exposure [42, 56].
2.1.3.3 Microinjection
This technique involves direct delivery of drugs or DNA materials into the cell using a glass
micropipette under a microscope. This technique has the advantage of high transfection
efficiency and homogenous response as the materials are injected directly into the cells. This
has been used primarily for pronuclear injection for producing transgenic mice and for in
vitro fertilization in clinical medicine [57]. Unfortunately, the technique involves a highly
skilled person who has to inject cells one by one leading to an extremely low throughput
[58]. This drawback has limited the use of this technique.
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2.1.3.4 Particle Bombardment
This is primarily an in-vitro method, which utilizes a gene gun to deliver a payload of
an elemental particle of heavy metal coated with plasmid DNA [59]. This is also referred
to as bioballistics. Even though so far it has been primarily used in plant cells it has a
potential to be used in mammalian cells as well. They have been used to deliver DNA
vaccines and transform C. elegans, as an alternative to microinjection [60]. Because this
technique involves heavy metals, its use is limited either because of cellular toxicity or price
per injection. In-vivo application of this technique is limited to skin and shallow tissue
targets [61, 62].
2.1.3.5 Magnetofection
Magnetofection involves the use of magnetic fields to concentrate iron oxide particles con-
taining nucleic acid into target cells. First, the nucleic acids are associated with cationic
magnetic particles; next they are concentrated in the vicinity of cells supported by appro-
priate magnetic field. But the primary delivery occurs through endocytotic pathway [63].
Nucleic acids are then released into the cytoplasm depending on the formulation used from
the endosome. So far, most of the studies involving magnetofection are in-vitro studies
though there is a promising potential of remote targeting in-vivo using magnets to tumors
and other hard to access areas [64].
2.1.3.6 Advantages of Physical Methods
Physical methods of drug delivery rely on an external physical force that causes temporary
disruption of cell membrane. This makes them relatively less sensitive to type of drug and
type of cells compared to its chemical and biological counterparts. Therefore, these methods
are considered generic and platforms are easily transferable to newer systems. Additionally,
the uptake occurs directly into the cytosol bypassing the endocytotic pathway resulting in a
whole cytoplasm delivery and not just local delivery to endosome, while avoiding endosomal
degradation of drug [39]. Physical methods are generally much faster than other types of
delivery methods (delivery timescale in minutes) because there is an active pore that is
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created on the cell membrane which results in active delivery and does not rely on the
inherent capabilities of cell to uptake the drug which are comparatively slower(delivery
timescale in hours). In physical methods, little to no modification of the drug is required
because the drugs are actively delivered to cells without any receptor binding or chemical
targeting. The advantage of using naked drug is in less off-targeting, less toxicity and ease of
preparation of samples. Physical methods involve the use of a physical force and generally
just the naked drug and sometimes inert materials that do not take part in bioeffects
generally. The result is a relatively simple and non-toxic system [65, 66]. Nevertheless,
physical methods suffer from a drawback of high cell death associated with high uptake
because forces that cause the delivery to occur is also responsible for cell death. Therefore
the greatest challenge is to optimize the condition such that there is very little cell death
but coupled with maximal viability [65].
2.1.4 Lasers in medicine
A laser is a device that emits light through a process if optical amplification based on
the stimulated emission of electromagnetic radiation [67]. The terms laser stands for light
amplification by stimulated emission of radiation. A laser consists of a gain medium, a
mechanism to supply energy to it, and something to provide optical feedback [68]. The gain
medium is a material with properties that allow it to amplify light by stimulated emission.
Light of a specific wavelength that passes through the gain medium is amplified (increases
in power). The process of providing external energy to the gain medium, in the form of
either electric current or light at a different wavelength than the laser output, is called
pumping and is usually achieved by a flash lamp or a seed laser. The feedback mechanism,
in most lasers, provided by an optical cavity which are generally a pair of mirrors that
let light bounce back and forth passing light every time through the gain medium. When
number of atoms in excited state is more than atoms in ground state, population inversion is
achieved in the gain media, and the amount of stimulated emission due to light that passes
through is larger than the amount of absorption, causing light amplification. Typically one
of the mirrors in the optical cavity is partially transparent allowing some of the light to
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pass through causing the final output beam.
Depending on the pumping mechanism and the optical cavity, lasers can be classified
into two different groups; continuous lasers and pulsed lasers. Continuous lasers have a
continuous beam output and require the population inversion to be replenished steadily. In
some lasing media this is impossible. In some other lasers it would require pumping the
laser at a very high continuous power level which would be impractical or destroy the laser
by producing excessive heat. Such lasers cannot be run in CW mode. In pulsed lasers, the
output is pulsed and can be achieved by pulsed pumping, mode locking or Q-switching.
Pulsed pumping involves pumping the laser material with a source that is itself pulsed,
either through electronic charging in the case of flash lamps, or another laser which is already
pulsed. Examples of such lasers are excimer lasers and copper vapor lasers, and they can
never be used in the continuous mode. Mode locking technique can produce extremely short
pulses (∼10 femtoseconds) [69]. These pulses will repeat at the round trip time, that is,
the time that it takes light to complete one round trip between the mirrors comprising the
resonator. Ti:Sapphire is an example of such laser, and is primarily used because it has a
very wide gain bandwidth and can thus produce pulses of only a few femtoseconds duration.
These lasers are used to maximize the non-linear effect of a system by depositing energy at
a very fast pace, causing optical breakdown in some cases [70].
In a Q-switched laser, the population inversion is allowed to build up by introducing
loss inside the resonator which exceeds the gain of the medium to store maximum possi-
ble pump energy in the laser medium. Then, after that, the introduced loss mechanism
(often an electro- or acousto-optical element) is rapidly removed (or that occurs by itself
in a passive device), allowing lasing to begin which rapidly obtains the stored energy in
the gain medium. This results in a short pulse incorporating that energy, and thus a high
peak power [71]. Nd:YAG lasers are a common examples of Q-switched lasers and pulse
lengths can be in the order of nanoseconds. Typically these lasers are much cheaper com-
pared to Ti:Sapphire femtosecond lasers. On May 16, 1960, Theodore H. Maiman operated
the first functioning laser [72] at Hughes Research Laboratories, Malibu, California. Only
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two years later, in 1962, a dermatologist named Leon Goldman used it to remove a tat-
too. Since the inception of lasers, it found its use in medicine. As the years progressed
its applications widened and currently they are used in a variety of applications such as
angioplasty [73],cancer diagnosis [73, 74], cancer treatment [75], cosmetic applications such
as laser hair removal, tattoo removal, dermatology, lithotripsy [73], mammography, medical
imaging, microscopy, ophthalmology (includes LASIK and laser photocoagulation), optical
coherence tomography, prostatectomy, surgery [76] etc. Lasers are attractive because they
are optically coherent which enables the light to be focused and targeted consistently, they
are generally monochromatic and therefore can be used to interact with specific targets and
finally they can generate very high peak power (mode locked and Q-switched lasers) which
give them unique characteristics and properties. The main challenge with laser is to find
the right wavelength, uniform beam profile and control the energy at a specific site in the
body especially in the tissue situated deep in the body.
2.1.5 Drug Delivery using laser
Some methods of intracellular drug delivery have used lasers. Methods like optoporation
[77] and optoinjection [78] are used to deliver exogeneous molecules directly into the cells.
Optoporation uses a focused laser light (less than 1 µm diameter) to thermally damage
cell walls and deliver molecules into cells on a cell by cell basis. Optoinjections uses laser
to create shockwaves through the use of laser absorbing media (typically polyimide) to
mechanically damage cells. Laser particle interaction has also been shown to lead to creation
of acoustic waves that have a potential to disrupt cell membrane [79, 80]. Another way of
creating a shockwave is to use a shocktube [81] which can then be used to deliver drugs into
the cells. Indirect methods which use laser for intracellular delivery involve nanoparticles
loaded with drugs which are released through shining of laser light on them, incurring a
time and spatial control over the release of drug [78, 82].
The generation of shockwave using laser has been subject to a lot of research lately.
A complete field of photo-acoustics has come forth as a result [83]. Drug delivery using
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shockwave generated by lasers is in reality a two-step process: the first being the trans-
duction of laser energy to acoustic waves and the second step is the interaction of that
pressure wave with the cell to cause membrane disruption. Shockwave generation has been
attributed to optical breakdown (plasma formation), ablation, thermoelastic expansion or
vapor formation [84]. The shockwave and acoustic waves generated from these mechanisms
are thought to temporarily disrupt the cell membrane allowing drugs and other molecules to
diffuse in [85-87]. The exact nature of pressure wave and cell membrane interaction which
causes membrane disruption is not well known and is still subject to debate. It is however,
believed that once the membrane disruption occurs the drug delivery into the cells occur
because of passive diffusion. Generation of pressure waves through laser irradiation poses
several advantages in the sense that there is more spatial control over the pressure wave
generation areas.
2.2 Carbon Nanoparticles in Medicine
Carbon occurs in various forms such as carbon black, graphite, nanotubes, fullerenes etc.
Carbon nanotubes (CNTs) are being widely used for targeted drug delivery research, owing
to their high internal volume and ease of functionalization of external surface. A popular
version of nanotubes is the use of soluble fullerene derivatives such as C60 which can be
easily used in drug loading and formulations [88]. Direct non-endocytic delivery of plasmid
DNA was also achieved using a technique called nanotube spearing [89]. But unfortunately
the toxicity of nanotubes is still under question and in some cases has been shown to be
acutely toxic to cells [90]. Carbon dots (C-dots) have been used in particle tracking and
imaging and are said to be non-toxic to cells [91].
Carbon black (CB) is another form of carbon and is one of the major components of
India ink. CB is composed of very small primary particles, which fuse to form branched
aggregates. Aggregates are the smallest functional unit of CB. They are formed through the
fusion of smaller units, called primary particles, into a three dimensional branched chain
structure [92]. They have found use as medical tattoos and markers for tissue and have
been also used as a model nanoparticle dye in some cases.
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2.3 Laser Particle Interaction
Laser particle interaction has found a significant place in medicine and other fields. In
photo-acoustics metal particles are used to map out the tissue region in vivo and also used
for particle tracking [93, 94]. In drug delivery laser particle interaction has mainly focused
on gold nanoparticles. Gold nanoparticles are preferred and have been used in various ways
to deliver drugs because of non-toxic nature and tunability to specific laser wavelengths.
For example, gold nanoshells have been used to load drugs inside and them, and targeted
to specific sites such as tumor and then once they reach the specific site, drug is released
through thermal ablation of the shell using a tuned laser leading to controlled drug delivery
[95]. Another way to use gold nanoparticles is to incubate cells with gold nanoparticles for
a few hours and once the gold particles are taken up, they can be irradiated with laser to
cause either endosomal escape [96] or cellular death [97]. By tuning the surface chemistry of
these nanoparticles can be preferentially taken up by cancerous cells thereby only selected
cell deaths can be caused. Most of the studies required gold to be either conjugated to
membrane surface [98, 99] or internalized into the cells to have an effect. Unfortunately
gold nanoparticles are hard to prepare, expensive and are not the most efficient absorbers
of lasers especially at wavelengths other than 532 nm because the gold can melt at certain
fluences of the laser and change its shape and stop interacting with the laser. Therefore
it is desirable to find other candidates than can more efficiently convert laser energies to
either heat or sound to cause more efficient disruption of cell membrane. Other studies have
shown that pressure wave and bubble formation occur at an interface of metal and water
[84].
2.3.1 Laser Carbon Interaction
Carbon black has a higher absorption across all wavelength compared to gold and no struc-
ture or shape modifications are needed in carbon to make it absorb light of various wave-
length and therefore makes it a competitive candidate for absorptive media for laser. In
1995, Chen et al. showed production of acoustic wave due to laser irradiation of carbon sus-
pension [100]. Irradiation of carbon nanoparticle suspensions with high power pulsed laser
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radiation have been reported to produce shock waves [101, 102], various chemical species
[103, 104], sonoluminescence [105] and an anomalously large sound wave called the ”Giant
Photoacoustic Effect” [100]. These pressure forces were believed to be caused by the sudden
volume change caused by vaporization of fluid surrounding the heated carbon particles and
potentially because of the reaction of this vapor with carbon to initiate the endothermic
carbon-steam reaction. Chemical reactions were also reported when the suspensions were
made in non-aqueous solvents like toluene and benzene [104]. Formation of gas bubbles due
to fluid vaporization around the heated particles as well as the product gases of chemical
reaction are also believed to cause cavitation bubble dynamics which may lead to the strong
pressure forces [106, 107]. This similarity with ultrasound led to the belief that it might
act as a potential drug delivery technique like ultrasound. It had the potential advantages
of better control over the acoustic field both spatial and temporal. The acoustic sources
(CB particles) are in the vicinity of the target therefore by varying the concentration a
greater control over the field is achieved. Chakravarty et. al. demonstrated the use of CB
to deliver molecules efficiently into DU145 cells by laser irradiation of carbon suspension in
the presence of cells [108]. But the mechanism of action is so far poorly understood and a
part of this thesis is dedicated to understanding some of the basic mechanisms that might
be responsible for efficient drug delivery.
2.4 RNA Interference and siRNA
RNA interference (RNAi) is a recently described mechanism for inhibiting gene expression.
It was originally identified in plants, fungi, and worms when introduction of control sense
oligonucleotides into cells unexpectedly led to reduced gene expression [109-111]. RNAi-
mediated gene silencing suppresses gene expression by several mechanisms, including the
targeted sequence-specific degradation of mRNA, translational repression, and the main-
tenance of silenced regions of chromatin. Silencing of endogenous genes regulates basic
biological processes, including the transition from one developmental stage to the next
[112]. In addition, RNAi is used as a form of primitive immunity to protect the genome
from invasion by exogenous nucleic acids introduced by mobile genetic elements, such as
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viruses and transposons. Interest in RNAi soared when it was shown that RNAi also occurs
in mammalian cells [113]. This raised the prospect of harnessing this potent and specific
gene-silencing mechanism for biomedical research and therapy. In the past few years, there
has been an RNAi revolution as researchers have sought to understand how RNAi works to
regulate gene expression, have used it to perform reverse genetics in mammalian cells, and
have begun to explore its potential therapeutic use.
RNAi pathways have been most fully described in Drosophila, but mammalian com-
plexes and mechanisms are thought to be similar. The effector molecules that guide mRNA
degradation are small [21- to 25-nucleotide (nt)] dsRNA, termed small interfering RNAs
(siRNAs), produced by the cleavage of long dsRNAs [114-116]. These short RNAs are
produced by the cytoplasmic, highly conserved Dicer family of RNase IIIlike enzymes, re-
sulting in a characteristic 2123-nt dsRNA duplex with symmetric 2- to 3-nt 3 overhangs
[113, 117]. RNAi can also be initiated by introducing chemically synthesized siRNAs into
cells. The siRNAs are taken up into a multisubunit ribonucleoprotein complex called RISC
(RNA-induced silencing complex). The antisense (guide) strand of the siRNA directs the
endonuclease activity of RISC to the homologous (target) site on the mRNA resulting in
mRNA cleavage [118].
Some have touted RNAi as the next new class of therapeutics. Because all cells are
thought to contain the machinery to carry out RNAi and all genes are potential targets, the
possible applications for medicine are, in principle, unlimited. This widespread applicabil-
ity, coupled with relative ease of synthesis and low cost of production (especially compared
to proteins such as antibodies or recombinant growth factors at the concentration needed
for therapeutic effects), makes siRNAs an attractive new class of small-molecule drugs. In
addition, siRNAs are chemically stable and can be stored lyophilized without refrigeration.
Moreover, as they enter the RNAi pathway later, siRNAs are less likely to interfere with
gene regulation by endogenous microRNAs. The sequence specificity of RNAi, even when
off-target effects are considered, promises potent therapies with little toxicity due to off-
target gene silencing. This high specificity also implies that the application of RNAi in
some instances, such as to treat viral infections or cancer, might lead to resistance due to
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sequence mutations. This has proved to be the case in several in vitro studies suppressing
viral replication by RNAi (e.g., poliovirus [119] and HIV-1 [120, 121]). But nevertheless,
siRNAs are the class of RNAi therapeutics that are most advanced in preclinical and clinical
studies. Major drawback for siRNA includes the poor pharmacokinetic property and biolog-
ical permeability restrictions, off-target effects and interferon response [122]. In particular,
siRNAs longer than 30 nucleotides, in specialized highly sensitive cell lines and at high
concentrations, lead to the activation of the immune system [123]. Also, a low transfection
efficiency, poor tissue penetration because of polyanionic nature [124]. SiRNA stability by
itself is also one of the major issues because siRNAs, like most RNA molecules, are readily
degraded by RNAses, which are ubiquitous both in the extracellular and the intracellular
space. Delivery remains a major hurdle for RNAi therapy, since siRNAs do not cross the
mammalian cell membrane unaided and since many of the transfection methods used for
in vitro studies cannot be used in most in vivo settings. There are two common strategies
for delivering siRNAs in vivo [125]. One is to stably express siRNA precursors, such as
shRNAs, from viral vectors using gene therapy; the other is to deliver synthetic siRNAs by
complexing or covalently linking the duplex RNA with lipids and/or delivery proteins.
In vitro siRNAs have been used to knockdown a variety of targets in vitro across multiple
cell lines. In vivo they have been used to target a variety of targets like, VEGF [126, 127] and
TGFβR2 [128], SARS [129], Ebola L gene [130]. The current method of delivery are either
using liposomes, nanoparticles formulations, ligand targeted lipoplexes, nano emulsions,
nanoparticles and chemical modification to siRNA itself to increase stability [131].
Lasers have been used to deliver genetic materials in the past. SiRNA has been delivered
into the cells using laser in a thermal mechanism [132]. Nanoshells are loaded with SiRNA
and once they have been uptaken by the cells, they are released by exposing to lasers which
aid them to escape the endosomal pathway [133].
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CHAPTER III
EFFICIENT INTRACELLULAR DELIVERY OF MOLECULES WITH
HIGH CELL VIABILITY USING NANOSECOND-PULSED
LASER-ACTIVATED CARBON NANOPARTICLES
Conventional physical and chemical methods that efficiently deliver molecules into cells are
often associated with low cell viability. In this study, we evaluated the cellular effects of
carbon nanoparticles believed to emit photoacoustic waves due to nanosecond-pulse laser
activation to test the hypothesis that this method could achieve efficient intracellular deliv-
ery while maintaining high cell viability. Suspensions of DU145 human prostate carcinoma
cells, carbon black (CB) nanoparticles and calcein were exposed to 5 - 9 ns long laser pulses
of near-infrared (1064 nm wavelength) light and then analyzed by flow cytometry for in-
tracellular uptake of calcein and cell viability by propidium iodide staining. We found that
intracellular uptake increased and in some cases saturated at high levels with only small
losses in cell viability as a result of increasing laser fluence, laser exposure time, and as
a unifying parameter, the total laser energy. Changing interpulse spacing between 0.1 s
and 10 s intervals, showed no significant change in bioeffects, suggesting that the effects of
each pulse were independent when spaced by at least 0.1 s intervals. Pre-treatment of CB
nanoparticles to intense laser exposure followed by mixing with cells also had no significant
effect on uptake or viability. Similar uptake and viability were seen when CB nanopar-
ticles were substituted with India ink, when DU145 cells were substituted with H9c2 rat
cardiomyoblast cells and when calcein was substituted with FITC-dextran. The best laser
exposure conditions tested led to 88% of cells with intracellular uptake and close to 100%
viability, indicating that nanosecond-pulse laser-activated carbon nanoparticles can achieve
efficient intracellular delivery while maintaining high cell viability.
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3.1 Introduction
Many pharmaceutical agents in development and used clinically need to be delivered in-
tracellularly to have their intended therapeutic effect [3]. Inside the cell they have various
targets, including nuclear targets for gene transfection, gene correction and other gene-based
therapies [134]; mitochondrial targets for certain proapoptotic drugs [135, 136]; and other
cytoplasmic sites, including those needed for protein knockdown by RNA interference using
siRNA or miRNA [137]. However, the highly structured and lipophilic nature of the cells
plasma membranes generally blocks the direct intracellular delivery of such compounds, such
that most molecules other than small ions enter cells by an active transport mechanism,
such as receptor-mediated endocytosis [16]. Uptake via that route can be accessed through
the use of lipid and polymer nanoparticles, especially if decorated with receptor-targeted
ligands [138]. However, such chemical delivery systems can be associated with cytotoxicity
and drugs administered by that route can be subject to lysosomal degradation after inter-
nalization [17]. Viral vectors also harness natural mechanisms of intracellular delivery, but
are primarily useful only for DNA delivery and suffer from risks of virus-induced toxicity
[139].
Another approach to intracellular delivery uses physical forces to transiently and re-
versibly disrupt the cell membrane, thereby allowing molecules to directly enter the cyto-
plasm of cells either by diffusion or, in some cases, by electrophoretically driven processes
through short-lived transmembrane pores [39]. Examples of such methods are electropo-
ration [140], ultrasound-mediated intracellular delivery [49, 141, 142] and microinjection
[143]. Some methods of intracellular delivery have used lasers, for example, to generate
acoustic waves from a shock tube to induce uptake by a mechanical mechanism [144, 145],
to heat nanoparticles to induce uptake by a thermal mechanism [146-150], to heat nanopar-
ticles for controlled release of encapsulated drugs [82] or to heat nanoparticles to cause cell
death [151]. A common limitation of intracellular delivery methods is a trade-off between
achieving high levels of intracellular uptake and maintaining high levels of cell viability,
since efficient uptake among viable cells is often associated with significant cell death.
In this study, we investigated a method of intracellular delivery that uses laser-activated
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carbon black (CB) nanoparticles. In this approach, nanosecond pulses from an infrared laser
are used to interact with CB nanoparticles, which are believed to emit acoustic waves by
a so-called giant photoacoustic effect [5] that mechanically acts on the cell membrane to
create transient pores through which molecules can enter the cell. In our previous work,
we used a femtosecond laser operating at 810 nm wavelength to demonstrate intracellular
delivery by this approach [152]. In the present study, we build off those initial findings in
two ways. First, we switched from the expensive and complex femtosecond laser used before
to a much simpler and less expensive nanosecond pulse laser. Second, we examine the effects
of varying laser exposure conditions over a range of parameters in order to optimize uptake
and viability, as well as to gain insight into mechanisms of action.
3.2 Methods
3.2.1 Laser Apparatus
The Nd:YAG infrared laser (Powerlite II Plus, Continuum, Santa Clara, CA) available in
the High-Strain-Rate Laboratory in the School of Materials Science and Engineering was
used to apply pulses of 1064 nm wavelength, 5 - 9 ns pulse length, and 50 - 175 mJ energy
per pulse. Pulses were applied at a repetition rate of 10 Hz (i.e., 10 pulses per second),
unless otherwise stated. In some cases, pulses were applied at 1 Hz or 0.1 Hz. The energy
was varied by manipulating the amplifier voltage of the system. The beam was passed
through a Faraday isolator to prevent back reflection. The 12 mm-diameter laser beam
was passed through a 9 mm-diameter aperture to block the edges of the beam and thereby
obtain a more uniform top-hat profile. The resulting 9 mm-diameter beam was then usually
diverged to 21.4 mm diameter using a lens to illuminate the entire cuvette (exposure area of
4 cm2), unless stated otherwise. In some cases, the beam was used directly without diverging
(exposure area of 0.63 cm2). Sham exposures were used as negative control experiments,
where solutions containing cells, calcein and CB nanoparticles went through all the same
steps as exposed samples (see below), except that the laser was not turned on. Another
negative control involved only cells without CB nanoparticles or calcein.
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3.2.2 Cell Preparation
Human prostate carcinoma cells (DU145, American Type Culture Collection, Manassas,
VA) and rat cardiomyoblast cells (H9c2, courtesy of Dr. Mike Davis, Emory University,
Atlanta, GA) were cultured as monolayers in a humidified atmosphere of 95% air and
5% CO2 at 37
◦C in RPMI-1640 medium (Cellgro, Herndon, VA) and DMEM (Cellgro),
respectively, which was supplemented with 100 g/ml penicillin-streptomycin (Cellgro) and
10% (v/v) heat inactivated FBS (Corning, Palo Alto, CA). For each experiment, cells at
80-90% confluence were harvested by trypsin/EDTA (Cellgro) digestion, washed using fresh
growth medium with FBS and re-suspended in RPMI at a cell concentration of 106 cells/ml.
The DU145 cells [153] were used as a model cell line in most experiments because they are
well characterized and have been used extensively in our previous related studies [50, 55,
152]. In some experiments H9c2 cells [154] were used as an alternative model representing
a different cell type from a different species.
3.2.3 Nanoparticle Preparation
To prepare the CB nanoparticle solution, 20 mg of CB (Black Pearls 470, Cabot, Boston,
MA) were added to 50 ml of 0.013% (v/v) Tween 80 (Sigma-Aldrich, St. Louis, MO;
added to reduce aggregation and settling of the nanoparticles) in DI water and sonicated
for at least 15 min to obtain the final CB solution at a concentration of 400 mg/l. The
size of the individual CB nanoparticles was 25 nm, but they were aggregated into larger
particles of 189.3 ± 1.5 nm (n = 3) diameter with a dispersity of 0.16 ± 0.03 (n = 3),
as determined from dynamic light scattering measurements. The individual nanoparticles
could not be further separated by sonication (neither bath sonicator nor a more powerful
needle sonicator). After making the 50 ml solution of CB nanoparticles, it was aliquoted
into smaller 1.5 ml samples.
India ink (Chartpak, Leeds, MA), as obtained from the manufacturer, was first diluted
to 1% (v/v) in DI water (without surfactant), which served as the stock solution for exper-
iments. Because the manufacturer did not provide technical information about the ink, we
dried 1 ml of the India ink solution on wax paper and determined the solids content to be
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129 ± 1.45 mg/l (n = 3) by weighing the dried mass. Dynamic light scattering measure-
ments suggested that the mean diameter of the India ink nanoparticles was 110.6 ± 0.74
nm (n = 3) with a dispersity of 0.23 ± 0.01 (n = 3).
Relative absorption by the India ink stock solution was determined by measuring absorp-
tion at 1000 nm wavelength and comparing it with the absorption of the CB nanoparticle
stock solution of the same volume, which determined that the ratio of the absorption of the
India ink stock solution to the CB nanoparticle stock solution was 2.91 ± 0.1 (n = 3). For
experiments where India ink and CB nanoparticles were added at the same level of laser
absorption, the volume of India ink stock solution added to a sample was 2.91 times less
than the volume of CB nanoparticle stock solution.
3.2.4 Sample Exposure
A volume of 520 µl of cells at a concentration of 106 cells per ml was suspended in RPMI,
transferred to 1.5 ml microcentrifuge tubes and stored on ice until exposure. CB nanopar-
ticle stock solution was added to achieve a final concentration of 25 mg/l CB nanoparticles,
unless otherwise noted. In some experiments different concentrations of CB were used.
High purity calcein (Molecular Probes, Eugene, OR) was used as an uptake marker and
was added from a stock solution at a final concentration of 10 µM. In some experiments
calcein was replaced by FITC labeled dextrans (Sigma-Aldrich) of 10 kDa, 70 kDa and 500
kDa molecular weights at a concentration of 10 µM. The final solution was mixed thoroughly
by vortexing and then exposed to laser in cuvettes (37-PX-2, Starna Cuvettes, Santa Clara
CA) made from Pyrex glass. The total volume of the cuvette was 600 µl. The top part of
the cuvette was cut at 2 mm from the base of the neck to facilitate transfer of liquids. A
total volume of 563 µl of the mixture was transferred to the cuvette using a transfer pipette.
The cuvette was placed in a custom-made stand to keep it stationary during laser exposure.
After laser exposure, cells were transferred back to microcentrifuge tubes and stored
on ice to reduce uptake due to endocytosis until all the samples were done. Propidium
iodide (Invitrogen, Grand Island, NY) was added at a concentration of 7.5 µM and cells
were incubated for at least 10 min to label necrotic and late apoptotic cells. Next, cells
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were centrifuged at 500 g for 6 min and washed with PBS (Cellgro) supplemented with
10% FBS twice. After the third centrifugation, the cells were suspended in PBS and then
transferred to flow cytometer tubes or were put on a microscope slides and cover slipped
for fluorescence imaging.
3.2.5 Cytotoxicity of CB Nanoparticles
Dimethyl thiazoldiphenyl tetrazoleum (MTT) assay was performed to assess the cytotoxicity
of CB nanoparticles on the cells. CB nanoparticles were added at concentrations ranging
from 50 mg/l to 400 mg/l to DU145 cells that were monolayer cultured on 96 well plates.
The cells were then incubated for either 24 h or 72 h with the CB nanoparticles. The cells
without CB nanoparticles served as the positive control. The negative control was created
by incubating cells with 70% methanol for 30 min. CB nanoparticles were removed from
the solution by centrifugation and absorbance measured at 570 nm was used to determine
the number of viable cells.
3.2.6 Analysis and Quantification
Cells were imaged using a Zeiss LSM META/NLO 510 multiphoton laser confocal mi-
croscope (Zeiss, Thornwood, NY). PMTs, laser power and pinhole aperture were set to
minimize bleeding of signal from one dye channel to the other. Images for both the dyes
(i.e., calcein and propidium iodide) were taken sequentially to avoid signal overlap. Cells
were observed at 20x and 60x magnification to visually inspect cellular uptake in viable
cells.
A bench-top flow cytometer (BD LSRII, BD Biosciences, San Jose, CA) was used to
quantify uptake, i.e. the number of live cells with calcein uptake, and viability, i.e. the
number of live cells that were not necrotic or fragmented, on a cell by cell basis. For
quantifying necrotic death, propidium iodide stain was analyzed using a PerCP-Cy5, 670
nm longpass filter. Calcein uptake into cells was detected using a FITC, 530/28 nm bandpass
filter. A cell gate was constructed based on forward-scattered and side-scattered light to
determine the size distribution of cells in the control. Any events lying within this gate were
considered to be cells, whereas events smaller than that were considered cells fragments. To
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determine the concentration of intact cells (and thereby account for possible cell loss due
to fragmentation), we multiplied the volumetric flow rate in the flow cytometer by the time
of analysis to determine the total volume analyzed. Dividing the number of cells detected
within the gate by the volume provided the cell concentration, which could be compared to
non-exposed controls to determine cell loss due to fragmentation. Approximately 105 cell
events were collected per sample which was approximately 20% of the total cells present in
each sample. To account for spectral overlap between the dyes, compensation controls were
run for each experiment. Propidium iodide-positive samples were made by incubating cells
in 70% methanol for 30 min and then washing with PBS. Calcein-positive samples were
made by exposing cells with CB nanoparticles and calcein at 44 mJ/cm2 per shot for 3 min.
At this condition, there was extensive cell death, but almost all cells which remained viable
had calcein uptake.
3.2.7 Statistical Analysis
A minimum of three replicates was performed for all conditions. Replicates enabled calcula-
tions of means and standard deviation. The equality of mean response (uptake or viability)
between treated samples and sham exposures and other control samples was tested using
ANOVA (α = 0.05). To test equality of mean response between pairs of data points, 1-way
ANOVA followed by the post hoc Tukeys pairwise comparison was used, whereas 2-way
ANOVA was employed to compare three or more data points using Microsoft Excel 2010
(Microsoft, Redmond, WA) and GraphPad Prism 6 (GraphPad Software, La Jolla, CA).
The null hypothesis was that the average fraction of cells with uptake (or average fraction
of viable cells) between a treated sample and a sham exposure were equal. To compare
between mean values of two data points, an unpaired Students t-test is performed (2 tails)
assuming unequal variances.
3.3 Results
3.3.1 Intracellular uptake due to laser-activation of CB nanoparticles
We first validated that exposure of cells to infrared laser pulses in the presence of CB
nanoparticles resulted in uptake of a marker compound, calcein, by viable cells. As shown
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in Fig. 3.1a, DU145 prostate cancer cells incubated with CB nanoparticles and calcein, but
without exposure to laser pulses, did not show significant intracellular uptake of calcein.
This treatment is referred to here as a sham exposure, where cell samples received the
same treatment as laser-exposed samples, except the laser was not activated. In Fig. 3.1b,
cells were exposed to laser pulses, but there were no CB nanoparticles present. Again,
insignificant uptake was seen.
In contrast, Fig. 3.1c shows the effects of pulsing with a laser in the presence of CB
nanoparticles, where the majority of cells appear green, indicating intracellular uptake of
green-fluorescent calcein. Finally, Fig. 3.1d shows a magnified view of cells exposed to laser
pulses and CB nanoparticles, further indicating that the calcein is located throughout the
interior of the cells rather than, for example, being sequestered in endosomal vesicles.
3.3.2 Effects of laser pulse fluence, number of pulses, beam spot size and pulse
repetition rate on intracellular uptake and cell viability
We next quantified intracellular uptake of calcein and viability in DU145 cells as a function
of laser fluence, while keeping all other exposure parameters constant (Fig. 3.2). The time of
exposure was set to 1 min at 10 Hz pulsing frequency. Laser exposure at the lowest fluence
studied (12.5 mJ/cm2 per pulse) caused no significant uptake or viability loss compared
to the sham negative control (Fig. 3.2). As laser fluence increased, intracellular uptake
increased as well, climbing from 30% of cells with uptake at a fluence of 18.75 mJ/cm2 to
76% of cells with uptake at a fluence of 44 mJ/cm2 (ANOVA, p<0.0001). Above 44 mJ/cm2,
intracellular uptake no longer increased and maintained a value of approximately 70 80%
of the cells (ANOVA, p = 0.98) with uptake. Over the full range of laser fluence conditions
studied, the viability remained insignificantly different from sham control samples in almost
all cases (ANOVA, p = 0.48) (Fig. 3. 2).
We expect that laser exposure time (i.e., number of laser pulses) would also affect
intracellular uptake and viability. Fig 3.3a and 3.3b demonstrates the effect of exposure
time on the uptake and viability of DU145 cells, while keeping all the other factors constant.
In Fig. 3.3a, the fluence was set to 18.75 mJ/cm2. The viability did not change significantly










Figure 3.1: Fluorescence imaging of intra-cellular uptake. Cells inspected visually using
a confocal microscope show that there is little uptake of calcein (green) when cells were
exposed to just carbon black (CB) nanoparticles but no laser (a), very little uptake when
cells were exposed to laser but not CB nanoparticles (b) and extensive uptake when cells
were exposed to laser with CB nanoparticles at 44 mJ/cm2 fluence, 1 min exposure time,
10 Hz pulsing frequency and 21.4 mm beam diameter (c). Closer inspection of these cells at
higher magnification, reveals that calcein is present throughout the interior of the cells and
not just localized, for example, to endosomes (d). In all samples, very few cells were stained
with propidium iodide (red), which is a marker of necrotic and late apoptotic deaths. Scale
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Figure 3.2: Effect of laser fluence on intra-cellular uptake and viability of DU145 cells.
Cells were exposed to laser for 1 min at various laser fluence levels. Asterisk (*) shows data
where viability is lower than sham and hash symbol (#) shows data where uptake is lower
than viability (p <0.05). The figure demonstrates saturation of both uptake and viability
beyond 44 mJ/cm2 exposure. All laser exposures were at 10 Hz pulsing frequency and 21.4
mm beam diameter. Data show average ± standard deviation (SD) (n = 3 replicates).
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(ANOVA, p = 0.97), whereas the uptake increased from 30% to 88% (ANOVA, p <0.0001).
At 7 min, the uptake value was statistically not different from the viability value (Students
t-test, p = 0.36), indicating that essentially all viable cells had uptake. When the laser
fluence was increased to 25 mJ/cm2 (Fig. 3.3b), there was a decrease in viability as exposure
time increased (ANOVA, p = 0.0014), and the uptake initially went up and then decreased
(ANOVA, p <0.0001). At all times, uptake was significantly less than viability values
(Students t-test, p <0.05).
The data on intracellular uptake from Figs. 2a, 3a and 3b are replotted in Fig. 3.3c as
a function of total energy input (i.e., pulse fluence x laser beam exposure area x number of
pulses). This analysis shows that uptake was proportional to the total energy input below
approximately 100 J, which then saturated at a constant uptake value at higher energy
inputs.
The data presented so far were generated using a laser beam that fully covered the
sample cuvette. When the spot size diameter of the laser beam was reduced from 21.4 mm
(full exposure of the cuvette) to 9 mm (16% of the cuvette area was exposed), it resulted
in reduced bioeffects. Fig. 3.4a shows that under full cuvette exposure, uptake was higher
(Student t-test, p = 0.002), but the viability was lower (Student t-test, p = 0.01) compared
to the partially exposed samples. The total percentage of cells affected by the laser (either
uptake or death) was 87% in the case of full cuvette exposure and it was just 40% in the
case of 9 mm beam diameter exposure. This value is greater than the 16% of cuvette area,
suggesting convection within the cuvette led to more cells entering the laser beam during
the exposure time. Additional studies showed that the location of the beam spot in the
cuvette did not matter as long as it was within the cuvette area filled with cell solution
(data not shown).
The pulsing frequency in the data generated so far was 10 Hz (i.e., 10 pulses per sec-
ond). We therefore also studied slower pulsing frequencies to determine the resulting effect
on uptake and viability. Decreasing the pulsing frequency separates each pulse by more
time, which means that the cells have more time to recover from the effect of the laser-CB
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Figure 3.3: Effect of exposure time and total energy on intracellular uptake and viability
of DU145 cells. (a) When fluence was set at 18.75 mJ/cm2, there was no change of viability
but uptake increased with exposure time until it was the same as viability at 7 min. (b)
When fluence was set at 25 mJ/cm2, viability was less than the sham and uptake was always
significantly lower than viability (p <0.05). (c) When total energy is plotted against uptake,
at ≥ 100 J, uptake remained approximately constant at ∼75% at higher energy levels. All
laser exposures were at 10 Hz pulsing frequency and 21.4 mm beam diameter. Asterisk
(*) shows data where viability is lower than sham and hash symbol (#) shows data where
uptake is lower than viability. Data show average ± SD (n = 3).
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10 Hz, keeping all the other parameters constant. The viability was unaffected by changing
pulsing frequency (ANOVA, p = 0.35). The uptake value for 0.1 Hz was a little higher
than the rest (ANOVA, p = 0.025). This indicates that greater spacing between pulses by
decreasing pulsing frequency has little effect on uptake and viability, which further suggests
that any recovery by cells after being exposed to a laser pulse and CB interaction processes
occurs on a timescale faster than 100 ms (corresponding to 10 Hz pulsing) or possibly slower
than 10 s (corresponding to 0.1 Hz pulsing).
3.3.3 Effects of interaction between sequential pulsing protocols on uptake and
viability
Our guiding hypothesis is that acoustic energy emitted by CB nanoparticles during laser
exposure impacts cells to transiently increase plasma membrane permeability. According
to this hypothesis, pre-treatment of CB nanoparticles in the absence of cells should have no
effect on cells added after the laser exposure. To test this hypothesis, we first exposed cells
at a mild laser condition (Fig. 3.5a, condition B) and found that there was no significant
change in viability or uptake compared to the sham control (Fig. 3.5a, condition A). In a
second experiment, we exposed CB nanoparticles (without cells) to a strong laser condition
and then added cells to this solution within 5 s after laser exposure. The resulting solution
was then exposed to laser condition B. This effect of CB nanoparticle laser pre-treatment
(Fig. 3.5a, condition C) had no effect on uptake or viability when compared with condition B
(Students t-test p = 0.26). This suggests that cells must be present during laser activation
of the CB nanoparticles, because the effects of the activation do not persist after laser
exposure.
We next performed an experiment to see if pre-conditioning cells would have an effect on
subsequent laser exposure. We first exposed cells to a mild laser condition, like before, which
had no significant effect on viability and minimal effect on uptake (Fig. 3.5b, condition B,
Students t-test p = 0.26 for viability and p = 0.003 for uptake) and subsequently exposed
cells to a moderate laser condition, which significantly increased uptake and decreased vi-
ability (Fig. 3.5b, condition D, Students t-test p = 0.041 for viability and p <0.001 for



























































Figure 3.4: Effect of beam diameter and pulsing frequency on intracellular uptake and
viability of DU145 cells. (a) Reducing the beam diameter from 21.4 mm (full cuvette) to
9 mm (16% of the cuvette surface area) resulted in lesser bioeffects, with higher viability
and lower uptake (44 mJ/cm2 fluence, 1 min exposure time, 10 Hz pulsing frequency). (b)
Increasing pulsing frequency from 0.1 Hz to 10 Hz while keeping number of pulses at 100
had no statistically significant effect on viability, while uptake was slightly higher at 0.1
Hz compared to 1 Hz and 10 Hz (44 mJ/cm2 fluence, 21.4 mm beam diameter). Asterisk
(*) and hash symbol (#) show statistically significant differences in uptake and viability,
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Figure 3.5: Effect of pretreatment and sequential laser exposures on intracellular uptake
and viability of DU145 cells. (a) Compared to sham treatment (A), there was no significant
effect of weak laser exposure of cells in the presence of CB nanoparticles (B). Very strong
laser exposure of CB nanoparticles (without cells) as a pretreatment followed by addition of
cells and weak laser exposure (C) was not significantly different from conditions (B) and (A)
in terms of uptake and viability. (b) The sequential combination of a strong laser exposure
and weak laser exposure (E) was statistically no different from the strong laser exposure
alone (D) and much greater than the weak laser exposure alone (B) in terms of uptake and
viability. (C) The sequential combination of two strong laser exposures with different laser
parameters (G) had lower viability but uptake was not statistically different from either
of the individual laser exposures alone (D, F). All laser exposures were at 10 Hz pulsing
frequency and 21.4 mm beam diameter. Asterisk (*) and hash symbol (#) show statistically
significant differences in uptake and viability, respectively (p <0.05). Data show average ±
SD (n = 3).
32
laser condition (thereby preconditioning them) and then exposing the cells to the mild laser
condition (Fig. 3.5b, condition E). However, there was no significant difference between
conditions D and E (Students t-test p = 0.61 and p = 0.6 for viability and uptake respec-
tively), indicating that pre-conditioning cells with a moderate exposure did not enhance the
effects of a mild exposure. While we examined only one of many possible preconditioning
scenarios, the data suggest that the effects of an initial exposure with significant bioeffects
do not make cells more susceptible to bioeffects from a subsequent sub-threshold exposure.
This is consistent with the observation made previously when testing the effects of puls-
ing frequency (Fig. 3.4b), which indicated that cells do not appear to have a memory of
previous exposures if the exposures are spaced by >100 ms.
Another combination of laser CB interaction was examined employing moderate laser
conditions. One exposure involved stronger fluence and shorter exposure time, while the
other exposure involved weaker fluence and longer exposure time. We found that each
condition by itself increased uptake and decreased viability (Fig. 3.5c, conditions D and F,
Students t-test p = 0.044 and p <0.001 for viability and uptake, respectively, for condition
F). The combination of applying condition D followed by condition F within 5 s led to
a significant decrease in viability (Students t-test p = 0.03) with no significant change in
uptake (Students t-test p = 0.53) (Fig. 3.5c, condition G). The viability in condition G
(i.e., 74%) was roughly the product of the viability in conditions D and F (88% x 87% =
76%), suggesting an additive, rather than a synergistic effect of this combination. The fact
that uptake did not increase further could be explained because the level of uptake was
statistically indistinguishable from the level of viability (Students t-test p = 0.23), meaning
that essentially all viable cells had uptake.
3.3.4 Effects of CB nanoparticle type and concentration on uptake and viabil-
ity
The proposed mechanism of molecular uptake into cells in this study involves laser en-
ergy absorption and transduction by carbon nanoparticles creating photo-acoustic effects.
Fig. 3.6 shows a comparison between India ink, another form of CB nanoparticle, and
CB nanoparticles used so far in this study at various concentrations under the same laser
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conditions. India ink includes CB nanoparticles as the main component along with other
components whose composition are insufficiently characterized [155, 156]. We determined
by dynamic light scattering, that the mean diameter of particles in India ink was 110 nm
(dispersity of 0.23), as compared to 189 nm (dispersity of 0.16) for the CB nanoparticle
aggregates. At each condition in the laser exposure experiments, the concentration of In-
dia ink particles was adjusted to have the same laser absorption as their CB nanoparticle
counterparts.
Considering the effect of nanoparticle concentration first, when CB nanoparticle concen-
tration was increased, keeping all other factors constant, the viability decreased (ANOVA,
p <0.0001), which resulted in a decrease of uptake as well (ANOVA, p <0.0001). Under all
the exposed conditions, the difference between uptake and viability was statistically non-
significant (Students t-test, p >0.05). When CB nanoparticles were replaced with India
ink particles, there was similarly a decrease in viability (ANOVA, p <0.0001), which again
resulted in a decrease in uptake (ANOVA, p <0.0001).
When the effects of the India ink and CB nanoparticles are compared, there is no
significant difference at low particle concentrations (Students t-test, p >0.05), but viability
and uptake are both lower in the India ink samples at the highest concentration (Students
t-test, p <0.05). Altogether, these results suggest that the specific chemistry of the CB
formulation is not as important as the concentration of CB nanoparticles.
3.3.5 Toxicity of CB nanoparticles
To assess possible toxic effects of the CB nanoparticles, an MTT assay was performed on
DU145 cells after exposure to CB nanoparticles at various concentrations for 24 h and 72 h.
MTT stains cells that are properly respiring, such that lack of staining is an indicator of cy-
totoxicity. Fig. 3.7 shows the absorbance values as a function of increasing CB nanoparticle
concentration. The data were normalized with respect to the CB nanoparticle-free control.
There was no significant difference between the absorbance values of the MTT assay at 24
h and 72 h (ANOVA, p = 0.39). Moreover, there was no significant loss of viability below






























Sham Sham        13.4  12.5 26.8    25            53.6    50           80.4    75 
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Figure 3.6: Effect of increasing India ink and CB nanoparticle concentration on intracel-
lular uptake and viability of DU145 cells. In each paired comparison, the concentration of
India ink and CB nanoparticles were adjusted so that the laser absorbance was the same.
Uptake and viability generally decreased with increasing nanoparticle concentration, and
India ink had stronger effects on uptake and viability than CB nanoparticles at the higher
concentrations. All laser exposures were at 44 mJ/cm2 fluence, 1 min exposure time, 10 Hz
pulsing frequency and 21.4 mm beam diameter. Asterisk (*) and hash symbol (#) show
statistically significant differences in uptake and viability, respectively (p <0.05). Data

































Figure 3.7: Toxicity of CB nanoparticles on DU 145 cells measured by MTT cytotoxicity
assay. Cells were exposed to CB nanoparticles for 24 h and 72 h, which yielded ED50
values of 350 mg/l and 360 mg/l, respectively. These values are ∼14 times higher than the
concentration (25 mg/l) used in most experiments in this study. Data show average ± SD
(n = 3).
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These data produce ED50 values of 360 mg/l for the 24 h data and 350 mg/l for the 72
hr data. For most experiments in this study, a CB nanoparticle concentration of 25 mg/l
was used, which is an order of magnitude lower than the ED50 value. Visual inspection of
cells incubated with high-concentration CB nanoparticles showed the particles coating the
cell surface (data not shown). This steric interaction, rather than a chemical interaction,
might have affected cell viability at the higher concentrations. The analysis indicates that
at the concentrations used in this study, there was no significant change to cell viability as
a result of extended exposure to CB nanoparticles.
3.3.6 Effects of cell type and molecular weight of uptake marker on uptake
and viability
In addition to DU145 prostate cancer cells, we also studied the effects of laser-activated
CB nanoparticles on H9c2 rat cardiomyoblasts. The experiments with these cells were
performed at exposures of 25 mJ/cm2 for 1 and 3 min, keeping all other parameters constant
(Fig. 3.9). When the performance of the two cell lines was compared, the viability was
statistically not different from each other (ANOVA, p = 0.94), but the uptake was lower
for H9c2 cells (ANOVA, p = 0.007). These data show that the effects of laser-activated CB
nanoparticles on cell uptake and viability are seen in multiple cell types.
The delivery efficiency was also characterized by varying the molecular weight of the
uptake markers. Calcein was replaced with FITC-labeled dextrans of molecular weights
10 kDa, 70 kDa and 500 kDa and exposed to laser at 44 mJ/cm2 for 1 min, keeping all
other parameters constant. There was no statistical difference between the viability of the
exposed samples (ANOVA, p = 0.92), whereas uptake decreased with increasing molecular
weight (ANOVA, p = 0.022).
3.3.7 Trade-off between maximizing uptake and maximizing viability
When mean values of cell viability are plotted against uptake (Fig. 3.10), all data points fall
below the viability = uptake line. This is because, being counted as an uptake cell requires
that the cell must be viable. Some points were at or just below the viability = uptake line,
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Figure 3.8: Comparison of intracellular uptake and viability of two cell lines (DU145 and
H9c2) after the same laser exposures. Cell viability was the same, whereas uptake after the
1 min exposure was significantly different between the two cell lines. All laser exposures
were at 25 mJ/cm2 fluence, 10 Hz pulsing frequency and 21.4 mm beam diameter. Asterisk


































Sham    Sham           1         1                 3          3
DU145   H9c2     DU145 H9c2       DU145 H9c2
* 
Viability Uptake 
Figure 3.9: Effect of molecular weight on intracellular uptake and viability after the same
laser exposures. There is no statistical difference in viability across all samples, whereas the
uptake decreased as the molecular weight was increased for calcein (Cal), 10 kDa dextran
(D10), 70 kDa dextran (D70) and 500 kDa dextran (D500). All laser exposures were at 44
mJ/cm2, 10 Hz and 21.4 mm beam diameter. Asterisk (*) shows statistically significant
difference in uptake (p <0.05). Data shows average ± SD (n = 3).
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100% uptake, although we did observe 88% uptake with close to 100% viability.
3.4 Discussion
This study was guided by the hypothesis that laser energy is absorbed by CB nanoparticles,
which transduce that energy into a form that transiently permeablizes cells, resulting in
intracellular uptake and possible loss of cell viability. Based on prior literature [5, 152, 157],
we further believe that the mechanism of energy transduction involves laser-CB nanoparticle
interactions leading to the sudden heating of the nanoparticles, which leads to generation of
acoustic emissions (i.e., pressure waves) caused by thermal expansion of the nanoparticles,
as well as possibly the vaporization of water and/or chemical reaction between water and
carbon (i.e., C (s) + H2O (l) → CO (g) + H2 (g)). Elucidating the details of this energy
transduction mechanism is beyond the scope of this study.
There should be two time scales associated with this process. The first time scale is that
of laser absorption by CB nanoparticles followed by pressure wave generation. The second
time scale is that of cell membrane permeablization, intracellular uptake and membrane
resealing. We expect that the time scale of the first step is at least nanoseconds (i.e., the
time scale of the laser pulse), but may be longer, given the time it may take to grow and
collapse gas bubbles, if they are involved in the mechanism [158]. The time scale associated
with intracellular uptake through permeablized membranes is likely much longer, given that
it involves transmembrane diffusion and cell membrane resealing mechanisms.
In general, we would expect that more energy transduction from laser irradiation to
acoustic emissions should increase bioeffects on cells. Thus, increased energy transduction
should be associated with both increased intracellular uptake as well as increased loss of cell
viability. Because of this, the goal for applications is to find conditions that optimize uptake
without significant loss of viability. The present study showed that increasing fluence and
number of laser pulses (i.e., time of irradiation), both increased energy input and, therefore,
increased energy output to cells. Increasing CB nanoparticle concentration increased the
number of acoustic sources and thereby increased energy output to cells without increasing

























Figure 3.10: Comparison between intracellular uptake and viability. This graph shows all
data generated in this study (i.e., from Figures 2 - 7). All data points are at or below the
uptake = viability line since there cannot be more cells with uptake than cells that are
viable.
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to increased uptake and loss of viability, depending on the details of the exposure conditions.
The optimal conditions found in this study involved, 18.75 mJ/cm2 laser fluence, 7 min
exposure of DU145 cells with 25 mg/l CB nanoparticle concentration, and thereby achieving
an intracellular delivery efficiency of 88% with 98% viability (Fig. 3.3a). There was no
significant effect on uptake or viability due to laser exposure alone (Fig. 3.1a), incubation
with CB nanoparticles alone (sham experiments), or pre-treatment of CB nanoparticles
with a strong laser exposure (Fig. 3.5a), which is also consistent with the mechanism
involving laser energy transduction by CB nanoparticles. Increasing laser fluence initially
increased uptake, but then the effects of increasing fluence saturated, which produced cells
with efficient uptake and little loss of viability (Fig. 3.2). In contrast, increasing the
duration of the laser exposure increased uptake until the point where it started killing cells
(Fig. 3.3b). This suggests that the effect of increasing the force applied to cells saturates
whereas increasing the time over which that force acts on the cells does not. This interesting
relationship is similar to previous observations in electroporation-mediated uptake, where
the effects of increasing voltage resulted in saturated uptake, but the effects of increasing
number or length of electrical pulses did not [159].
At the conditions used in this study, increasing the concentration of CB nanoparticles
increased bioeffects in the form of killing more cells. We did not see an increase in uptake,
because at the lower CB nanoparticle concentration used, almost all viable cells already had
uptake. Thus, we saw a decrease in uptake due to cell death. At the lowest CB nanoparticle
concentration studied (12.5 mg/l), the nanoparticle-to-cell ratio was approximately 100:1
whereas at the highest concentration (75 mg/l) it was approximately 600:1. In general, more
acoustic emission sites should produce more pressure waves impacting cells. However, the
details of this interpretation are complicated by constructive and destructive interference of
waves in the complex acoustic field. Uptake and viability did not depend strongly on pulsing
frequency of the laser (Fig. 3.4b). This suggests either that each pulse creates independent
effects on the cells, which would mean that the time scale for onset and reversal of the
direct bioeffects of the laser exposure is shorter than 100 ms (corresponding to pulsing at a
frequency of 10 Hz) or possibly that the time scale is much longer than 10 s (corresponding
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to pulsing at a frequency of 0.1 Hz), such that interacting effects of each pulse on the next
one(s) are not affected by changing their separation from 0.1 s to 10 s. Given the nanosecond
time scale of the laser exposure itself, we hypothesize that the first scenario above is the more
likely scenario, such that intracellular uptake and bioeffects that initiate loss of viability
occur on a time scale shorter than 100 ms. Our interpretation is further supported by the
data in Fig. 3.5b, which showed that pre-treatment of cells with a moderate laser condition
did not make them more susceptible to subsequent exposure to mild laser conditions a few
seconds later.
When CB nanoparticles were replaced by India ink at concentrations which had the
same laser absorbance, the India ink particles were yielded lower viability (Fig. 3.6), which
suggests a stronger mechanical effect on the cells. This may be because the nanoparticles in
India ink are smaller than CB nanoparticles, which means that for the same mass of carbon,
there was a larger number of India ink nanoparticles than CB nanoparticles. An alternative
explanation could be that the poorly characterized additional component particles found in
India ink might have effects on cells during laser exposure.
Molecules ranging from 0.6 kDa to 500 kDa were delivered into cells, but with decreased
efficiency at higher molecular weight. This could be explained by a pore size distribution
created in the cell membrane similar in size to that of the molecules, such that the larger
molecules were excluded, or at least hindered, by a fraction of the pores. The smallest
dextran (10 kDa) has a radius of approximately 2.7 nm and the largest dextran (500 kDa)
has a radius of approximately 15 nm [160], which suggests pores of similar size. Alterna-
tively, decreased uptake of the larger molecules could be explained by their slower diffusion
through short-lived membrane pores. According to the Stokes-Einstein equation, the 500
kDa dextran has a diffusivity 5.5 times smaller than the 10 kDa dextran.
Finally, we can consider future possible applications for targeted intracellular drug deliv-
ery guided by this studys findings. Flow cytometry analysis and MTT cytotoxicity analysis
suggested that the procedure was well tolerated by cells under the conditions of this study.
Similar bioeffects were seen in two cell lines, DU145 human prostate carcinoma cells and
H9c2 rat cardiomyocytes, suggesting the generality of the approach to multiple cell types.
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Uptake was also seen for molecules as big as 500 kDa dextran, although the uptake was
significantly reduced at higher molecular weight. Bioeffects were reduced by reducing the
beam diameter, which was interpreted to mean that bioeffects were only felt where the laser
was focused. This can enable targeting the effects to certain locations.
Altogether, these capabilities suggest an efficient method to load cells with molecules
at high cell viability, which can be used for in vitro laboratory applications for research
or, in the future after additional development, for in vivo drug delivery applications in
medicine. Some of the advantages of this approach are its relatively simple procedure, the
rapid timescale of delivery into cells and the localization of effects at the site of laser focus.
A concern is how the nanoparticles of sizes close to 200 nm will be cleared from the tissue
after the laser exposure. This approach is mechanistically similar to electroporation and
sonoporation, both of which are used clinically [161, 162], but differs in its ability to achieved
highly efficient intracellular delivery with high viability using a non-invasive method.
3.5 Conclusion
This study examined the use of nanosecond laser pulses in the presence of CB nanopar-
ticles to increase intracellular delivery of model compounds, calcein and dextrans, while
maintaining high cell viability. We believe that CB nanoparticles absorb the laser energy
and transduce it into acoustic outputs that transiently permeablize the cell membranes,
although the details of this mechanism are not explored in this study. We found that lower
fluence, with lower concentration of CB nanoparticles and longer exposure times resulted in
a gentler photo-acoustic environment that allowed uptake of molecules in up to 88% of cells
with no significant loss of cell viability. Increased fluence or CB nanoparticle concentration
were also able to yield high uptake but generally had more cell death. We conclude that the
method investigated in this work uses a straightforward protocol to enable efficient intra-
cellular delivery of molecules with high cell viability using nanosecond-pulse laser-activated
carbon nanoparticles for laboratory use and possible future in-vivo applications
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CHAPTER IV
POLOXAMER SURFACTANT PRESERVES CELL VIABILITY
DURING PHOTOACOUSTIC DELIVERY OF MOLECULES INTO
CELLS
Efficient intracellular delivery of molecules is needed to modulate cellular behavior for lab-
oratory and medical applications, but is often limited by trade-offs between achieving high
intracellular delivery and maintaining high cell viability. Here, we studied photoacoustic
delivery of molecules into cells by exposing DU145 human prostrate carcinoma cells to
nanosecond laser pulses in the presence of carbon black nanoparticles. Under strong laser
exposure conditions, less than 30% of cells were viable and exhibited uptake. Addition of
poloxamer surfactant at those laser exposure conditions increased cell viability to almost
90%, with intracellular uptake in >80% of cells. This remarkable increase in efficiency of
intracellular delivery and cell viability may be attributed to enhanced cell membrane re-
sealing by poloxamer surfactant after photoacoustic delivery. While F-68 poloxamer was
effective, the larger, more-hydrophobic F-127 poloxamer provided the best results. There
was no significant protective effect from addition of Ca2+, BAPTA-AM, ATP, fetal bovine
serum or glycine betaine, which were expected to promote active cell membrane repair
mechanisms and other active intracellular protective processes. We conclude that polox-
amer surfactant preserves cell viability during photoacoustic delivery of molecules into cells,
thereby enabling highly efficient intracellular delivery.
4.1 Introduction
With advances in medicine and pharmaceutical technologies, patient treatment options are
often limited not by the availability of an efficacious drug, but by the ability to deliver
the drug to its therapeutic target [2, 8, 163]. The ultimate target of many therapeutics
is inside cells, where the drug can alter cellular biochemistry and gene regulation [1, 164];
however, the cells plasma membrane regulates movement of molecules into cells and presents
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a difficult barrier to uptake of many therapeutics. Intracellular drug delivery is of recent
interest due to an increasing number of intracellular targets that have potential applications,
for example, in cancer and AIDS [165, 166]. Techniques that deliver drugs intracellularly can
be broadly classified into three categories; viral, non-viral biochemical and non-viral physical
methods [3]. While each method has advantages and disadvantages, physical methods, like
electroporation and sonoporation, are attractive because they are fast and can serve as
a platform for many types of molecules and cells, but they suffer from the drawback of
low efficiency because the physical force that is responsible for intracellular delivery is also
responsible for causing cellular damage, making a trade-off between maximizing intracellular
uptake and maximizing cell viability [49, 141, 167].
We recently introduced an intracellular delivery method involving laser-activated carbon
nanoparticles [108, 168]. The method involves exposing cells in a dilute suspension of
carbon black (CB) nanoparticles to nanosecond-pulsed laser. In previous studies, high
levels of intracellular uptake of molecules present during laser exposure were seen with
high viability. We hypothesize that laser irradiation of CB nanoparticles selectively heats
the nanoparticles, which results in particle expansion, liquid vaporization and/or chemical
reaction (C (s) + H2O (l) → CO (g) + H2 (g)), each of which generates acoustic pressure
waves that can interact with the cell membrane to transiently permeabilize it.
Using this approach, drug molecules can diffuse into cells, but if the membrane perme-
abilization is too severe, it can result in death of the cell. Extensive cell viability loss can
occur under strong laser fluence and/or long exposure times. The goal of this study is to
protect cells from irreversible damage associated with membrane permeabilization in order
to increase cell viability and thereby increase uptake efficiency as well.
The literature suggests a number of strategies to increase cell viability during photoa-
coustic delivery. In one approach, addition of poloxamer surfactants has been shown to
prevent cell death from mechanical insult [169]. For example, F-68 poloxamer has been
shown to prevent cells from dying in a gas sparge reactor [170], to promote drug delivery
into cells during electroporation [171] and to save muscle cells from death after high-voltage
electrical injury [172], and F-127 poloxamer has been shown to increase gene transfection
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and viability during ultrasound exposure [173]. Poloxamers used in this study consist of
hydrophilic ethylene oxide (EO) and hydrophobic propylene oxide (PO) blocks arranged in
a triblock structure with strings of EO monomers flanking a core of PO monomers [174,
175]. Poloxamers have been hypothesized to protect cells from shear-induced damage by
reducing cell-bubble interactions, increasing plasma membrane fluidity and resealing holes
in lipid bilayer membranes [171, 176]. Other approaches have addressed the effects of ele-
vated intracellular Ca2+ on cells, which has been shown to mediate cell death, especially by
apoptosis, after cell membrane permeabilization by acoustic cavitation and other physically
traumatic interventions [42, 177-180]. Previous studies showed that controlled addition
and/or chelation of Ca2+ could be used to modulate cell viability; Ca2+ chelation can be
accomplished using the well-known Ca2+ chelator BAPTA-AM [181]. We also hypothesize
that ATP, which provides cellular energy [182] and fetal bovine serum, which provides nu-
trients, growth factors and other protective compounds [183], could help protect cells from
lasting damage. Finally, glycine betaine (GB) has been shown to accumulate in cells with-
out causing osmotic stress [184] and protects the cells in two ways: as an osmoprotectant
by accumulating at high concentrations inside cells [185] and as a chemical chaperon [36],
which deteriorates protein aggregation and enhances renaturation after heat shock [186].
4.2 Materials and Methods
4.2.1 Cell Preparation
Human prostate carcinoma cells (DU145, American Type Culture Collection, Manassas,
VA) were cultured as monolayers in a humidified atmosphere of 95% air and 5% CO2 at
37◦C in RPMI-1640 medium (Cellgro, Herndon, VA), which was supplemented with 100
g/ml penicillin-streptomycin (Cellgro) and 10% (v/v) heat-inactivated fetal bovine serum
(FBS, Corning, Palo Alto, CA) in T-150 flasks (BD Falcon, Franklin Lakes, NJ). For each
experiment, cells at 80-90% confluence were harvested by trypsin/EDTA (Cellgro) diges-
tion, washed using fresh growth medium with FBS and re-suspended in RPMI at a cell
concentration of 106 cells/ml.
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4.2.2 Nanoparticle Preparation
To prepare the CB nanoparticle solution, 20 mg of CB (Black Pearls 470, Cabot, Boston,
MA) were added to 50 ml of 0.013% (v/v) Tween 80 (Sigma-Aldrich, St. Louis, MO;
added to reduce aggregation and settling of the nanoparticles) in DI water and sonicated
for at least 15 min to obtain the final CB solution at a concentration of 400 mg/l. The
size of the individual CB nanoparticles was 25 nm, but they were aggregated into larger
particles of 189.3 ± 1.5 nm (n = 3) diameter with a dispersity of 0.16 ± 0.03 (n = 3), as
determined from dynamic light scattering measurements. After making the 50 ml solution
of CB nanoparticles, it was aliquoted into smaller 1.5 ml samples. Consistency of samples
was determined by measuring the absorption spectra using a spectrophotometer (Synergy
H4, BioTek, Winooski, VT) and compared to predetermined standards.
4.2.3 Additive Preparation
BAPTA-AM (Sigma-Aldrich) is a cell-permeant Ca2+ chelator in live cells, effectively se-
questering Ca2+ from interacting with other molecules. For chelation experiments, a stock
solution containing 130 mM BAPTA-AM in dimethyl sulfoxide was added to cell solutions
immediately after the laser exposure to a final concentration of 260 µM at room temperature.
To increase the extracellular Ca2+ concentration, a stock 10 mM CaCl2 (Sigma-Aldrich)
solution in DI water was added at a final concentration of 200 µM before the laser exposure.
Adenosine triphosphate (ATP, Sigma-Aldrich) is the basic energy unit of eukaryotic cells
that directly provides cells with energy. ATP was added at a final concentration of 100
µM before laser exposure from a stock of 5 mM ATP in DI water. Glycine betaine (GB,
Life Extension, Ft. Lauderdale, FL) was used as a thermoprotectant in this study. A stock
of 50 ml of 100 g/l was prepared by adding GB powder to DI water. A volume of 50 µl
of the stock was added to the cells before exposure and cells were incubated for 30 min
at room temperature for internalization of GB into the cells. Pluronics F-68 and F-127
(BASF, Florham Park, NJ) were added to the cell suspension at 2%, 5% and 10% (v/v)
from a stock solution of 120 µM and 150 µM, respectively.
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4.2.4 Laser Apparatus
A Nd:YAG infrared laser (Powerlite II Plus, Continuum, Santa Clara, CA) was used to
apply pulses of 1064 nm wavelength, 5 - 9 ns pulse length, and 100 - 175 mJ energy per
pulse. Pulses were applied at a repetition rate of 10 Hz (i.e., 10 pulses per second). The
energy was varied by manipulating the amplifier voltage of the system. The beam was
passed through a Faraday isolator to prevent back reflection. The 12 mm-diameter laser
beam was passed through a 9 mm-diameter aperture to block the edges of the beam and
thereby obtain a more uniform top-hat profile. The resulting 9 mm-diameter beam was
then usually diverged to a 1.4 mm diameter using a lens to illuminate the entire cuvette
(exposure area of 4 cm2). Sham exposures were used as negative control experiments, where
solutions containing cells, calcein and CB nanoparticles went through all the same steps as
exposed samples (see below), except that the laser was not turned on. Another negative
control involved only cells without CB nanoparticles or calcein.
4.2.5 Sample Exposure
A volume of 520 µl of cells at a concentration of 106 cells per ml was suspended in RPMI,
transferred to 1.5 ml microcentrifuge tubes (Eppendorf, Hauppauge, NY) and stored on ice
until exposure. CB nanoparticle stock solution was added to achieve a final concentration
of 25 mg/l CB nanoparticles, unless otherwise noted. In some experiments different con-
centrations of CB nanoparticles were used. High purity calcein (Molecular Probes, Eugene,
OR) was used as an uptake marker and was added from a stock solution at a final concen-
tration of 10 µM. The final solution was mixed thoroughly by vortexing and then exposed
to laser in cuvettes (37-PX-2, Starna Cuvettes, Santa Clara CA) made from Pyrex glass.
The top part of the cuvette was cut at 2 mm from the base of the neck to facilitate transfer
of liquids. A total volume of 563 µl of the mixture was transferred to the cuvette using a
transfer pipette. The cuvette was placed in a custom-made stand to hold it during laser
exposure. The entire cuvette was exposed to laser pulses.
After laser exposure, cells were transferred back to microcentrifuge tubes and stored on
ice to reduce uptake due to endocytosis until all the samples were done. Propidium iodide
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(Invitrogen, Grand Island, NY) was added at a concentration of 7.5 µM and cells were
incubated for at least 10 min to label necrotic and late apoptotic cells. Next, cells were
centrifuged at 500 g for 6 min and washed with PBS (Cellgro) supplemented with 10% FBS
twice. After the third centrifugation, the cells were suspended in PBS and then transferred
to flow cytometer tubes or were put on microscope slides and cover slipped for microscopic
imaging.
4.2.6 Analysis and Quantification
A bench-top flow cytometer (BD LSRII, BD Biosciences, San Jose, CA) was used to quantify
uptake, i.e. the number of live cells with intracellular calcein, and viability, i.e. the number
of live cells that were not necrotic as determined by propidium iodide staining or fragmented,
on a cell-by-cell basis. For quantifying necrotic death, propidium iodide (PI) staining was
analyzed using a PerCP-Cy5, 670 nm longpass filter. Calcein uptake into cells was detected
using a FITC, 530/28 nm bandpass filter. A cell gate was constructed based on forward-
scattered and side-scattered light to determine the size distribution of cells in the control.
Any events lying within this gate were considered to be cells, whereas events smaller than
that were considered cells fragments or dead cells.
To determine the fraction of intact cells post-irradiation compared to sham (and thereby
account for possible cell loss due to fragmentation and necrotic death), we compared the
number of PI-negative cells detected within the gate for the exposed sample and the sham.
The flow cytometer was run for 90 s, which resulted in collection approximately 105 cell
events per sample (∼ 20% of the total cells present in each sample).
To account for spectral overlap between the dyes, compensation controls were run for
each experiment. Propidium iodide-positive samples were made by incubating cells in 70%
methanol for 30 min and then washing with PBS. Calcein-positive samples were made by
exposing cells with CB nanoparticles and calcein at 44 mJ/cm2 per shot for 7 min. At this
condition, there was extensive cell death, but almost all cells which remained viable had
calcein uptake.
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In some experiments, a bench-top cell sorter (BD Aria) was used to separate popula-
tions that were PI-positive, i.e. nonviable cells, from cells that were PI-negative. In these
experiments, at least 95% of the cellular solution was run through to get enough samples in
each population. After the two sorted population were collected in 15 ml centrifuge tubes,
they were centrifuged once at 500 g for 6 minutes to remove the flow cytometer sheath fluid
and re-suspended in 100 µl PBS. A drop of this solution was put on a slide cover-slipped
and imaged.
Cells were imaged using a fluorescence microscope using appropriate filters (Olympus
IX70, Olympus, Center Valley, PA). Cells were observed at 40x magnification to visually
inspect cellular uptake in viable cells.
4.2.7 Statistical Analysis
A minimum of three replicates was performed for all conditions. Replicates enabled calcula-
tion of means and standard deviation. The null hypothesis was that the average fraction of
cells with uptake (or average fraction of viable cells) between a treated sample and a sham
exposure were equal. To compare between mean values of two data points, an unpaired
Students t-test was performed (2 tails) assuming unequal variances using GraphPad Prism
6 (GraphPad Software, La Jolla, CA).
4.3 Results
4.3.1 Effect of Laser Exposure Conditions on Photoacoustic Delivery of Molecules
into Cells and Cell Viability
Previous studies have shown that exposure of cells in the presence of CB nanoparticles to
pulsed laser light can lead to intracellular uptake of molecules and loss of cell viability [108,
168]. In general, stronger laser exposure conditions (e.g., higher fluence, longer exposure
time) initially increase uptake, but then reduce uptake efficiency due to increased loss of cell
viability. The goal of this study is to protect cells from viability loss so that stronger laser
exposure conditions can be used to increase uptake further without associated cell death.
We therefore first identified laser exposure conditions that lead to good intracellular
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Figure 4.1: Effect of photoacoustic delivery using nanosecond-pulsed laser and CB nanopar-
ticles on uptake and viability of DU145 prostate cancer cells. (A) Percentage of cells re-
maining viable and exhibiting intracellular uptake of calcein is shown as a function of pho-
toacoustic exposure conditions, including laser fluence (mJ/cm2) and exposure time (min).
Representative flow cytometry scatter plots are shown for cells at the same six conditions
shown in part (A): (B) untreated cells (cells only), (C) cells exposed to CB nanoparticles
but no laser (sham), (D) cells exposed to laser (44 mJ/cm2, 7 min) but no CB nanopar-
ticles, and cells exposed to CB nanoparticles and laser at (E) 25 mJ/cm2, 1 min, (F) 25
mJ/cm2, 7 min and (G) 44 mJ/cm2, 3 min. The asterisk symbol (*) represents statistical
difference of viability between two samples (p <0.05) and hash symbol (#) signifies that
uptake and viability for a given sample are significantly different (p <0.05). Data show
average ± standard deviation (SD) with three replicates each (n = 3).
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for intracellular delivery of a model compound (calcein) into a model cell type (DU145
prostate cancer cells). When cells incubated with CB nanoparticles and calcein were not
exposed to laser (sham), there was minimal uptake (Students t-test, p = 0.04) and no
significant change in viability (Students t-test, p = 0.4). Cells exposed to high-fluence
laser (44 mJ/cm2 for 7 min) without CB nanoparticles similarly showed minimal uptake
(Students t-test, p = 0.04) compared to cells with no treatment and no significant loss of
viability compared to both sham and cells with no treatment (Students t-test, p >0.06 0.3)
This shows that exposure to laser alone or exposure to CB nanoparticles alone has little
effect on cells under the conditions used in this study.
When cells were exposed to laser (25 mJ/cm2, 1 min) and CB nanoparticles, 55%
of cells exhibited uptake of calcein (Students t-test, p <0.001), while viability did not
change significantly (Students t-test, p=0.4), which demonstrates the synergistic effect of
CB nanoparticles and laser exposure resulting in the uptake of calcein. When the exposure
time was increased to 7 min, while keeping the power constant at 25 mJ/cm2, the uptake
remained constant at 55%, but the viability went down to 63%, which was significantly lower
than the sham (Students t-test, p = 0.04). Because there was no statistically significant
difference between uptake and viability at this condition (Students t-test, p = 0.6), this
means that essentially all viable cells had uptake and that the barrier to still higher uptake
was preventing loss of viability (note that uptake in this study is expressed as a fraction of all
cells exposed to laser and not a fraction of just those remaining viable after laser exposure).
When we increased the laser fluence to a higher level (44 mJ/cm2) at an intermediate
exposure time (3 min), we observed even lower uptake of 27%, which was essentially equal
to the viability of 28%.
When the size distribution of the flow cytometry events recorded in cell samples are
plotted in terms of forward and side scatter (log values), we found that control cells with
no treatment displayed a tight distribution on the upper right corner, corresponding to
relatively large (high forward scatter) and textured (high side scatter) events (Fig. 4.1B).
There was almost no PI or calcein staining of events in this population (data not shown).








Figure 4.2: Cell sorting between two populations of cells seen after exposure to strong
photoacoustic conditions. (A) Representative flow cytometry scatter plot of cells exposed
to CB nanoparticles and laser at 44 mJ/cm2, 3 min. Fluorescence microscopy image shown
of representative cells from (B) the population with higher forward scatter (P1), exhibiting
green fluorescence from calcein uptake and (C) the population with lower forward scatter
(P2) exhibiting red fluorescence from PI staining. Scale bars are 20 µm.
(based on lack of PI staining) cells without calcein uptake (based on lack of calcein staining).
When sham control cells and cells exposed to laser without CB nanoparticles were
assessed (Figs. 4.1C and 4.1D), we found that these populations looked similar to cells
without any treatment (Fig. 4.1B). Cells exposed to laser at 25 mJ/cm2 for 1 min (which
caused little loss of viability, see Fig. 4.1A) also did not exhibit significant changes in the
scatter plot (Fig. 4.1E), with most of the cells PI-negative (intact, viable cells) and many
of the cells calcein positive (intact, viable cells with uptake) (data not shown).
In contrast, cells exposed to harsher laser conditions associated with significant cell
death resulted in visibly different scatter plots that included two populations (Figs. 4.1F
and 4.1G). The original population remained, with a few cells PI positive (intact, nonviable
cells) and most of the cells calcein positive (intact, viable cells with uptake) (Fig. 4.2B).
The other population had similar side scatter, but weaker forward scatter, indicating a
smaller size. These events all stained positive for PI, indicating that they were nonviable
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(Fig. 4.2C). We interpret the events in this new population as remnants of nonviable cells,
consistent with previous observations [42]. In conclusion, we interpret only those cells in
the population with higher forward-scatter and no PI staining as viable cells and only cells
in that population having calcein uptake with no PI staining as uptake cells. Most of
the nonviable cells were found in the lower forward-scatter population, corresponding to
PI-positive cell remnants (i.e., very few cells were PI-positive in the higher forward scatter
population or in the lost population of fragmented cells). The goal of this study is to prevent
cells from being part of the PI-positive, low-forward scatter population of nonviable cells
and instead retain them in the PI-negative, high-forward scatter population of viable cells.
4.3.2 Effect of Poloxamer Surfactants
To prevent the cell death seen at strong laser exposure conditions, we tested the hypothesis
that these strong laser conditions would lead to high levels of uptake if viability loss could
be prevented. We first tried adding poloxamer surfactants to cells during and after laser
exposure, because these nonionic triblock copolymers have been shown to protect cells
from mechanical damage associated with shear stresses and other physical forces, possibly
mediated by sealing leaky membranes or other interactions with the cell membrane [171,
176].
As a control experiment shown in Fig. 4.3A, we first incubated cells with three different
concentrations (2, 5, and 10% (v/v)) of the poloxamer Pluronic F-68 (i.e., F-68 sham) and
found that viability and uptake were unaffected compared to the untreated sham (Students
t-test, p >0.6). Cells were then exposed to the laser (25 mJ/cm2, 7 min) in the presence
of Pluronic F-68 at the same three concentrations, which resulted in somewhat higher
viability and uptake compared to cells exposed to the laser without Pluronic F-68, but these
differences were not statistically significant (Students t-test, p >0.1). Despite the lack of
significant effect of poloxamer at the conditions tested, we next chose a more powerful laser
exposure condition (44 mJ/cm2, 3 min), where we would normally kill about 75% of the
cells, and added the highest concentration of Pluronic F-68 (10% (v/v)), as shown in Fig.
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Figure 4.3: Effect of poloxamer surfactants on the viability and uptake of DU145 cells
when exposed to laser in the presence of CB nanoparticles. (A) Effect of F-68 poloxamer
at different concentrations (2%, 5%, 10% (v/v)) on cell viability and uptake with sham
or actual exposure to laser (25 mJ/cm2, 7 min). (B) Effect of F-68 poloxamer at 10%
(w/v) concentration on cell viability and uptake with sham or actual exposure to laser
(44 mJ/cm2, 3 min). (C) Effect of F-127 poloxamer at different concentrations (5%, 10%
(v/v)) on cell viability and uptake with sham or actual exposure to laser (44 mJ/cm2, 3
min). Representative flow cytometry scatter plots are shown for cells exposed to laser (44
mJ/cm2, 3 min) with (D) no poloxamer, (E) 10% (v/v) F-68 poloxamer (F) 5% (v/v) F-127
poloxamer, (G) 10% (v/v) F-127 poloxamer. The asterisk symbol (*) represents statistical
difference of viability between two samples (p <0.05) and hash symbol (#) signifies that
uptake and viability for a given sample are significantly different (p <0.05). Data show
average ± SD (n = 3).
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addition of the poloxamer. The laser-exposed samples with Pluronic F-68 had 55% of cells
viable and 52% of cells with intracellular uptake of calciein, compared to 28% viability and
27% uptake among cells exposed to the laser without the poloxamer (Students t-test, p =
0.02 for viability and p = 0.015 for uptake).
The reason why the poloxamer was able to increase cell viability at the more powerful
laser exposure condition (Fig. 4.3B), but not at the moderate laser exposure condition (Fig.
4.3A), may have a statistical explanation. Perhaps the bigger difference in viability between
sham cells and laser-exposed cells at the more powerful laser exposure condition provided a
larger dynamic range between the viability levels of the two control groups, which facilitated
establishing statistically significant differences from the controls due to the poloxamer.
Building off these results, we hypothesized that a different poloxamer, Pluronic F-127,
would provide still better protective effects because of its greater molecular weight and hy-
drophobicity [187], which might facilitate its interaction with cell membranes and sealing
of membrane pores. Consistent with this hypothesis, cells exposed to laser without polox-
amer had 28% viability and 27% uptake (Fig. 4.3C). Remarkably, the addition of F-127
poloxamer increased viability and uptake both to approximately 90%.
We can interpret this finding by examining scatter plots associated with these data.
Laser-exposed samples without poloxamer show the two characteristic populations, includ-
ing the intact cells on the right and the cell remnants on the left (Fig. 4.3D). The addition
of the less-effective F-68 poloxamer shifted some cells from the left population to the right
(Fig. 4.3E). Addition of the more-effective F-127 poloxamer shifted even more of the cells
to the right (Figs. 4.3F and 4.3G). This indicates that the addition of poloxamer protected
the cells from damage, thereby retaining them in the PI-negative, high-forward scatter pop-
ulation of viable cells and saving them from the PI-positive, low-forward scatter population
of nonviable cells.
4.3.3 Effect of Cell-Repair Mechanism Enhancers
We next tried to increase cell viability using chemicals that enhance active cellular repair
mechanisms. The approach was guided by previous studies of intracellular delivery by
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acoustic cavitation and other mechanical wounding of cells. This literature shows that after
making hole(s) in the cell membrane, (i) Ca2+ enters the cell, thereby signaling to the cell
that its plasma membrane has been breached, (ii) the cell undergoes active repair of the
plasma membrane using intracellular lipid vesicles and (iii) excessive and extended high
levels of intracellular Ca2+ can be toxic to the cell [42, 180].
We first addressed possible toxic effects due to elevated intracellular Ca2+ levels by
determining if addition of a Ca2+ chelating agent (i.e., BAPTA-AM) immediately after
laser exposure could reduce viability loss. As shown in Fig. 4.4A, a control experiment that
incubated cells with BAPTA-AM (i.e., BAPTA-AM sham) without laser exposure was no
different in terms of uptake and viability than the sham without BAPTA-AM (Students
t-test, p = 0.3 for both uptake and viability). To test our hypothesis, cells incubated with
BAPTA-AM immediately after laser exposure (25 mJ/cm2, 7 min), however, showed no
statistical difference from laser-exposed cells without BAPTA-AM in terms of viability or
uptake (Students t-test, p = 0.21 for both viability and uptake). This indicates that Ca2+
chelation immediately after laser exposure did not significantly affect viability or uptake.
Cell membrane resealing can be an energy-intensive process requiring active repair mech-
anisms by the cell [180]. For this reason, we hypothesized that addition of ATP during and
after laser exposure could facilitate membrane repair and thereby reduce cell death. Fig.
4.4B shows that in the control experiment, incubation with ATP by itself (i.e., ATP sham)
had no effect on viability or uptake compared to the sham without ATP (Students t-test, p
= 0.5 for viability and p = 0.4 for uptake). When cells were incubated with ATP during and
after laser exposure, however, these was no statistical change in viability or uptake relative
to sham (Students t-test, p = 0.92 for viability and p = 0.54 for uptake). This indicates
that addition of ATP did not protect the cells from viability loss.
Because Ca2+ can play a dual role of signaling the need for repair initially, but becoming
toxic later, we hypothesized that cell viability and uptake could be increased by the addition
of Ca2+ and ATP before and during laser exposure to promote plasma membrane repair
and addition of BAPTA-AM immediately after laser exposure to prevent toxic effects of
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Figure 4.4: Effect of treatment with various cell-repair mechanism enhancers on the viabil-
ity and uptake of DU145 cells when exposed to laser in the presence of CB nanoparticles.
(A) Effect of BAPTA-AM, an intracellular Ca2+ chelator, added before laser exposure. (B)
Effect of ATP, a source of cellular energy, added before laser exposure. (C) Effect of ATP
and CaCl2, which triggers plasma membrane repair mechanisms, added before laser expo-
sure and BAPTA-AM added after laser exposure. (D) Effect of FBS, a source of nutrients,
growth factors and protective compounds found, added before laser exposure. The aster-
isk symbol (*) represents statistical difference of viability between two samples (p <0.05)
and hash symbol (#) signifies that uptake and viability for a given sample are significantly
different (p <0.05). Data show average ± SD (n = 3).
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involving the sequential addition of Ca2+, ATP and BAPTA-AM without laser exposure
(CaCl2, ATP, BAPTA-AM sham) had no significant effect on viability or uptake compared
to the sham without these chemicals (Students t-test, p >0.4). To test our hypothesis, cells
exposed to laser and incubated with Ca2+, ATP and BAPTA-AM, however, showed no
statistical difference from laser-exposed cells without these chemicals in terms of viability
or uptake (Students t-test, p = 0.07 for viability and p = 0.66 for uptake). This indicates
that the combined use of Ca2+, ATP and BAPTA-AM did not significantly affect viability
or uptake.
Finally, we hypothesized that the addition of fetal bovine serum (FBS) immediately after
laser exposure might help stabilize cells during their recovery. Fig. 4.4E shows incubation in
FBS without laser exposure as a control experiment (i.e., FBS sham). In the laser-exposed
samples, however, the addition of FBS had no statistically different viability compared to
the laser-exposed samples without FBS (Students t-test, p = 0.42), but the uptake was
slightly lower in the samples with FBS (Students t-test, p = 0.05). This indicates that
addition of FBS after laser exposure did not significantly affect viability.
4.3.4 Effect of Glycine Betaine
Intracellular uptake in this study is mediated by laser irradiation of CB nanoparticles that
heats the nanoparticles and is believed to cause transient disruption of the cell membrane
[108, 168]. This could lead to cell damage from the heat, as well as from possible osmotic
effects associated with membrane permeabilization. These stresses could play a role in the
observed loss of cell viability. We therefore hypothesized that addition of GB to cells before
laser exposure could prevent cell death from these damaging effects, because GB is known
to protect cells and proteins against heat shock and osmotic damage [184, 186]. Fig. 4.5
shows that the GB sham was statistically no different than the sham without GB (Students
t-test, p = 0.5 for both viability and uptake). The samples exposed to laser with GB were
statistically no different than cells exposed to laser without GB (Students t-test, p = 0.31
for viability and p = 0.21 for uptake). Thus, the addition of GB during and after laser
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Figure 4.5: Effect of treatment with glycine betaine (GB) on the viability and uptake
of DU145 cells when exposed to laser in the presence of CB nanoparticles. The asterisk
symbol (*) represents statistical difference of viability between two samples (p <0.05) and
hash symbol (#) signifies that uptake and viability for a given sample are significantly
different (p <0.05). Data show average ± SD (n = 3).
61
4.4 Discussion
It is desirable to deliver molecules efficiently into cells without loss of viability. Intracellular
delivery methods are often limited by the trade-off between high uptake versus high viability.
Our previous work using photoacoustic delivery suffered from the same limitation [168]. The
goal of this study is, therefore, to protect cells from viability loss and thereby achieve both
high uptake and high viability.
Flow cytometry analysis indicated that nonviable cells were partially intact cell remnants
(Fig. 4.1), as opposed to fully fragmented cells. This is consistent with previous reports, for
example, after exposure to acoustic cavitation under conditions used to drive intracellular
uptake [50]. This is important, because it should be easier to protect a cell from damage
that leaves the cell structure largely intact than from damage that fragments the cell into
many pieces.
We found that poloxamers were able to protect cells from loss of viability. Previous
studies have hypothesized that poloxamers can be incorporated in the cell membrane [169,
188] to decrease membrane fluidity and thereby increase its resistance to shear in vitro
[173]. However, such a resistance to mechanical damage to the cell membrane would not
only protect cell viability, but would also be expected to decrease intracellular uptake, be-
cause the membrane would be less susceptible to poration. Others have hypothesized that
poloxamers could help seal leaky membranes by associating with the cell membrane surface
at sites of poration [189, 190] . This latter hypothesis would not interfere with membrane
pore formation, which is needed to increase intracellular uptake, but should help in mem-
brane resealing through membrane-poloxamer interaction, thereby increasing cell viability.
Poloxamers have previously been shown to increase cell viability after electroporation [171,
172], where pore resealing is thermodynamically driven largely on the sub-second time scale,
without the need for active cellular processes [191].
The ability of the F-127 poloxamer to protect cells more effectively than the F-68 polox-
amer can be attributed to difference hydrophobic and hydrophilic balances of the poly-
mers [170]. F-68 has the structure (EO)75-(PO)30-(EO)75 and F-127 has the structure
(EO)100-(PO)65-(EO)100, where EO represents the hydrophilic ethylene oxide monomers,
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PO represents the hydrophobic propylene oxide monomers, and the numbers represent the
number of monomeric units in each block of the triblock copolymers [174, 175]. Based on
the ratio of EO and PO, F-127 is more hydrophobic than F-68 and has more interaction
sites to incorporate in the membrane. F-127 also has a longer chain, which gives it a better
chance of plugging a bigger hole, which may result in greater success in saving cells.
Other methods that we studied to protect cells were not effective. The use of techniques
involving Ca2+, BAPTA-AM, ATP and FBS were hypothesized to protect cells by pro-
moting cell membrane resealing by active mechanisms known to occur after cell membrane
disruption by other mechanisms [42, 180], but they did not show significant effects in this
study. In our previous study [168], the data suggested that membrane disruption associ-
ated with intracellular delivery and cell viability was repaired within 100 ms after firing of
the laser. This suggests that the events leading to loss of cell viability occur during this
time scale, which may explain why methods to improve active cell-repair mechanisms were
unsuccessful, since active cell repair of cell membrane breaches has been reported to occur
on a time scale of minutes [42, 180].
GB, which is known to protect cells against heat shock and osmotic effects [184, 186],
also did not have significant protective effects on cells in this study. We expect that GB
was able to reach its sites of action inside cells [192], because it is a small molecule (MW =
117 Da) that should have been taken up efficiently during the laser exposure, if not during
the incubation period. It may be that the active intracellular processes influenced by GBs
protective response to heat shock and other insults are not relevant to protection against
photoacoustic cell viability loss in this study.
The finding that photoacoustic delivery combined with poloxamer surfactant can yield
efficient intracellular delivery is significant. The combination overcomes the common trade-
off between increasing intracellular uptake versus preserving cell viability. The use of polox-
amer enables stronger photoacoustic conditions to be used in order to increase uptake while
still maintaining cell viability. Moreover, the fact that poloxamer is the protective additive
is also fortunate, as a various of different poloxamers, including F-127, are used in approved
pharmaceutical formulations [187], which facilitates possible future uses of photoacoustic
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delivery with poloxamer surfactant in medical applications.
4.5 Conclusion
Photoacoustic delivery into cells using laser-activated CB nanoparticles has the potential to
be an efficient method for intracellular delivery of bioactive molecules. This study showed
that loss of cell viability could be reversed by addition of poloxamer surfactant during pho-
toacoustic exposure. More specifically, addition of 10% (v/v) F-127 poloxamer increased
viability from less than 30% to more than 90%, which similarly increased uptake to occur in
more than 90% of cells. In this way, photoacoustic delivery combined with poloxamer surfac-
tant enabled very efficient uptake into viable cells. In contrast, the addition of BAPTA-AM,
Ca2+, ATP, FBS or GB did not protect cells from loss of viability, suggesting that active
cell membrane repair mechanisms or other active intracellular protective processes that
these compounds mediate may not be responsible for protecting cells against damage from
photoacoustic delivery. In conclusion, efficient intracellular delivery of molecules can be
achieved by photoacoustic delivery using laser-activated CB nanoparticles in combination
with F-127 poloxamer surfactant.
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CHAPTER V
MECHANISM OF ENERGY TRANSFER FROM LASER TO
NANOPARTICLE TO FLUID MEDIUM TO CELL
Previously we have shown efficient intracellular drug delivery as result of laser irradiation
of carbon black (CB) nanoparticles. In this study we try to understand the underlying
mechanism of energy transduction from the laser to the final cell membrane breach. We
hypothesize that the laser heats the nanoparticles leading to thermal expansion, vapor
bubble formation and/ or chemical reaction which results in the production of acoustic
waves. Then all of these phenomena interact with the membrane to cause drug delivery.
Through experiments we go step by step to prove and disprove parts of this hypothesis. We
find that at 44 mJ/cm2, the particle temperature can go as high as 1000◦C and there is
probably no reaction occurring at the given conditions. The reason for drug delivery might
actually be because of vapor cell interaction.
5.1 Introduction
Many infections are intracellular in nature and often require drugs to be delivered into
the cells. Unfortunately delivering drugs into the cells is a huge challenge because of the
presence of a highly structured lipophilic cell membrane; existence of P-glycoproteins which
efflux the drugs out [193]; the occurrence of degradative enzymes, and the development of
endosomes which are highly acidic [17] and which degrade xenobiotics that are endocytised
into the cells. Thus very highly specialized systems capable of overcoming these barriers
can achieve successful intracellular drug delivery. Currently, a variety of techniques exist to
deliver drugs into cells, each with some sort of drawback.
Many of the techniques are based on mimicking natural processes that are known to
breach the cell membrane, such as the use of lipophilic molecules which passively diffuse
through the cell membrane [194], or taking advantage of the endocytotic pathway by using
receptor-targeted ligands on nanoparticles [195]. However such systems have a slow rate of
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uptake, and there are toxicity issues associated with the process. Viral systems which are
naturally known to penetrate the cell membrane are useful for delivery of DNA but also
suffer from the virus induced cyto-toxicity [139].
Another class of intracellular drug delivery methods relies on physically disrupting the
membrane using a physical force and achieving delivery of molecules by either passive
diffusion or in some cases, though electrophoretic mobility of charged molecules through
short lived pores [39]. Some examples of this kind of technique include electroporation [140],
ultrasound mediated intracellular drug delivery [49, 142] and microinjection [143]. Laser-
based methods have been used for some intracellular drug delivery applications, including
heating nanoparticles to either cause cell membrane disruptions [146-150] or cell death [151].
They have also been used to generate pressure waves from shock tubes to induce uptake
by mechanical mechanisms [144, 145]. The primary challenge associated with any of these
methods is the achievement of high uptake rates while maintaining high cell viability, since
the physical force creating transient pores also causes cell death if not carefully controlled.
An alternative technique employing nanosecond laser irradiation of carbon black (CB)
nanoparticles in solution with cells demonstrated high uptake of calcein with high viability
[196]. The belief was that the laser-CB interaction caused temporary disruption of the cell
membrane, leading to uptake of molecules. This technique showed promise of delivering
even bigger molecules like mRNA, proteins and SiRNA, but the specific permeabilization
mechanisms were not understood. We hypothesize a four step process: first, a portion
of the incident laser energy is absorbed by nanoparticles, which raises their temperature;
second, the heated nanoparticles expand in size and transfer heat to the surrounding liquid,
which vaporizes the liquid and possibly drives chemical reaction; third, nanoparticle and
bubble expansion generate acoustic emissions and finally, the energy from the heated and
expanded nanoparticles and surrounding bubbles is transferred to the cell membrane, which
transiently increases its permeability. In the present paper, we primarily address the first
three parts of the hypothesis. We will also touch on the possible causes of membrane
disruption, but the nature of cell membrane structural re-organization under mechanical

























Figure 5.1: A schematics of laser carbon interaction and drug delivery. The nanosecond
laser heats the carbon black (CB) nanoparticles and heats them, producing a pressure wave
along with a vapor bubble. This leads to intracellular drug delivery of calcein.
addressed in other contexts before [55].
5.2 Materials and Methods
5.2.1 Laser Apparatus
A Nd:YAG nanosecond (Surelite III, Continuum, Santa Clara, CA) was used to irradiate
samples. The pulse duration was 5 - 7 ns operated either in the single shot mode or in the
continuous mode at a pulse repetition rate of 10 Hz for exposure times of 1 - 60 min (i.e.,
600 - 36000 pulses). Laser fluence was varied between 18.75 - 446 mJ/cm2 per shot. The
fluence was varied by manipulating the Q-switching time internally and using polarizable
quarter plates (Thorlabs, Newton, NJ) externally. The laser beam (8 mm diameter) was
passed through a 3 mm pinhole to achieve a more uniform laser energy profile by only
allowing the central portion of the beam to pass. The beam was then either used directly
in acoustic measurements or diverged using a convex lens to a final diameter of 21.4 mm
for cell-exposure experiments. Measurements with a pyroelectric laser sensor (see below)
indicated a variation of less than 1% in laser intensity across the beam profile.
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5.2.2 Nanoparticle Preparation
Carbon black (CB) nanoparticles (Black Pearls 470, Cabot Corporation, Alpharetta, GA)
were dispersed in DI water at a concentration of 0.4 g/l using a needle sonicator (Sonics
& Materials, Newtown, CT) for 5 min. A black-colored aqueous dispersion was obtained,
whose absorption spectrum was measured using a spectrophotometer (Synergy H4, BioTek,
Winooski, VT). Each time a solution was made, the absorption spectrum was compared to
a reference spectrum to maintain consistent sample preparation. The CB nanoparticle stock
solution was then either diluted using DI water to a concentration of 25 - 400 mg/l or added
to a cell suspension solution (see below) to a final concentration of 12.5 - 75 mg/l. In some
cases, the CB nanoparticles were dispersed in pure acetic acid (Sigma-Aldrich, St. Louis,
MO) instead of DI water. We found that the absorption spectrum remained essentially
unchanged when compared with DI water, as long as the CB nanoparticle concentration
was held constant (data not shown).
Gold nanorods (Nanopartz, Loveland, CO), which are engineered to absorb 1064 nm
wavelength light, were diluted using DI water to 6% (v/v) from an initial stock solution of
optical density (OD) 1.1. The gold nanorods measured 168 nm in length and 25 nm in diam-
eter, according to the manufacturers specifications. An iron oxide nanoparticle suspension
in water at an initial concentration of 5 g/l and a mean size of 5 nm (Sigma-Aldrich) was
diluted (6% v/v) to a final concentration of 0.3 g/l. Carbon nanotubes (Nanostructured
& Amorphous Materials, Houston, TX), in the form of single-walled carbon nanotubes
(SWCNT) or multi-walled carbon nanotubes (MWCNT), were diluted in DI water from an
initial stock solution of 30 g/l to achieve the same absorption spectrum as a CB nanoparticle
solution at a concentration of 0.4 g/l. The resulting SWCNT and MWCNT solutions had
concentrations of 1.1 g/l and 0.4 g/l, respectively. The length and diameter of SWCNT
were 5 - 30 µm and 1 - 2 nm, respectively, and the length and diameter of MWCNT were
10 - 30 µm and 20 - 30 nm, respectively, as reported by the manufacturer.
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5.2.3 Cell Preparation, Exposure and Imaging
Human prostate carcinoma cells (DU145, American Type Culture Collection, Manassas,
VA) were cultured as monolayers in a humidified atmosphere of 95% air and 5% CO2 at
37◦C in RPMI-1640 medium (Cellgro, Herndon, VA), which was supplemented with 100
g/ml penicillin-streptomycin (Cellgro) and 10% (v/v) heat inactivated FBS (Corning, Palo
Alto, CA) in T-150 flasks (BD Falcon, Franklin Lakes, NJ). For each experiment, cells
at 80-90% confluence were harvested by trypsin/EDTA (Cellgro) digestion, washed using
fresh growth medium with FBS and re-suspended in RPMI at a cell concentration of ∼106
cells/ml.
A volume of 520 µl of cells was transferred to 1.5 ml microcentrifuge tubes and stored on
ice until exposure. CB nanoparticle stock solution was added to achieve a final concentration
of ranging from 25 - 75 mg/l CB nanoparticles. High purity calcein (Molecular Probes,
Eugene, OR) was used as an uptake marker and was added from a stock solution at a final
concentration of 10 µM. The final solution was mixed thoroughly by vortexing and then
exposed to laser in cuvettes (37-PX-2, Starna Cuvettes, Santa Clara CA) made from Pyrex
glass. The top part of the cuvette was cut at 2 mm from the base of the neck to facilitate
transfer of liquids. A total volume of 563 µl of the mixture was transferred to the cuvette
using a transfer pipette. The cuvette was placed in a holder stand to keep it stationary
during laser exposure. The entire cuvette was exposed to laser fluences ranging from 25 -
200 mJ/cm2 for 1 minute.
After laser exposure, cells were transferred back to microcentrifuge tubes and stored on
ice to reduce uptake due to endocytosis until all the samples were done. Cells were then
centrifuged at 500 g for 6 min and washed with PBS (Cellgro) supplemented with 10%
FBS twice. After the third centrifugation, the cells were suspended in PBS and then were
put on a microscope slides and cover slipped for fluorescence imaging using a fluorescent
microscope (Olympus IX70, Olympus, Center Valley, PA) using appropriate filters.
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5.2.4 Transmittance Measurements
Nanoparticle solutions at appropriate concentrations were placed in the starna cuvettes and
exposed to the laser. A pyroelectric laser sensor (Ophir-Spiricon, LLC, North Logan, UT)
with appropriate power rating connected to a power meter (Ophir Nova II, Ophir-Spiricon),
was placed in front to measure the energy coming into the system. Then the power sensor
was quickly moved to the back of the cuvette to measure the energy transmitted through
the cuvette. The cuvette with DI water was used as a control. The difference between in
and out energy gave the approximate extinction in the cuvette.
5.2.5 Acoustic Measurements
Parametric assessments of acoustic output from laser-irradiated nanoparticle solutions were
carried out using an irradiated stream experiment. An overview of the arrangement of
the system for acoustic measurement can be found in supplementary information. Briefly,
nanoparticle suspensions were loaded in a 30 ml (BD Falcon) syringe which was connected to
a 23 G blunt needle (Brico Medical Supplies, Inc., Dayton, NJ) via a tube extender (Baxter,
Deerfield, IL). The blunt needle was held submerged in a bracket inside a 37 l glass-walled
water-filled tank. The nanoparticle suspension was injected at a known volumetric flow
rate of 85 ml/h using a syringe pump (New Era Pump Systems, Inc., Farmingdale, NY),
creating a stable particulate stream. Using a stream surrounded by a relatively large water
body eliminated possible artifacts associated with compact sample containers, minimized
observational effects over relevant timescales by physically separating the radiating volume
from large-scale environmental boundaries (walls and free surface), and also provided a
simple method for acquiring statistics on large quantities of suspensions of a particular
composition.
Acoustic pressures were measured using a needle hydrophone (HNC-0200, ONDA Corp.,
Sunnyvale, CA), chosen for its broad response bandwidth, small scattering cross section, and
small receiving aperture that minimizes field integration of wave fronts that are not planar
or incident normally to the sensitive aperture. The hydrophone was mounted to a moving
x-y stage so that the position of the hydrophone could be changed relative to the stream.
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The position of the hydrophone relative to the stream needle tip was determined using data
collected from a focused ultrasound transducer (Panametrics V310-SU, Olympus) and pulser
receiver (Panametrics 5072PR, Olympus). Positions were calculated from cross-correlation
of scattered signals from the needle tip and hydrophone tip, needle dimensions, and the
speed of sound at the water-bath temperature. Stream acoustic output measurements were
typically made at with a 5 mm lateral separation between the hydrophone tip and needle
center, but varied between 2 and 10 mm.
Stream acoustic output and positioning transducer data were collected with a 100 MHz
digitizer (Cleverscope CS320A, Cleverscope Ltd, Auckland, New Zealand) triggered by a
sync pulse from the laser. Background sound levels were continuously monitored and ex-
periments halted when the tank water, incrementally seeded with dilute nanoparticles,
generates measureable acoustic output when irradiated without stream flow. Experiments
were recorded with a video camera zoomed (Canon EOS 60D, Canon USA Inc., Melville,
NY) in on the stream and needle nozzle, allowing post-test estimation of stream dimensions
using the needle diameter for reference.
5.2.6 Temperature Measurement
A custom made cuvette made using a rubber gasket between 2 calcium fluoride crystal
windows of 1” diameter (Thorlabs), was used to hold the CB suspension for laser exposure.
The hole is made in the rubber gasket to let fluid into the space between two windows. The
final volume was about 550 µl, which was very similar to the Starna cuvettes. An IR Camera
(IRC 900, IRCameras, Santa Barbara, CA) was used to measure the temperature rise in the
cuvette. The optical window of the cuvette was designed for optimum transmission from
600 nm to 10 µm, beneficial for both the laser and IR camera. The cuvette, being about 5
mm thick, made them a very good thermal insulator, thus there is little heat loss from the
system while heating the laser occurs resulting in a more accurate measurement. A total of
500 µl of CB nanoparticles suspended in DI water at a final concentration of 25 mg/l or 50
mg/l were pipetted in. The system was exposed to laser pulses for 7 minutes at either 25
or 44 mJ/cm2 for 7 minutes. Photon counts emitted from the cuvette were recorded using
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the IR camera during the laser exposure and for another 7 minutes after laser exposure
to measure the system cooling. The photon count was later converted to temperature by
calibrating against a standard J-type thermocouple.
5.3 Results and Discussion
5.3.1 Intracellular Drug Delivery
Previously [152, 168], intracellular drug delivery was achieved with high viability and effi-
ciency when CB suspension was exposed to low fluence laser pulses in the presence of DU145
cells. The study also demonstrated that the uptake was in the entire cytosol and not just the
vesicles or membranes suggesting a membrane breach. Under the optimal condition about
90% uptake was observed with almost no loss of viability. Small molecules had significantly
higher delivery than bigger macromolecules like dextran. This suggests that the system
creates either small or extremely short lived pores. Fig. 5.2a demonstrates that both laser
and CB has to be present if there is to be statistically significant uptake of calcein. The
calcein has to be added before the exposure, and adding it after does not result in significant
delivery, which indicates that the uptake process is short-lived. From Fig 5.2b it can be
observed that as the laser fluence is increased the uptake (green cells) first goes up and then
it saturates, whereas when the CB concentration is increased (Fig. 5.2c), the uptake first
goes up and then it goes down. In other words, the laser fluence does not have additional
effect whereas when CB concentration has a continual effect and it never saturates in the
range of parameters tested. Increasing either the fluence or the CB concentration should,
in theory, increase the bioeffects because or more/ stronger interaction between the CB and
the laser. In fact, what we see in terms of uptake is the effect of fluence saturates beyond a
point whereas the effect of CB concentration does not, meaning first there is more uptake
and then less uptake because more cells die so effectively the uptake gets lower. In order to
investigate this, we decided to look at the process in a step by step manner, the first being
the laser absorption by CB and heating, followed by the transduction of that energy into
pressure and then finally its impact on the cells.
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Figure 5.2: Fluorescence imaging of intracellular uptake of calcein in DU145 cells. Both
laser and carbon black are necessary for significant uptake of calcein under the conditions
tested and calcein should be added before the exposure for delivery to be efficient (a). With
increasing concentration of CB the uptake initially increases but after a certain concentra-
tion of CB, the uptake falls (b). Calcein uptake initially goes up and then it saturates as
the fluence of the laser is increased (c). Scale bars are 100 µm.
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5.3.2 Light Absorption and Heating
A spectrophotometer was used to measure the extinction of light by the CB suspension.
In the spectrophotometer the highest wavelength achieved was 999 nm, but we believe
that the absorption does not change much between 999 nm and 1064 nm based on the
previous data from CB absorption spectra [196]. Fig. 5.3a shows that the extinction goes
up linearly with concentration (ANOVA, p <0.05). The CB absorbs more in the in the UV
region (300 nm) and less at IR region (999 nm) when the concentration is held constant.
Another way to measure the extinction by CB suspension was to use laser power meter
to measure the energy coming into the suspension and the amount that is transmitted.
The difference between the two should be the amount of energy absorbed and scattered
(collectively called extinction). It was found (fig 5.3b) that the extinction of nanosecond
laser went up with concentration and it was higher compared to other nanoparticles like iron
oxide or gold at the same volume fraction (Student’s t-test, p <0.05), which indicated the
CB has a greater extinction capability than other nanoparticles on a volume basis. Since
in this study we are primarily interested in the heating of the nanoparticles by the laser
light, we concentrate on finding the fraction of light energy that was absorbed. Mie theory,
which has been previously used extensively to predict the absorption and scattering areas by
solving the Maxwells equations for scattering by a spherical entity [197], was used to predict
the scattering and absorption by CB particles. Mie theory was modified, as suggested by
previous literature [198] to accommodate for particle aggregation in CB suspension. CB
aggregates had a mean diameter of 200 nm determined by DLS (see SI), made up of smaller
25 nm spherules. Assuming that the aggregate was spherical it was calculated that there
were 133 spherules per aggregate. Scattering and absorption efficiency of these spherules
were calculated using Mie theory. The scattering of the total aggregate was summation
of the squares of individual areas and absorption was a linear summation of individual
spherule absorption areas. Once the total scattering and absorption areas were found, the
total energy absorbed was calculated by scaling by the laser fluence. The refractive index of
CB played a vital role in determining the absorption and scattering. A refractive index of
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Figure 5.3: Absorption of IR light by CB nanoparticles using two different techniques.
Absorption of light increases linearly when CB concentration is increased at different wave-
lengths of light when measured using a spectrophotometer (a). Absorption of IR nanosecond
laser using power meter shows increase in absorption of laser when the concentration of CB
is increased (b). Data show average ± standard deviation (SD) (n = 3 replicates).
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was calculated from Mie theory was about 6.7% which was in good agreement with the
value measured in Fig. 5.3b, which was about 7%. From Mie theory it was also calculated
that about 5.8% out of the 6.7% was absorbed and the rest to be scattered. For a fluence
of 44 mJ/cm2/pulse over an area of 4 cm2, the total energy absorbed by the nanoparticles
was found to be 10.15 mJ/pulse.
Another way to determine the total absorption was to first determine the bulk rise of
temperature of the CB suspension. Assuming that: i) the particle gets heated to the same
temperature every pulse; ii) all the heat that goes into the nanoparticle eventually goes into





= Q̇w,l + Q̇p,l + Q̇cuvette − Q̇cooling (5.1)
Q̇cooling = −h∗A(Tamb − T ) = −bmwCpw(Tamb − T ) (5.2)
Solving for T, we get,
T − Ti = (
˙Qtot
bmwCpw





, Q̇tot = Q̇w,l + Q̇p,l + Q̇cuvette (5.4)
Q̇tot is the total heat absorbed by the system and is assumed to be constant per pulse, T is
the bulk temperature, Ti is the initial bulk temperature, h is the heat transfer coefficient,
mw is the mass of water, Cpw is the specific heat of water, Tamb is the ambient temperature,
A is the surface area of the cuvette. If we subtract the total heat absorbed by the water
alone from the water with CB nanoparticles we can get the amount of heat absorbed by the
nanoparticles. The timescale for the system to reach equilibrium (L2/4*αw = 75 µs), where
L is inter-particle distance (= 4µm, for 25 mg/l CB concentration) and αw is the thermal
diffusivity of water, is much less than the time between the pulses (=100 ms). This means
that the system has enough time to reach equilibrium before the next pulse comes in. Fig.
5.4 shows the experimental data (the markers) and the modeled system (the lines). For a




Figure 5.4: Bulk temperature rise measured using an IR camera of a CB suspension at
two different concentrations (12.5 and 25 mg/l) and two different laser fluences (25 and 44
mJ/cm2). The temperature rise was lower when CB suspensions were replaced with pure
DI water. Higher temperature rise resulted when either the fluence or the CB concentration
was increased. The solid lines were the modeled temperature rise.
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pulse by the nanoparticles was about 2.75 mJ/pulse. This value was significantly lower than
what was calculated from Mie theory or power meter measurements. One of the reasons
for the value to be lower might be because a part of the energy is going towards reaction,
vaporization and/or pressure generation. These energy losses do not contribute to the bulk
rise of the temperature and therefore dont appear in this analysis because potentially they
escape the system.
5.3.3 Heating Timescale, Particle Temperature, Bubble Formation and Reac-
tion
The laser pulse is in the order of 10 ns, which given the aggregrate diameter of 200 nm, is
sufficient time to heat the nanoparticle uniformly. The characteristic timescale for heating
the particle is R2/4*α = 0.011 ns, where R is the radius of the aggregate and α is the
thermal diffusivity of CB, and is seen to be much lower than the pulse length, pl (=10 ns).
Moreover, the parameter Rλ <1, where λ (=10,000 cm-1 [157]) is the absorption coefficient
of CB at 1064 nm wavelength, which means that a considerable amount of laser reaches
areas of the CB particles far away from the incident beam side. Since we know how much
energy got absorbed by the CB nanoparticles (from Mie theory), assuming all the energy
went to heating the nanoparticle and there was no loss of heat to the surroundings during
the heating process, the peak particle temperature can be calculated from basic calorimetry
to be close to 1000◦C (see SI) for 44 mJ/cm2 fluence and 25 mg/l CB concentration. This
is expected to occur on the order of tens of nanoseconds, i.e. in the order of the duration
of pulse, because the heating timescale is much shorter than pulse length. The maximum
temperature is much less than the melting point of CB, so we can assume that there is no
melting of CB itself under these conditions.
Since the particle temperature goes beyond 100◦C we would expect some of the sur-
rounding liquid water to convert to vapor, leading to formation of bubble. The maximum
bubble radius can be achieved if we assume that the final bubble formed is at 100◦C so
that no there is no loss of heat, causing the water vapor to superheat (according to our
calculation decrease in density therefore more volume because of superheating steam is less
important than creating more steam at 100◦C). From this the maximum radius achieved is
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around 762 nm. Another way to measure the bubble radius is to assume that the difference
in energies calculated with the Mie and IR camera methods goes to vaporization. From
those calculations the value comes out to be 645 nm. In either case the size of the bubble
is less than 1 µm. Assuming an uniform distribution, the interparticle distance at a CB
concentration of 25 mg/l is about 4 µm and particle cell distance is in the similar whereas
intercellular distance is about 20 µm at a concentrations of 106 per ml used in this study
(See SI). Under these circumstances, only the bubbles formed in the vicinity of the cell can
interact with the cell membrane making the CB particles very close to the cell relevant if
vapor plays a role in the membrane disruption.
Because the nanoparticles are extremely small, they have a very high surface to volume
ratio, and hence have a very high heat transfer coefficient. Assuming that there is no heat
transfer to the surroundings during the nanoparticle heating may be overly simplistic. A
more realistic situation is for heat transfer to the surroundings to occur while the laser is
heating the nanoparticle. The maximum heat transfer can occur if we assume that the
bulk temperature initially stays constant at 23◦C, but when the particle temperature goes
beyond 100◦C, the water instantly converts to vapor at 100◦C and stays that way. It was
found that the particle temperature goes beyond 100◦C within the first two nanoseconds
of heating and there is significant heat loss during that phase from the particle to the
surrounding but once the there is a vapor shell formed around the particle, it acts as a
thermal insulator and then the particle can reach extremely high temperature. Under those
conditions the particle temperature goes to about 1000◦C after 10 ns of heating. This is
basically the same as predicted by no heat transfer; this might be because the heating time
scales are too fast. This is further elucidated by the fact that the characteristic timescale
for heat transfer to the surrounding, R2/4*αw, is 175 ns, where R is radius and αw is the
thermal diffusivity of water, which is much longer than the pulse duration. Hence, there is
little to none heat conduction during the heating of particle which lasts only 10 ns.
Based on predicted particle temperature, there may be a reaction between CB and steam
to generate CO + H2 through the water-gas pathway. In order for the reaction to occur it
has to be both thermodynamically and kinetically feasible. From thermodynamic point of
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view, there is enough energy absorbed to consume the entire carbon within 20 pulses if all
the energy absorbed goes to reaction and the reaction occurs at 100◦C. But even so, the
volume of gas produced (CO +H2) would be a 1/3
rd of the volume of vapor produced if
all the energy went into vapor formation. In other words, the reaction mechanism is three
times less efficient in producing a gas bubble compared to just water vaporization for the
same energy delivered to the nanoparticles. From the kinetics perspective, the reaction
rates are extremely slow [200] (1.72e-4 m3 of CO+CO2/kg of C/s at 1300
◦C) compared to
the pulse length, and heat transfer rates which would result in formation of 2.55e-13 m3
of gases per pulse (less than 0.003% of the vapor bubble). So it is not expected to have a
significant contribution. If the process is allowed to run for 7 minutes at 10 Hz (4200 pulses)
and if the reaction occurs at the predicted rate, only 1% of the CB would be consumed only
if a temperature of nearly 1000◦C was maintained for the entire time. We consider this
unlikely because first there is heat loss to the surrounding in the time scales of 200 ns
which reduces the temperature and secondly a certain amount of heat goes into forming
vapors which is needed for the reaction to occur. Another way to test the reaction was to
expose CB for an hour and testing if there was either a change in absorption or a change
in size by DLS. If the reaction occurs even at the slowest rate determined, there should
be about 10% reduction in CB content in an hour long exposure, enough to be resolved
by spectrophotometric measurement. A 10% reduction in individual particle size should
also be evident in DLS. At 44 mJ/cm2 laser fluence (an intense exposure condition for in
vitro experiments) and up to an hour long exposure, there were no statistical differences
observed in either of the measurements, indicating that the reaction might not occur under
these conditions (See SI for all the calculations).
5.3.4 Pressure Generation
Fig. 5.5a shows hydrophone data obtained with the laser irradiated stream experiment. The
observed delay time between the laser trigger and hydrophone response was as expected for
propagation in water between the stream and the hydrophone tip. The data shows a short
overall response characterized by a sudden rise to a positive pressure of several atmospheres,
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followed by lower level oscillations that are hypothesized to be due to the hydrophone itself.
The whole event lasts several hundred nanoseconds which indicate its an extremely fast
process. Similar acoustic events have been noted in a liquid metal interface [201]. Fig. 5.5b
shows that the frequency spectrum (corrected with the hydrophone factory calibration) is
very broad, ranging from several kHz to about 30 MHz after which the signal falls into the
measurement noise. The acoustic attenuation coefficient in water increases proportional
to the square of frequency, i.e. αac = 2.5 x 10
-15.f 2, [202] where the acoustic attenuation
coefficient αac is given in 1/m and the frequency f is in Hz. At a frequency of 30 MHz, the
frequency attenuation at 15 mm is 3.6%, which is within the experimental error bound. It
is noted however, that there might be higher frequency components which attenuate even
faster and might not be recorded by the hydrophone.
There are four main hypotheses proposed for the generation of acoustic wave from
the heating of nanoparticles viz. a) Plasma formation b) Expansion of nanoparticles c)
Vaporization of surrounding fluid d) Reaction resulting in bubble formation. Fig. 5.6 shows
the dependence of the peak pressure signal from the hydrophone on distance from the source,
CB concentration and laser fluence. All the data points are an average of 115 replicates
and the error bars are extremely tight which indicated the signal was extremely consistent
and repeatable. When the distance from the source was increased the signal decreased
in a 1/r fashion, which is consistent with literature (ANOVA, p <0.0001) [203]. When
the CB concentration was increased the peak pressure signal went up linearly (ANOVA,
p <0.0001), as expected when the number of acoustic sources is increased [203]. Peak
pressure increased with fluence, although not in linear proportion (ANOVA, p <0.0001).
Another experiment that was performed to characterize the system was to see whether the
pressure generation was particular to the CB and water system. Fig. 5.7 shows that when
water is replaced with pure acetic acid, under the same CB concentration (which also had
the same extinction) the peak pressure increased (Student’s t-test, p <0.001) by a factor
of 1.7. When CB in DI water was replaced with nanotubes, under the same absorbance,
single walled carbon nanotubes (SWCNTs) had a higher signal than CB (Student’s t-test,




Figure 5.5: Acoustic output of 25 mg/l CB suspension measured using a hydrophone. The
time domain shows there is a sudden rise of pressure followed by a slower fall (a). The
frequency domain shows the constituent frequency of the system decreases significantly
after 30 MHz (b).
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signal than CB (Student’s t-test, p <0.001). We concluded that the pressure generation is
not particular to CB and water system. There are four main hypotheses proposed for the
generation of acoustic wave from the heating of nanoparticles viz. a) Plasma formation b)
Expansion of nanoparticles c) Vaporization of surrounding fluid d) Reaction resulting in
bubble formation.
5.3.4.1 Plasma Formation
Plasma formation is one of the most efficient ways to convert laser energy to acoustic
energy. A universal parameter, namely, the conversion efficiency, η, defined as the fraction
of energy converted from the laser energy to the acoustic energy, is used to determine the
nature and mechanism of pressure generation. Typically η ranges from 10-4 for a thermal
expansion mechanism [204] to 0.3 for plasma formation and optical breakdown [206]. The
conversion efficiency for our case is less than 10-5 (see SI), which shows that there is no
plasma formation under these fluences.
5.3.4.2 Expansion of Nanoparticles
The particle temperature predictions, along with a volumetric expansion coefficient of 1.8e-
04 /K, indicate that the change in diameter of the nanoparticle (assuming a sphere) is about
6%, and the total volume change is about 20%. So the average velocity of the moving wall
of the sphere is about 0.9 m/s which is very slow compared to speed of sound.
5.3.4.3 Reaction
The carbon steam reaction is endothermic and both the high heat of reaction and high
temperatures need to be maintained for long periods of time for the reaction to occur
appreciably. Based on thermodynamic calculations it also appears to be a less efficient use
of energy to create a bubble. Reaction between CB and steam might occur but kinetically
its extremely slow and might not result in any effect. CB exposed to 44 mJ/cm2 for 1 h
did not show any change in absorbance or DLS measurement data suggesting there was no
consumption of nanoparticles. When CB was replaced by nanotubes and water was replaced



























































Figure 5.6: Effect of measurement distance from source, CB concentration and Laser Flu-
ence on the peak pressure. Pressure signal is inversely proportional to the distance from the
source (a). Increasing the CB concentration increases the signal linearly (b). Increasing the
Fluence increases the pressure non-linearly (c). Data show average ± standard deviation

























Figure 5.7: Effect of acetic acid and carbon nanotubes on pressure waves. When water
is replaced with non-reacting acetic acid and carbon black is replaced with less chemically
active nanotubes there was still pressure detected.
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5.3.4.4 Vaporization
If the particle temperature as predicted by Mie scattering goes beyond 100◦C then some
vaporization is expected of the surrounding liquid water. The existence of vapor is also
demonstrated by the non-linear rise of peak pressure as a function of fluence. Ideally it
should be linear if thermal expansion of nanoparticle was the only mechanism [201]. If the
amount of vapor formed is proportional to the total pressure output, it might explain why
CB with acetic acid has a higher output. The heat of vaporization of acetic acid is about
1.7 times less than water, therefore under the same fluence a bigger vapor bubble is formed
in acetic acid keeping all other parameters the same.
From the above, we conclude that the pressure generation is caused due to a combination
of thermal expansion and vapor generation. If that is the case, then getting consistent signal
over many pulses also mean that the particle is reaching similar temperature each time a
laser pulse interacts with the CB, this justifies our previous assumption in the modeling of
Fig. 5.4.
5.3.5 Impact on Cells
In terms of bio-effects one of the key things to note is that while pressure increases with
both laser fluence and CB concentration, uptake saturates when fluence is increased, but
not when the CB concentration is increased. Drug delivery or membrane permeabilization
can occur due to two main reasons: 1) There is a distant, indirect interaction between
bubble and cell, mediated through pressure emitted by the nanoparticles; and 2) There
is a direct interaction between bubble and cell, mediated through direct contact between
the heated vapor bubbles and the cells. To map the spatial domain of the bioeffects,
cells and nanoparticles were separated by a saran wrap and then exposed to various laser
conditions. The frequency attenuation coefficient, αac at this distance is so small that the
total attenuation is less than 0.0001% for a 30 MHz signal. To account for the pressure
attenuation through saran wrap, the calibration curve from Fig 5.6a was used. Assuming
a thickness of 10 µm a 14 fold increase in fluence was required to have the same down the













Figure 5.8: Effect of placing a saran wrap between the cells and the nanoparticles. When
cells and nanoparticles are placed on the same side there is significant damage observed
whereas when they are placed in either side there is no damage observed.
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was observed even when a fluence 200 mJ/cm2 was used. This suggested that either the
pressure waves attenuate too fast or a vapor bubble must be physically in the vicinity of
the cell. In either case its a short distance effect. Another reason might be that the cells
are inhomogeneous themselves and some don’t respond to laser treatment while others do,
but this seems unlikely because we see a continual effect with increasing CB and time of
exposure.
5.4 Conclusion
Laser exposure to CB nanoparticles in the presence of cells leads to intracellular drug
delivery. Based on all the presented data, the most likely pathway is:
1. the laser gets absorbed by the nanoparticles and gets converted to heat;
2. the CB then reaches a temperature close to 1000◦C at 44mJ/cm2 laser fluence;
3. Water surrounding the CB vaporizes and forms a vapor shell
4. The bubble growth produces acoustic pressure
The cause of transient cell membrane permeability that facilitates intracellular delivery
might not be the pressure waves by themselves, but a vapor cell membrane interaction, which
may temporarily re-organize the membrane, resulting in uptake. Such a kind of membrane
disruption is expected to be short lived and small, which probably explain why there is
high viability associated with the process. The bubble radius is a very weak function of the
energy but the number of bubbles produced is linearly proportional to the number of CB
nanoparticles. Beyond a threshold a bubble does not have any additional effect explaining
why the increase of fluence does not result in additional delivery whereas increasing CB
concentration continues to have more and more effect for the range of parameters tested.
We believe this is a new kind of delivery mechanism that has not been proposed in
the literature in the past. Cell-bubble contact is new mechanism not proposed before in
literature and is very different from ultrasound, electroporation, and fluid mechanical shear.
Perhaps this new mechanism explains why we have such efficient uptake, rapidly reversible
effects and sharp dependence of uptake on MW. This method owing to its high efficiency has
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a potential to be applied to both in-vitro and in-vivo intracellular drug delivery for not just
calcein but also molecules like SiRNA, small proteins etc. But understanding this vapor cell
interaction is key to future applications and maybe in fact, vapor cell interaction generated
by other techniques can result in a high efficiency intracellular drug delivery system.
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CHAPTER VI
siRNA DELIVERY USING PHOTOACOUSTICS
The introduction of short-interfering RNA (siRNA) into cells is an attractive tool for RNAi-
mediated knock-down of gene expression for research and therapeutic purposes. However,
delivery of siRNA into cells has been challenging. To address this challenge, here we report,
for the first time, on a method that involves irradiation of carbon black (CB) nanoparticles
with near-infrared (NIR, 1064 nm), nanosecond (5 - 9 ns) laser pulses to achieve intra-
cellular delivery of siRNA. In initial studies, physical properties of CB nanoparticles were
characterized and then ovarian cancer cells irradiated by NIR laser in the presence of CB
nanoparticles were shown to have significant uptake of fluorescein isothiocyanatedextran
(FITC-dextran, 70 kDa). Follow-up studies demonstrated significant uptake of siRNA tar-
geting the epidermal growth factor receptor (EGFR) gene, as well as down-regulation of the
target EGFR gene on the mRNA level. This new physical method for siRNA delivery ex-
pands the tools available for RNAi-mediated gene knock-down and may show future promise
for delivery of therapeutic siRNAs for treatment of ovarian cancer and other indications.
6.1 Introduction
Since the discovery of siRNA-mediated gene knockdown in C. elegans [109] and its sub-
sequent implementation in mammalian cells [206], this method has gained considerable
attention because it has the potential to knock down any specific gene in the body and
specifically modulate more therapeutic targets than typical small-molecule drugs [207]. Us-
ing this RNA interference (RNAi) approach, in vitro and in vivo studies have already
demonstrated therapeutic potential of siRNA-mediated gene knock-down in diseases like
hypercholestrolaemia [208], liver cirrhosis[209], hepatitis B virus (HBV) [210, 211], human
papilloma-virus[212] and bone cancer [213]. Human clinical trials are also underway [214,
215]. However, a key challenge to clinical translation is delivering siRNA into cells, because
siRNA molecules are big (∼13 kDa), heavily negatively charged and subject to degradation
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by endogeneous enzymes in-vivo [131, 207].
Most of the current techniques to deliver siRNA involve the use of viral vectors [216, 217],
lipid vesicles [183, 218], solid nanoparticle formulations [219-221] or hydrodynamic injections
[222]. Viral methods suffer from drawbacks like cytotoxicity, insertional mutagenesis and
activation of immune response [223, 224]. A major hurdle in non-viral delivery is avoiding
endosomal degradation and achieving endosomal escape [225-227]. Another approach is
to directly deliver siRNA into cytoplasm, which avoids the endocytic pathway completely.
Examples of such methods are electroporation, ultrasound-induced poration, microinjection
etc. A common challenge with these methods is to maintain high viability at conditions
associated with high intracellular uptake [65].
In this study, we propose a method that uses laser-irradiated carbon black (CB) nanopar-
ticles to achieve intracellular delivery of siRNA. In this method, we expose CB nanoparticles
to nanosecond pulsed laser, causing the nanoparticles to preferentially heat up, which re-
sults in particle expansion [84], liquid vaporization [84, 228] and/or chemical reaction (C +
H2O → CO + H2)[5], followed by generation of acoustic waves, leading to poration of cell
membranes [168, 229]. Molecules then passively transport into the cell without the need
of endocyotosis. Previously we demonstrated this method to be very efficient in delivering
small molecules like calcein and larger proteins like bovine serum albumin [168, 229]; here
we seek to extend the application to siRNA.
This method of intracellular delivery does not involve internalization of the CB nanopar-
ticles, unlike other methods of intracellular delivery based on laser-particle interactions [230].
In our approach, the nanoparticles transduce laser energy (i.e., photons) into mechanical en-
ergy (i.e., acoustic waves) that impact the cell membrane to increase its permeability [168].
In this way, siRNA provided in the extracellular medium can then diffuse directly into its
area of target, i.e., cytoplasm, where the mRNAs are present. For this reason, we believe
the siRNA delivery to the cytoplasm is especially well suited to delivery by laser-activated
CB nanoparticles, as opposed to, for example, DNA, which typically has an intranuclear
target for transfection.
We carried out this study in ovarian cancer cells in anticipation of future applications
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to treat ovarian cancer. Ovarian cancer is the most lethal of all gynecological cancers
and the fifth leading cause of cancer-related deaths in women in the United States [231].
According to the U.S. National Cancer Institute, in 2014 there will be almost 22,000 new
cases of ovarian cancer and more than 14,000 women will die of this disease nationally
[232]. Current treatment of advanced ovarian cancer, which includes debulking surgery
and platinum-based chemotherapy, is initially effective in the majority of patients; however,
most of them eventually develop disease recurrence [233].
We have previously shown that targeting epidermal growth factor receptor (EGFR) by
siRNA-mediated gene knock-down increased sensitivity of ovarian cancer cells to a tradi-
tional anticancer agent cisplatin [234]. This suggests that EGFR can serve as a viable target
for development of siRNA-based therapies of ovarian cancer.
In this study, we first tested the hypothesis that laser-activated CB nanoparticles cause
enhanced uptake of FITC-dextran (70 kDa) by ovarian cancer cells and then show uptake of
anti-EGFR siRNA into ovarian cancer cells and knockdown of EGFR protein. We believe
that this is the first study to examine intracellular delivery in ovarian cancer cells and the
first to demonstrate siRNA delivery and knock-down using laser-activated CB nanoparticles.
6.2 Delivery System Design
The long-term goal of this study is to introduce nanoparticles into a tissue, irradiate the
tissue with laser in order to heat the CB nanoparticles selectively through absorption of the
laser energy by the nanoparticles, which causes them to generate acoustic emissions leading
to intracellular delivery of siRNA into ovarian cancer cells.
Given this goal, we chose to irradiate the CB nanoparticles with a 1064 nm wavelength
NIR laser because light at this wavelength can be generated using relatively inexpensive
commercial lasers and is poorly absorbed by biological tissues [235], thereby enabling deeper
penetration in tissues [236] . We chose CB nanoparticles as the photoacoustic transducers
because they absorb IR light efficiently [237], can be of suitable size for injection and
enhanced permeation and retention (EPR) effects [238], and have been shown to generate
photoacoustic emissions [5].
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To make CB nanoparticle suspensions, commercial CB powder was dispersed in an aque-
ous solution of Tween 80, a non-ionic surfactant, using a needle sonicator for 15 min at a
final concentration of 400 mg/l. Dynamic light scattering showed that this process yielded
CB nanoparticles with a mean particle size of ∼200 nm and a dispersity of 0.21 ( Fig. 6.1A
). Further analysis by transmission electron microscopy revealed that the CB nanoparticles
were aggregates of even smaller spherules of 25 - 30 nm in size (Fig. 6.1B inset). Assuming
a spherical shape (with a 200 nm diameter) for the aggregate and a spherical shape (with a
25 nm diameter) for the spherules, we calculated that each aggregate had ∼133 spherules.
Given our goal of heating particles to generate photoacoustic emissions, nanoparticle size
and composition are critically important. Nanoparticle temperature is maximized by pre-
venting heat transfer from the nanoparticle to the surroundings during the laser exposure,
so that all heat is retained within the nanoparticle. Minimizing heat loss is achieved by
reducing thermal conductivity and surface-to-volume ratio of the nanoparticle. CB has a
relatively low thermal conductivity (e.g., compared to metal nanoparticles) [237], which
facilitates heat retention and. at 200 nm mean diameter. The time scale of thermal con-
duction to the surroundings is ∼175 ns (see SI) which is much slower than heat deposition
time scale of the laser pulse (i.e., 5-9 ns). In contrast, the time scale of heat loss to the sur-
roundings for a 50 nm diameter nanoparticle is ∼11 ns (see SI), which is similar to the laser
pulse length, suggesting that a 50 nm nanoparticle is too small, because it would lose heat
to its surroundings during the pulse. Moreover, as nanoparticle size decreases, the melting
point of decreases as well [239], which further motivated us to avoid making nanoparticles
too small. We therefore concluded that 200 nm nanoparticles would be effective for our
application.
We finally tested the acoustic output of the CB nanoparticle suspension when subjected
to laser irradiation. To do so, CB suspensions were exposed to pulsed nanosecond lasers
and pressure signals were detected using a hydrophone. CB suspensions exposed to 100
mJ/cm2 produced a peak pressure of 0.17 MPa measured at a distance of 5 mm from the
CB suspension (Fig. 6.1B); the pressure within the CB suspension was probably significantly























   
       
A 
B 







Figure 6.1: Phyical characterization of carbon black (CB) nanoparticles. (A) Representa-
tive dynamic light scattering measurement of hydrodynamic diameter of CB nanoparticle
aggregates in DI water suspension at a final concentration of 25 µg/l shows a single peak and
no particle settling. Transmission Electron Microscope image (inset) of dried CB nanopar-
ticle aggregates shows the individual spherules constituting the aggregates. The scale bar
is 50 nm. (B) Representative acoustic output (pressure) versus time measured using a hy-
drophone when CB nanoparticle suspension (50 mg/l) was exposed to a single laser pulse at
250 mJ/cm2 fluence. The frequency distribution calculated from the hydrophone calibration
curve reveals a broadband signal up to approximately 30 MHz (inset).
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to the time for the acoustic wave to reach the detector from the source (i.e., t = d / c
= (0.005 m) / (1490 m/s) = 3.35e-06 s, where t is time delay, d is distance between the
CB nanoparticle suspension and hydrophone and c is the speed of sound in water at 23◦C),
followed by a sudden rise of pressure within 100 ns, followed by a slower recovery within 1 µs.
The whole event from pressure rise to negligible signal lasts less than 1 µs, which suggests
that the sound generation was due to an expansion-type mechanism involving thermal
expansion of CB nanoparticles themselves or expansion of vapor/gas bubbles produced
by heat transfer from the hot CB nanoparticles [84]. The frequency spectrum showed
a broad range of signals from few kHz up to 30 MHz, beyond which the signal became
largely indistinguishable from background noise. Overall, these studies show that the CB
nanoparticles and laser irradiation conditions used in this study are capable of generating
photoacoustic outputs.
6.3 Intracellular Drug Delivery with Laser Activated CB
To address our long-term goal of treating ovarian cancer by intracellular delivery of siRNA,
we next identitified conditions that enable efficient delivery of molecules into ovarian cancer
cells guided by prior literature [168]. Human ovarian cancer cells, Hey A8-F8 cells, were
mixed with CB nanoparticles and 70 kDa FITC-dextran (used as a surrogate for siRNA),
exposed to laser, washed by centrifugation and then imaged by fluorescence microscopy
and analyzed quantitatively by flow cytometry (Fig. 6.2). Cells with intracellular uptake
of FITC-dextran were identified by green fluorescence. Non-viable cells were identified by
red-fluorescent propidium iodide staining.
Microscopic imaging revealed that laser-irradiation with CB nanoparticles induced up-
take of FITC-dextran (as indicated by the green cells) and caused loss of cell viability
(as indicated by the red cells) (Fig. 6.2A). Flow cytometry analysis provided quantitative
data (Fig. 6.2B). In control experiments using untreated cells (i.e., cells with no FITC-
dextran, no CB nanoparticles and no laser irradiation) or sham-treated cells (i.e., cells with
FITC-dextran and CB nanoparticles, but no laser irradiation), there was high viability
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Figure 6.2: Intracellular delivery of FITC-dextran in Hey A8-F8 ovarian cancer cells. (A)
Cells inspected by microscopic imaging show uptake of 70 kDa FITC-conjugated dextran
(green) when cells were exposed to laser at 44 mJ/cm2 for 1 min in the presence of 25
mg/l CB nanoparticles. Cells were also stained with propidium iodide (red), which is a
marker of nonviable cells: (I) fluorescence microscopy, (II) brighfield microscopy. Scale
bars are 100 m. (B) Flow cytometric analysis of percentage of cells remaining viable and
exhibiting intracellular uptake of dextran is shown as a function of photoacoustic exposure
conditions, including laser fluence (mJ/cm2) and exposure time (min). The asterisk symbol
(*) represents statistically different viability compared to sham samples (p <0.05) and the
hash symbol (#) signifies that percentage of cells with uptake and viability for a given
sample are significantly different (p <0.05). Data show mean ± standard deviation (SD)
with three replicates each (N = 3). (C) Representative flow cytometry histogram plots
of FITC-dextran fluorescence are shown for cells incubated with FITC-dextran at four
conditions shown in (B): (I) untreated cells (no laser, no CB nanoparticles), and cells
exposed to CB nanoparticles and laser at (II) 19 mJ/cm2, 7 min (III) 25 mJ/cm2, 3 min,
(IV) 44 mJ/cm2, 1 min.
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which were selected because they had previously been shown to drive intracellular uptake
into another cell line DU145 prostate cancer cells [168] and we therefore expected them to
be similarly effective in the ovarian cancer cells used in this study. At each of these three
laser irradiation conditions, there was significant uptake of FITC-dextran (Students t-test,
p <0.05) with associated loss of viability (Students t-test, p <0.05). More specifically, all
three laser-irradiation conditions led to similar effects: uptake seen in about half of the cells
and loss of viability in about one-third of the cells (Fig. 6.2B). These results are similar to
those seen with the prostate cancer cells previously [168].
Closer examination of the flow cytometry data allowed us to assess the relative intracel-
lular concentration of FITC-dextran taken up into the cells. The representative histogram
plots (Fig. 6.2C) show the levels of green fluorescence among the viable cells in each sample.
In graph I, background fluorescence is shown. In graph II, heterogeneous uptake is seen,
with most cells exhibiting significant uptake (i.e., high uptake cells) and a fraction of cells
with low signal (low/no uptake cells). In graph III, a larger fraction of the cells exhibit
high uptake and, finally, in graph IV almost all cells exhibit high uptake. Note that these
data only include viable cells and do not account for the fact that viability was lower for
the cells shown in graph IV.
These data are interesting because they suggest a threshold phenomenon, where cells
either have high uptake (i.e., the population of cells on the right side of each graph) or they
have low/no uptake (i.e., the population of cells on the left side of each graph). We do not
see a broad distribution of uptake levels in these graphs. This finding is consistent with
previous observations in the context of intracellular delivery by acoustic cavitation and by
electroporation [45, 50].
The three laser-irradiation conditions shown in Fig. 6.2B have increasing laser fluence
that is compensated for by decreasing irradiation time to keep the total fraction of cells
affected by the exposure approximately constant (i.e., the sum of cells with intracellular
uptake and nonviable cells). However, at higher laser fluence, there were more cells with
high uptake (Fig. 6.2C). Combined, these observations suggest that at the three conditions
studied, the same fraction of cells experienced permeabilizing effects of laser-activated CB
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nanoparticles, but the effects on the cell were stronger at higher laser fluence, resulting in
more molecules delivered into each affected cell.
6.4 siRNA Delivery and Knockdown
The next step was to assess delivery of anti-EGFR siRNA to see siRNA uptake and knock-
down of EGFR. Anit-EGFR siRNA or a negative-control (NC) siRNA were added to ovar-
ian cell suspensions with 25 mg/l CB nanoparticles and either laser-irradiated (19 mJ/cm2
for 7 min) or not exposed to laser (sham). Some samples were alternatively exposed to
laser without the presence of CB nanoparticles. After 24 h post-exposure incubation, cel-
lular RNA was isolated and then analyzed for siRNA uptake and for EGFR knockdown
by quantitative polymerase chain reaction (PCR) assays. Intracellular glyceraldehyde 3-
phosphate dehydrogenase (GAPDH) was used as an internal control against which RNA
levels were normalized. To assess siRNA uptake, cells were laser-irradiated in the pres-
ence of anti-EGFR siRNA with CB nanoparticles (experimental group), anti-EGFR siRNA
without CB nanoparticles (negative control) or NC iRNA with CB nanoparticles (negative
control). There was no statistical difference (Students t-test, p >0.05) in normalized anti-
EGFR siRNA signal between the two negative controls (Fig. 6.3A). However, there was
significantly higher anti-EGFR siRNA signal in the experimental group (2-tailed t-test with
Welchs correction, p <0.001) compared to either of the negative controls. The fold change
of normalized anti-EGFR siRNA signal of the experimental group compared to the no-CB
negative control was 12,000 and compared to the NC-siRNA negative control was 360.
As a positive control, we delivered anti-EGFR siRNA to ovarian cancer cells using
a commercial transfection agent, Lipofectamine 2000. This delivery method also showed
significantly higher intracellular delivery of anti-EGFR siRNA compared to NC-siRNA neg-
ative control (Fig C.4A in SI), which provides a further validation of the assay works. While
delivery using this lipid-based method was effective, our photoacoustic approach has the
advantage of potential use in vivo, whereas Lipofectamine 2000 is only for in vitro use.
Visual inspection of cells 24 h post treatment (Fig. C.3 in SI) revealed confluence in the
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Figure 6.3: Uptake of anti-EGFR siRNA (s564) and knockdown efficiency of EGFR mRNA
after photoacoustic delivery in ovarian cancer cells. (A) Amount of intracellular siRNA
(s564) (in arbitrary units) normalized per 10 ng of total RNA, quantified using qPCR, when
Hey A8-F8 cells with anti-EFFR siRNA or NC siRNA were exposed to laser at 19 mJ/cm2
for 7 min in the presence (CB) or absence (no CB) of 25 mg/l CB nanoparticles. (B) EGFR
mRNA level normalized relative to GAPDH level measured using qPCR showing knockdown
when cells were exposed to laser with CB nanoparticles with, anti-EGFR siRNA compared
NC-siRNA. Asterisk symbol (*) shows statistically significant differences in uptake and
knockdown (p <0.05). Data show mean ± SD (N = 3).
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and NC-siRNA negative control samples both of which were exposed ot laser irradiation in
the presence of CB nanoparticles, indicated some loss of cell viability consistent with the
dextran-uptake experiments (Fig. 6.2B).
Encouraged by evidence of intracellular delivery of siRNA, we finally assessed knock-
down of EGFR mRNA compared to the negative control that was laser-irradiated with CB
nanoparticles and NC-siRNA. The mean knockdown was approximately 49%, which was
significantly lower than the negative control (Students t-test, p <0.05). There was also
knockdown of EGFR mRNA in positive control cells exposed to anti-EGFR siRNA with
Lipofectamine 2000 (Fig. C.4B in SI). This result is consistent with the central question of
this study concerning the ability of our photoacoustic method to deliver siRNA into ovarian
cancer cells to knock down protein expression.
Fifty four percent of cells took up dextran at the conditions used in the siRNA exper-
iment (Fig. 6.3B). If we assume that a similar percentage took up siRNA uptake and we
assume that the degree of EGFR knockdown was the same in each affected cell, then 49%
knockdown of EGFR mRNA (Fig. 6.3B) corresponds to approximately 90% of cells with
siRNA uptake exhibiting knockdown (i.e., 49% / 54% = 91%). In other words, most cells
that had siRNA uptake had knockdown. This indicated not only that our photoacoustic
method efficiently delivered siRNA into ovarian cancer cells, but that functionally intact
siRNA was delivered, and it was delivered into a cellular compartment (i.e., cytosol) that
allowed it to silence protein expression.
6.5 Conclusion
This study showed for the first time that laser-activated CB nanoparticles enabled intra-
cellular delivery of siRNA and knockdown of its target EGFR mRNA.. Initial experi-
ments showed that CB nanoparticles generated photoacoustic emission upon NIR irradia-
tion and intracellular delivery of dextran molecules into viable cells. Photoacoustic delivery
of siRNA into ovarian cancer cells resulted in 12,000 times higher normalized EGFR-siRNA
signal compared to negative control cells, indicating dramatically increased uptake of siRNA
molecules. This led to 49% knockdown of EGFR mRNA levels. We conclude that delivery
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of siRNA to ovarian cancer cells using laser-activated carbon nanoparticles is a promising




With recent advances in biomedical research and pharmaceutics, more focus is being put on
targeted drug delivery techniques [7, 8]. Targeted delivery ensures that there is no excess
dosage or exposure of healthy tissues to the drug. Most of the drawbacks associated with
conventional drug delivery can be overcome by improving drug localization, targeting, and
entry into the specific cell or tissue of interest. These advances in drug delivery can help
minimize the required dosages and side effects and thus can also improve the efficacy of
even currently used drugs.
While there are several approaches achieve intracellular drug delivery, physical methods
like ultrasound and electroporation use physical force to disrupt the cell membrane to
deliver drug molecules directly into the cells. These methods are attractive because of
their relative non-specificity to cell type and drug type. They create transient pores in
the cell membrane which allow drug molecules to enter the cell through passive diffusion
or electrophoresis. A direct introcytoplasmic delivery occurs bypassing the endocytotic
pathway thereby avoiding the issue of lysosomal degradation. However the major challenge
associated with these techniques is controlling the pore size/ size of wound created by the
physical force. Controlling the pore size is important because if the pore size is too small the
drug molecules will not be able to enter the cell. On the other hand, too large a pore can lead
to cell death. A good control over the physical force is required to control the pore size but
because of the complex nature of tissues in the body it is hard to control the nature of the
physical force both spatially and temporally. Our solution to the problem of controlling the
physical force and pore size was the use of photo-acoustic delivery using CB nanoparticles
and nanosecond laser. Our study with the nanosecond laser and CB was driven by the
initial success we had with the study using the femtosecond laser [229]. Even though the
femtosecond laser is more efficient in heating the nanoparticles which implies more efficient
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drug delivery, it is expensive, complicated to use, and is not widely available. A nanosecond
laser on the other hand is already used clinically. It is also relatively cheap and easy to
use. We had flexibility in our choice of the wavelength of laser pulses because CB absorbs
well across a wide range of wavelengths (300 nm to 1100 nm). Our choice of 1064 nm as
the wavelength was driven by the fact that our bodys primary absorptive materials (tissue,
water, and hemoglobin) have a relatively high transmittance to this wavelength. This way
the CB would preferentially absorb the laser while the rest of the tissue would remain
relatively inert to the exposure. The method has some intrinsic advantages compared to
its counterparts in physical method of intracellular drug delivery, such as: i) The source of
physical force, i.e. the CB particles, is situated in the vicinity of the target cells and thereby
provides more localized effect ii)The temporal nature of the force can be controlled with CB
concentration and laser intensity. iii) There are more parameters, external (intensity, time
of exposure) and local near the cells (CB concentration, additive addition), which can be
varied to get a better control on the drug delivery. Encouraged by our initial femtosecond
results and potential advantages of our method, we proceeded to test this technique on cells.
Our first goal was to test the hypothesis that exposing cells in the presence of CB leads
to uptake of molecules. To test the hypothesis, we exposed DU145 cells in the presence
of CB at concentrations varying from 12.5 mg/l to 75 mg/l to nanosecond laser pulses at
fluences between 18.75 mJ/cm2 and 200 mJ/cm2 for 10 s to 7 minutes exposure times.
We used calcein as our uptake marker. Visually, green cells were observed, which not only
showed uptake but also proved that the calcein molecules were all over the cytoplasm and
not just localized in one part of the cell. When cells were counted using a flow cytometer
to quantify uptake and viability, it was observed that initially with increasing laser fluence
uptake increases whereas viability decreases. Beyond a certain threshold, increasing laser
fluence had no observable effect on uptake and viability. Increasing the time of exposure had
two kinds of effect: below certain laser intensity, increase in uptake was observed with no
apparent loss in viability, whereas beyond the threshold, the viability and uptake increased
initially but then decreased in a continuous fashion. Increasing CB concentration resulted
in initial increase of uptake and viability and then a continuous decrease. In other words,
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parameters like fluence and time of exposure had strong correlation with final uptake and
viability. Whereas the effect of fluence saturated beyond a certain threshold, increasing
CB concentration and time exposure had a stronger effect on the cells leading to increased
deaths. Under optimal condition, there was about 88% uptake of calcein with almost no loss
of viability. It was also shown that the laser exposure to cells without CB results in less than
15% uptake even at a strong fluence 200 mJ/cm2. The CB without laser exposure also did
not result in any significant uptake. Adding calcein immediately after the exposure caused
less than 10% uptake of calcein which meant that the pores close faster than ultrasound
induced or electroporation induced pores [240, 241]. We also demonstrated uptake using two
different cells lines (DU145 and H9c2), two different types of CB nanoparticles (India ink
and normal CB suspension), and various uptake markers with increasing molecular weights
(calcein and dextrans, 10 kDa to 500 kDa range). All of the combinations had comparable
efficacies except the uptake of larger molecules (>150 kDa) which was markedly lower than
the small molecules. This indicates that the technique can be used across various cell lines
and drug types with some restrictions in drug size.
Cell death was observed under more intensive laser conditions both because of necrosis
(suggested by red cells in microscope images and a separate population in flow scatter plots)
and fragmentation (suggested by fewer cell events compared to sham for similar volume of
cells analyzed in flow cytometer). Adding additives like BAPTA-AM, Ca2+ ions, and ATP
to enhance the repair mechanism did not result in increased viability. We hypothesize
that this is either because the timescales of damage are too fast that there is no time to
recover or the damage was too great to be recovered. In either case, enhancing the active
repair mechanism of the cell did not help. So we added an external agent like poloxamer
F-68 and F-127 which prevented shearing of cells either by mitigating the acoustic waves
or by plugging pores on the cells immediately as they formed. This resulted in significant
increase of viability but did not compromise the uptake efficiency. Adding glycine betaine
(a thermoprotectant) should have helped if there was a thermal damage to the cells, but
that was not the case. So we have reasonable confidence to believe that the damage is
mechanical. We believe, by controlling laser fluence, CB concentration, time of exposure,
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and finally pluronic concentration, a high uptake with high viability can be achieved in
various cell lines in vitro and in vivo.
The photo-acoustic effect can be broadly divided into two parts. The first is trans-
duction of laser energy into heat, vapor bubbles, and pressure waves, and second is the
interaction of pressure waves and vapor bubble with the cell which transiently porate the
cells and cause uptake of molecules. After showing good efficacy with DU145 cells and cal-
cein and comparable results with other cell lines, nanoparticles and uptake molecules, our
next goal was to understand the underlying mechanism of the first stage, i.e., production
of the physical force and its nature. We demonstrated that CB absorbs the laser much
more efficiently than surrounding water. A suspension with less than 1% v/v CB showed
significant temperature rise compared to pure DI water. It was shown through timescale
measurements and acoustic data that each pulse is independent of each other, i.e., the CB
goes back to its original state after each pulse and the process repeats. By measuring the
bulk temperature rise it was possible to calculate the peak nanoparticle temperature. It was
verified through Mie theory and absorbance measured using power meter. At 44 mJ/cm2
fluence, the estimated temperature rise was about 1000◦C which possibly occurs in about 10
ns. This is a really fast heating step and only pulsed lasers like femtosecond and nanosecond
lasers are capable of doing that. We also devised a way to measure the acoustic output
of the system without letting too much noise interfere the system. We then characterized
acoustic output as a function of laser fluence, CB concentration, and distance from source.
We concluded that increasing all the parameters resulted in increased acoustic output.
The possible ways of production of pressure waves from laser CB irradiation were nar-
rowed to thermal expansion, vaporization, and carbon steam reaction. In the fluence range
that we used, we eliminated the possibility of carbon steam reaction playing role in the
bioeffects by demonstrating the presence of pressure waves when water was replaced with
pure acetic acid. In fact, for same concentration and fluence, acetic acid had a higher output
than water. This, along with non-linear rise of peak pressure with fluence, led us to believe
the final acoustic pressure waves are produced as a combination of thermal expansion and
vaporization.
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There were two competing hypotheses about the nature of the physical force causing
the poration: the first was the pressure waves interacting with the cell membrane and the
second was the vapor bubble formed during the heating of the nanoparticle. In order to
distinguish between the two, we devised an experiment where we physically separated the
nanoparticles from the cells and uptake marker by about 50 m and found that there was
no delivery of molecules. We chose a separation distance that was not enough to cause
a significant attenuation of the pressure waves. We therefore concluded that there is a
strong possibility that a physical interaction between vapor bubble and cell causes the
intracellular delivery. This is a very near field effect and also addresses the discrepancy
between the observed saturation with increasing fluence and no saturation with increasing
CB concentration. We believe that this is because when fluence is increased, it heats the
particle more creating bigger vapor bubbles. The increment in radius is, however, less and
less as fluence is increased, because the increment is proportional to the cube root of fluence.
Therefore beyond certain fluence the probability of encountering a cell does not change
significantly. Whereas, when CB concentration is increased, the number of nucleation sites
for vapor bubble formation increases which increases the probability of vapor bubble - cell
interaction. We then applied the method for delivery of a therapeutic molecule. We chose
siRNA as one our molecule because of its size (∼13 kDa) and its intra-cytoplasmic target,
both of which fit well for the method that we developed. We chose to knockdown EGFR
in ovarian cancer cells as proof of concept because the cell line and the target were well
understood. To determine the conditions of laser fluence, CB concentration, and time of
exposure, we chose the 3 most optimal parameters from the DU145 study. We used FITC-
dextran (70 kDa) as a model uptake marker which is a good representation of the size of
siRNA. They all performed similarly and we picked the mildest condition to ensure good
viability 24 h post irradiation. We showed that there was significant intracellular uptake of
siRNA and 49% knockdown of EGFR. This is the first proof of concept and we expect a
better efficiency with more optimization of conditions.
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The final objective of this project was in vivo demonstration of our method (see Ap-
pendix for more details). We demonstrated PI uptake in TA muscles of mice. A simple in-
jection of CB suspension with propidium iodide followed by laser irradiation at 200 mJ/cm2
for 2 minute resulted in uptake of 30%, but we did not know if this uptake occurred in vi-
able or nonviable cells. The main challenge was to achieve a uniform spreading of CB in
the entire tissue. Unfortunately, CB concentrated around the injection site with little or
no spreading. Post irradiation, the mice were sacrificed after 2 days and 7 days to observe
the muscle recovery from damage. It was seen that the muscle damage persisted even after
7 days. While this indicates that our method is doing something to the tissue, significant
improvements need to be made to CB particles and optimization of the laser fluence and
exposure time.
In summary we investigated: i) a novel method for intracellular drug delivery that can
achieve high efficiency in vitro; ii) the reasons for cell death and possible ways to protect
the cells from permanent damage; iii) a way to optimize the parameters to ensure maximal
uptake with minimum loss of viability; iv) the underlying mechanism and nature of the
physical force that causes membrane disruption; v) the possibility of the use of this method
in siRNA delivery; and vi) possible in-vivo applications.
We believe this study will lead to a new paradigm in exploiting laser-material inter-
action for targeted intracellular drug delivery. In this study we demonstrated that other
materials like MWCNT and SWCNT can generate acoustic waves similar to CB. We also
demonstrated intracellular drug delivery using India ink. With more investigation we hope
there will be newer materials discovered with even higher drug delivery efficiency. Exploit-
ing laser particle interaction to achieve intracellular drug delivery has been around for quite
some time now. Most of these techniques prefer gold as their laser absorptive media. The
gold needs to be either internalized or at least attached to the cell surface in order for the
drug delivery to occur [99, 230]. The nanoparticle also needs to be modified to bind to
the cell membrane. The drug delivery occurs through heating of the nanoparticles which
causes thermal damage. These methods are therefore significantly slower, complicated, and
in most cases require higher laser energy. The system we developed takes advantage of
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mechanical damage which can be caused from a greater distance and therefore no binding
to cell surface is necessary. This also bypasses the incubation step which is required for
gold based technique for cell surface binding, making it faster. CB is also cheap and abun-
dantly available and there is no particle modification required making it a simpler protocol
to follow. However, more study needs to done in order to find particles which can perform
better than CB. There is also a potential of using an implantable biomaterial made of CB
entrapping the drug within it that is released only when irradiated with nanosecond pulsed
laser. This would lead not only to controlled release but also poration of surrounding tissue
and more efficient delivery of the drug.
Apart from intracellular drug delivery, this method also has a potential application
in tattoo removal. The potential use of lasers for tattoo removal was shown back in 1963
[242]. In more recent years, the Q-switched laser has become the preferred method of tattoo
removal because of efficient removal with minimal side effects [243]. The mechanism under-
lying the removal of tattoo using short laser pulses is photoacoustic material breakdown.
Although Q-switched lasers have been shown to be highly effective in tattoo removal, they
are not without adverse effects. Acute events include purpura, crusting, blistering, infec-
tion, and oxidative darkening of pigment [244]. The current study can provide some insights
into improving the technique and minimizing side effects. For example, adding polaxomers
during tattoo removal might save some cells from being damaged while the laser ablation
of tattoo occurs. We now know that poration of cells occur during laser ablation of CB. So,
while the tattoo is being removed doctors can take the opportunity to deliver drugs during
tattoo removal either to minimize side effect or for other medications.
Another use of this technique might be in the field of photodynamic therapy (PDT).
Currently, most PDT absorptive media are molecules called photosensitizers that absorb
laser and generate oxidative species destroying cells. From our current study we know that
when the time of exposure or particle concentration is increased, more destruction of cells
occurs. We can take advantage of that fact and use CB nanoparticles that migrate towards
tumor through EPR effect (200 nm is a good size for that) or decorate the nanoparticles
with ligands so that they specifically target tumors. The advantage of this method would
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be once the particles are injected into the tumor they should remain there for longer period
of time than normal PDT photosensitizer molecules and can be used for multiple exposures
without the need of multiple injections. Since there is no generation of reactive oxygen
species, the toxicity associated with PDT can be avoided.
The most common application of photo-acoustics in biomedical engineering is imaging
wherein nanoparticles are injected and tracked using laser light from the acoustic feedback.
The most common particle used is gold but from this study we propose the use of CB,
nanotubes, and other forms of carbon. The current study not only allows us to track
particles from the acoustic output but it can also be potentially calibrated to know the
depth of nanoparticles and changes in the surrounding tissue which can indicate migration
from one tissue to other, crossing of some barrier, etc. Another form of carbon called
carbon dots (C-dots) are being used as imaging substitutes for quantum dots because of
its non-toxic nature. C-dots are extremely small CB particles (<1 nm) and there is a
strong possibility that these particles will also cause intracellular drug delivery if exposed
to nanosecond laser pulses. If we conjugate them with a payload, then these particles can
be tracked using fluorescence and/or photo-acoustics, and then when they reach the proper
target, they can deliver their payload.
Microsurgery with laser has been around for quite a while now. The use of LASIK
to correct vision was one of the revolutions in modern surgery. Since then techniques
like photorefractive keratectomy [245], laser endarterectomy [246], and endoscopic laser
lithotripsy [247] have been popularly used to surgically treat various part of the body.
Currently very fine surgery like transoral surgery is also being performed to treat throat
cancer [248]. With our current technique fine surgeries can be done in a more convenient
manner because the destructive effect on cells only occur where both the CB nanoparticle
and the laser is present. If we can clearly label our target area with CB then we do not
need to worry about the destruction of healthy tissue. The use of CB will also result in the
use of lower fluences to achieve similar effect.
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7.1 Contribution
Overall this thesis progresses the field of drug delivery and biotechnology in several ways:
i) it demonstrates a way to achieve efficient intracellular drug delivery across several cell
types and delivery molecule type; ii) it helps us understand the nature of cell damage and
possible ways to counter the effect which can potentially be used in other damage related
studies; iii) it provides insights about mechanism of generation of pressure waves through
laser irradiation of CB nanoparticles which can not only be used in drug delivery but in
other applications as well; iv) it demonstrates delivery of siRNA which opens up possibility
of therapeutic use of this technique; v) it promises to have an in-vivo applications in the
future with proper design and optimization; and vi) it lays foundation for designing new
materials for laser particle interaction to achieve controlled damage or acoustic signals.
The use of CB in medicine has so far been limited to tattoos, vascular labeling [249, 250],
phagocytic labeling agent [251], imaging [91], and in studies of pollution induced toxicity in
lungs [252]. We identified a novel application for this easily available nanomaterial with very
little structural or functional modification. The study uniquely integrates advanced laser
technology and nanoscience in the context of drug delivery by exploiting an aspect of laser-
nanoparticle interaction that had almost never been used for drug delivery. Even though the
main focus of this thesis is drug delivery, the physical science of acoustic wave generation
can be applied to various other fields. The technique also has promising minimally-invasive,
targeted in-vivo drug delivery applications. It lays the foundation for new medical devices





A fundamental component of this intracellular delivery technique is the nanoparticles, which
are used to preferentially absorb the laser energy. The nanoparticle mostly used in this study
was the CB, which was prepared through sonication of the CB powder in DI water followed
by addition of a stabilizing surfactant. DLS measurements revealed a Gaussian distribution
in size with a dispersity of around 0.21. For good monodispersed nanoparticle formulations,
the dispersity is below 0.1 [253]. I recommend a study that focuses on achieving monodis-
persed CB suspension and scientific way to control the size which will help understand the
effect of size on acoustic output. This will also be very useful in future in-vivo applications
where clearance of nanoparticles is a concern. One possible way to do it is through centrifu-
gation and selective filtering: first big particles are centrifuged out following sonication and
next the samples are passed through progressively finer filters to get a desired cut-off in size.
Another more sophisticated method is to use Field Flow Fractionation (FFF) which will
separate into any given size range (Instrument: Eclipse DUALTEC, Wyatt Technology).
Apart from just controlling the size, it might be worthwhile to look into functionalizing
the CB nanoparticle surface with cyclic RGD[254], CRGDK[141] so that it can be better
targeted into tumors. It can also be PEGylated for creating stealth nanoparticles that can
be used in systemic delivery with higher residence times in the blood stream.
In this study apart from CB nanoparticles, other nanoparticles such as SWCNT, MWCNT,
and India ink have been used, all of which are some form of carbon. I recommend pur-
suing further with the search for new nanoparticles. The design of new nanoparticles will
be guided by both its size and its behavior when exposed to laser. Keeping in mind fu-
ture in-vivo applications, a nanoparticle should be small enough to diffuse through tissue
and get cleared easily (<150 nm [255]). However, there is a restriction on the minimum
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size as well. Our hypotheses for acoustic wave generation are primarily thermal expansion
and vapor formation. For that, the size of the nanoparticle should be big enough for it to
absorb significant part of the laser light to get hot. However, smaller size means better
heat transfer to surroundings. Therefore, the problem can be bound by determining the
minimum size required for the particle to get heated faster than losing heat to the surround-
ings. Material properties like laser absorption efficiency, thermal conductivity, scattering
efficiency, melting point, thermal expansion coefficient, and bulk modulus also play a role
in this. We would want our particles to have high laser absorption efficiency (ideally at
wide range of wavelengths), low thermal conductivity (to retain the heat and get hot), less
scattering (for more absorption, the shape, size, and surface roughness also plays a role),
high melting point (so that high temperatures can be reached without changing the shape of
the material permanently), and low bulk modulus with high thermal expansion coefficient
(such that more particle surface acceleration occurs for the same temperature rise). For CB
the minimum size chosen can be as low as 25 nm, at which point the time scales for heat
deposition would be the same as time scales heat transfer rate to the surrounding. But we
have to careful because the melting point of particles also decreases dramatically with size
[239].
Possible candidates for future nanomaterials can be gold nanorods [256], gold nanoshells
[257], gold nanocages [258], and silica nanoparticles, Polymeric nanoparticles can also be
tested for acoustic output and intracellular drug delivery. I also suggest studying SWCNT
and MWCNT for their efficiency in drug delivery. We have already tested that under the
same absorbance of light SWCNT generates a significantly higher acoustic output so it is a
more efficient converter of heat to sound. It might be an interesting study to see how well
it performs in drug delivery.
With regards to the type of carbon particles, I recommend the use extremely small CB
particles called carbon dots (C-dots) [91] as laser absorbers. They are used for particle
tracking and imaging but might also possess the capability of intracellular drug delivery
under the influence of laser. I recommend pursuing a characterization study with C-dots.
This also holds the potential of integrating an imaging technique with a drug delivery
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technique using the same material, though they might be too small to be heated up to the
right temperatures.
A common problem with the current CB nanoparticles is its inability to get cleared from
tissues even after 7 days. One way to solve this would be to coat the carbon over polymeric
particles. The laser irradiation can break the polymer and disperse the smaller CB particles
in the tissue leading to better clearing than using just one big CB particle. For example we
can use the C-dots and coat them over PLA/PLGA particles. After irradiation the C-dots
will eventually get cleared and PLA/PLGA will slowly degrade.
8.2 System Characterization
In this thesis we have performed a series of characterization experiments to understand the
system thoroughly and we believe that we have some understanding of the system. But
there is still room for more experiments. I recommend studying the laser beam profile as
the first thing to do. A primary reason for error in laser CB drug delivery was caused by
non-uniform beam profile. Ideally we want a very uniform beam profile but unfortunately
in most of our experiments we encountered diffraction rings, dead spots, and bright spots
which resulted in temporally non-uniform exposure of sample. One way to address the
problem is to use a top-hat output laser rather than a Gaussian output laser which can be
done by replacing the internal mirrors of the current lasers or using a beam profiler.
The other important thing that needs to be done is the study of long term viability and
uptake of the system. So far we have only quantified uptake and viability immediately after
the laser exposure. For intracellular delivery of therapeutics like siRNA, mRNA cells are
required to be incubated for some time post treatment. Therefore it might be a good idea
to characterize the system through uptake and viability measurements 24 h and 48 h post
treatment to see not just necrotic death but also apoptotic death.
Another issue with regards to measuring uptake is that, so far, we only count the number
of cells that have a certain amount of fluorescence. That is not the only way to quantify
uptake. For example, one could calculate how many molecules actually went in each cell as a
function of exposure parameters. Similar studies have been done in the past for ultrasound
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exposure and from those measurements the increase in cell permeability can be numerically
calculated [259].
We demonstrated that poloxamer F-127 was efficient in mitigating the damaging effect
of laser CB interaction at intense conditions. It would be worth doing a control experiment
using less intense conditions and evaluate effectiveness of F-127.
8.3 Understanding Hypothesis
The mechanism of intracellular drug delivery through laser particle interaction can be di-
vided broadly into two parts. The first being the energy transduction from laser to creation
of acoustic waves and the second is the interaction of the physical force generated through
laser CB interaction with the cell leading to reorganization of the cell membrane and pore
formation followed by drug uptake and recovery. One of the highlights of this thesis is that
we made some progress in the first part of the problem, i.e. understanding the mechanism of
acoustic pressure generation from laser irradiation of CB nanoparticles. We have character-
ized the system by varying few important parameters like fluence and CB concentration and
demonstrated their relationship with the pressure output. We also predicted peak particle
temperature, bubble radius, etc. Our broad conclusions were that the acoustic output is
caused by mainly three pathways viz. thermal expansion, vapor formation, and/or reaction
of CB with steam. The three phenomena are not independent from each other and the final
outcome is a sum total of all of the effects making it a very complicated system. But even
so, there might be ways to separate them from one another.
For that, I recommend, finite element modeling (FEM) of the system such that whenever
laser fluence, pulse width, and particle concentration are known, spatial and temporal
profiles of particle temperature, pressure, bulk pressure, bubble radius can be calculated
[260]. This will help us in two ways: first we can establish the relationship between the
input conditions like fluence, material properties, laser properties etc. to the final outcome
of pressure and bubble formation which will help us in determining the most important
factors that decide the outcome of the system in terms of bioeffects. This will give us an
idea about what material properties are needed to get maximal efficacy when designing new
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nanoparticles. Secondly to test the current hypothesis of pressure generation, one can find
the laser fluence threshold where vapor starts just forming and use fluences below that to
study the effect of just thermal expansion on intracellular drug delivery. Another way to
determine the threshold fluence experimentally would be to plot laser fluences vs. peak
pressure. If the relationship is linear then thermal expansion is the mechanism and if it is
non-linear then vapor formation has begun [84]. The data generated so far indicates that the
fluences we tested do not produce enough reaction of CB with water. This, however, does
not mean that there might not be reaction at higher fluences, but separating it out from
the other phenomena would be difficult because for reaction, vapor formation is a must.
But at higher fluences we expect reaction to occur and the way to show the existence of
the reaction is to either see consumption of nanoparticles or actually measure the change in
headspace gases through real time gas chromatography. If the products formed are CO and
H2 then performing real time GC is a must because H2 escapes from the system very fast.
Even though the acoustic output of the irradiated particles is an indication of the effect,
it might be that the cell interaction with the vapor bubble formed during laser irradiation
of CB is the real cause of delivery. If that is true, then we can test the hypothesis by
reducing the fluence to the bare minimum such that there is a little vapor formation and
then increase the CB concentration to get the maximal use of laser energy. Incidentally,
our optimal condition is a very low fluence with longer time of exposure. This rationale can
be extended to other cell lines to achieve optimal delivery conditions.
One of the hypotheses proposed in this thesis is that the vapor bubble interaction might
be necessary for cellular impact. Some experiments in this thesis are presented as a proof
of that hypothesis but further testing needs to be done. For that I recommend building
a chamber where the spatial profile of pressure can be controlled. This can be achieved
through a series of pressure transducers radially positioned and calibrated to have a net
resultant effect. When cells are placed in this chamber, we can simulate a pressure profile
similar to the one that is created during laser irradiation but without the formation of vapor
bubbles. If indeed the acoustic waves are responsible for drug delivery we should be able
to see uptake and death similar to laser irradiation in this case as well. But, if there is
115
no delivery, we can almost be certain that the acoustic waves do not, by themselves, cause
uptake of molecules.
Another interesting and important thing to do next would be the study of cell defor-
mation as a result of laser particle interaction. To do that, I recommend, building a live
imaging system that consists of a microscope mounted on a fast video camera, capturing
frames at quick succession between each pulse. If a big cell like oocyte is chosen it would be
easier to observe the cell membrane deformation with proper labeling of the membrane. It
might also be a good idea to track the fluorescent molecule during the laser exposure to see
the transport of the molecule across the cell membrane. A key thing that can be learnt from
this study is how does the nature of the cell (size, Youngs modulus of cell membrane, etc.)
play a role in the final outcome of the process. A major hurdle in building this system with
high temporal and spatial resolution will be lighting the system and I recommend using the
nanosecond laser itself as a lighting source because of its high peak output.
8.4 siRNA Delivery
In this work, we have shown a proof of concept of EGFR knockdown in ovarian cancer cells
in vitro. We did not optimize the system for knockdown and yet were able to achieve 49%
EGFR knockdown. We believe if we optimize the laser input conditions we can do even
better. This opens up a whole new avenue to do more work. The first thing would to be
to optimize laser exposure conditions to achieve maximum knockdown with minimum loss
of viability. We believe that this technique is relatively non-specific to the type of delivery
molecule used, so it should perform similarly across various siRNAs. Other targets like her-
pes simplex virus (HSV-2) associated viral proteins UL27 and UL29, human papillomavirus
oncogenes (HPV E6/E7), etc. can be chosen which might have more clinical relevance [207].
One can also theoretically extend the technique to deliver other interesting molecule like
shRNA, mRNA, proteins, ZFNs and TALENs.
8.5 Characterization in-vivo
We have demonstrated proof of concept in-vivo delivery of PI in TA muscle cells, but we
realized that muscle might not be the best target spot for laser irradiation study. Since
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the muscle cells are very long and this method creates only localized pores, the effect was
not observed across the length of the muscle cell. The inflammation response is also very
complicated in muscle cells making it hard to track the effect of laser CB interaction in-
vivo. A good choice of tissue might be skin because it is easy to target, extract, and perform
analysis on. Another big issue is particle size. The current CB particle hardly shows any
diffusion, and therefore, I recommend pursuing the nanoparticle study recommendation
first before the in-vivo studies. Once the nanoparticle issues and target has been fixed,
laser parameters can be varied. There is a possibility that in future therapeutics can be
delivered in-vivo. For example EGFR or HER2 siRNA can be delivered into ovarian cancer




The delivery of large molecules and therapeutic drugs is a challenging task due to the
barrier of the plasma membrane. One approach to facilitate the delivery of a variety of
large molecule drugs, while mitigating membrane selectivity, is to induce transient pores in
the cellular membranes.
It has been observed that carbon black nanoparticles (CB), when struck with nanosecond
pulsed lasers, create photoacoustic effects which can potentially be used to induce these
transient pores. It has been already determined in an in vitro study that such a phenomenon
has made delivery of macromolecular drugs into cells possible.
This study now aims to assess the implications of the photoacoustic effects on in vivo
intracellular drug delivery. The first steps of the study have been to observe and assess
the delivery of a fluorescent viability marker drug, propidium iodide (PI), in murine tibialis
anterior (TA) muscles. Muscle samples, when injected with 100 µM solutions of propidium
iodide (PI) and 0.4 g/l CB and exposed to a 200 mJ/cm2 power nanosecond pulsed laser,
exhibited significantly compromised cell membranes. This showed enhanced uptake of PI
compared to non-exposed controls. However there is the possibility of other variables such
as potential cell damage, the range and resulting effects of intramuscular CB distribution
the process, and the clearance of PI (or any other drug in question).
A.1 Methods
A.1.1 Nanoparticle Preparation
To prepare the CB nanoparticle solution, 20 mg of CB (Black Pearls 470, Cabot, Boston,
MA) was added to 50 ml of 0.013% (v/v) Tween 80 (Sigma-Aldrich, St. Louis, MO;
added to reduce aggregation and settling of the nanoparticles) in DI water and sonicated
for at least 15 min to obtain the final CB solution at a concentration of 0.4 mg/l. The
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size of the individual CB nanoparticles was 25 nm, but they were aggregated into larger
particles of 189.3 (± 1.5 nm (n = 3) diameter with a dispersity of 0.16 (± 0.03 (n = 3), as
determined from dynamic light scattering measurements. After making the 50 ml solution
of CB nanoparticles, it was aliquoted into smaller 1.5 ml samples.
A.1.2 Mice Preparation
Live female mice (CD1IGS) weighing approximately 22-24 g were anaesthetized first using
isoflurane gas and then injected with a rodent injectable anesthetic (containing ketamine
and xylazine) to keep them under anesthesia for approximately 2 hours. After that, the
hair at the sites of their TA muscles was removed using the hair removal product (Nair).
A.1.3 Sample Injection
A total volume of 80 µl containing PI at a final concentration of 100 µM and CB at a final
concentration of 400 g/l was injected into the murine TA using an insulin syringe. The
syringe was injected perpendicular to the muscle to a finite depth using a special injector
that could control the amount injected volume with a screw gauge. Injections were made
while pulling out the syringe. At each step about 10 µl of solution was injected. This
ensured a uniform distribution along the depth of the muscle. For control experiments
either the CB was replaced with DI water or the PI was replaced with DI water. Generally
one leg served as control while the other was exposed. The control leg was wrapped in
aluminum foil to prevent fluorescence.
A.1.4 Laser Exposure
After injections, some mouse muscles were exposed to a nanosecond pulsed laser (Continuum
Surelite III) at different fluences respectively per leg. Fluences used were 100 mJ/cm2 and
200 mJ/cm2 per pulse and the exposure time was 2 minutes for both of these fluences. Mice




After exposure, mice muscles were either extracted immediately post exposure or housed
for 2 days or 7 days before muscle extraction was performed. A 25 gauge needle was used
to separate the muscle from the bone and cut out with small scissors. The extracted muscle
is then washed in Dulbecco Phosphate-Buffered Saline (DPBS) and then lightly dried on a
tissue to remove excess moisture. Then immediately picked up with tweezers and immersed
in liquid nitrogen cooled Isopentane to be snap frozen. Frozen muscles are kept with dry
ice in a freezer at -80◦C until cryosection histology is to be performed on the tissues.
A.1.6 Sample Collection
The muscles to be sectioned were cut using a cryostat (Cryostar NX70). The cryosectioning
was performed at a -28◦C chamber temperature and each section taken was cut at a 20 µm
thickness. Mounting of the muscle sample for stability in cutting was done using an Optimal
Cutting Temperature (OCT) compound which froze a segment of the muscle in place in the
Cryostar chamber. Each muscle section was cut such that minimal OCT appeared in the
sections. Sections were collected on special slides (VWR Superfrost R©Plus Micro Slides).
Sections were taken at a given representative point in the muscle, once the point was chosen
3 successive cuts were made a replicates for the same area as measure to avoid or identify
cutting artifacts.
A.1.7 Analysis and Quantification
Extracted samples were stained with Hematoxylin and Eosin (H & E) for bright field imaging
and samples were untouched for fluorescence imaging. For fluorescence imaging, sections
were observed under a Carl Zeiss NLO 510 Multi-photon confocal microscope for signals
of PI presence in tissues. The PI signals in a sample indicated that cells of a given tissue
are compromised, whether this involves irreversible or reversible damage for PI to enter a
cell. The viewing magnification was at 20x. Two image channels, a fluorescence channel
and a bright field channel, were used to observe each section. The used lasers excited PI
at 535 nm and there was an emission at 617 nm in the fluorescence channel. In order to
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capture an image of an overall section at 20x magnification, the section was captured by
an automatic tile-scan, taking an image of the sample frame by frame. Excess noise in
the imaging process had to be accounted for in the fluorescence channel so that relevant
the relevant PI signal was not overshadowed. As a control for fluorescence, samples with
only PI injections and no exposure were imaged first. Subsequent samples that had been
laser irradiated and/or had CB nanoparticle injections were then imaged using the same
acquisition parameters that were used to image samples with only PI. Bright field imaging
was done using bright field setting of a fluorescence microscope (Nikon E50).
A.1.8 Quantification
In order to analyze the amount of PI signal, 3 replicates of mice TA samples were used.
For each mice sample at least 3 representative sections were imaged. Two quantities were
calculated from each image: i) the total number of pixels having certain PI fluorescence
(threshold gating) ii) the total pixels of the muscle section. For each muscle the sum of
total pixels of PI was divided by the sum of total pixels of muscle. This gave us an estimate
of the area that had certain PI fluorescence. This quantity was calculated for all 3 muscles
samples. Values are reported as mean of the 3 samples with their standard deviation.
A.2 Results and Discussion
Fig. A.1 shows various combinations of treatments done on Murine TA. First TA muscles
were injected with PI with no CB and no laser exposure which served as a control whether
there is a background signal. Next, the TA muscles injected with PI were either exposed to
laser at 200 mJ/cm2 for 2minutes or injected with CB. Finally muscles were injected with
both PI and CB and exposed to laser at 100 mJ/cm2 for 2 minutes and then to laser at 200
mJ/cm2 for 2 minutes. It was observed that PI by itself did not show any PI signal. There
was no PI signal even under laser exposure without CB. The CB injection by itself showed
some PI signal which was in fact very similar to the signal observed when the muscle was
exposed to laser at 100 mJ/cm2 for 2 minutes in the presence of CB. But when muscles
were exposed to 200 mJ/cm2 for 2 minutes brighter fluorescence was observed.






Figure A.1: Representative fluorescent and bright field images of tissue sections extracted
immediately post treatment under various conditions. Fluorescence imaging shows that
there is no propidium iodide signal (PI) signal when there is no carbon black (CB) in the
tissue. The CB by itself without laser exposure shows a little signal whereas when laser
and CB is used at 100 mJ/cm2 for 2 minutes there is some signal which increases when the
laser fluence is increased to 200 mJ/cm2. Bright field imaging with H & E staining shows




Figure A.2: Representative fluorescent and bright field images of tissue sections extracted
2 days post treatment under various conditions. Fluorescence imaging shows that there is
decrease in propidium iodide signal (PI) signal in the tissue with carbon black (CB) and
no laser compared to immediate extraction. The laser by itself without CB does not show
any sign of long term PI staining (thus signifying damage) whereas tissue exposed to 200
mJ/cm2 for 2 minutes in the presence of CB still shows PI signal. Bright field imaging with
H & E staining shows the accumulated CB still present even after 2 days and separation of
muscle tissue. Scale bars are 500 µm.
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not affect cells, it is only under the combination of the two that results in intracellular drug
delivery. To see PI fluorescence in samples with just CB was a bit odd. We did a control
where we just exposed murine TA to CB without laser or PI, to find out if the CB fluoresces
by itself and we found that there was no fluorescence (data not shown). Therefore, there
were two hypotheses that might have resulted in PI positive samples: i) the CB is causing
some sort of damage to the tissue resulting in uptake of PI ii) the CB being a non-specific
absorber, absorbs the PI and fluoresces. The bright field images revealed that the CB was
not diffusing across tissue, in fact it just localized around the needle track, and this may
lead to formation of a CB mesoporous structure which can cause non-specific absorption of
PI. When samples were analyzed for fraction of PI fluorescence area, (Fig. A.4A) it was
seen that there was statistically higher fluorescence in samples with just CB compared to
other controls (Students t-test, p <0.05). The exposed samples both had statistically higher
signal compared to laser only and no laser no CB control (Students t-test, p <0.05). The 100
mJ/cm2 for 2 minutes sample did not have a statistically higher PI signal compared to CB
only sample (Students t-test, p >0.05) but the sample exposed to laser had a statistically
higher signal of PI than both the CB and the 100 mJ/cm2 for 2 minutes sample (Students
t-test, p >0.05). But because we saw statistically higher signal with 200 mJ/cm2 we decided
to observe the muscles for longer times post irradiation.
When the muscles were extracted 2 days and 7 days post irradiation, it was observed
that the signal with just the CB had gone down after 2 days and remained low after 7 days
also compared to day 0 experiments (Fig. A.2 and Fig. A.3). But the sample exposed to
laser at 200 mJ/cm2 for 2 minutes retained PI signal even after 7 days and the amount of
signal did not go down statistically. When analyzed numerically it was confirmed that the
PI signal indeed lowered compared to day 0 in day 2 and day 7 (Students t-test, p <0.05)
experiments (Fig. A.4B and A.4C). This leads us to believe that the PI in the CB only
sample had slowly cleared away with time. This is only possible if the PI was present in
the extracellular space. This leads us to believe that the CB non-specifically absorbed the
PI and therefore the fluorescence at the initial time was an artifact. When we look at the






Figure A.3: Representative fluorescent and bright field images of tissue sections extracted
7 days post treatment under various conditions. Fluorescence imaging shows that tissue
exposed to 200 mJ/cm2 for 2 minutes in the presence of CB still shows PI signal. Bright
field imaging with H & E staining shows the accumulated CB still present even after 7 days






















































































































Unexposed    200 mJ/cm2     Unexposed       100 mJ/cm2        200 mJ/cm2 
     No CB           Exposed No CB             CB       Exposed CB         Exposed CB 
     Unexposed     200 mJ/c 2            Unexposed       200 mJ/cm2 
          No CB                    Exposed No CB                     CB                     Exposed CB 
                 200 mJ/cm2                Unexpose         
                    Exposed CB                    CB                      
Figure A.4: Pixel of PI positive normalized to total pixel counts for analyzed tissue sections
as a function of various treatment conditions at different days. Percentage of PI positive
area relative to total area in the tissues under various treatment conditions when the muscle
is extracted immediately after exposure (A), 2 days post exposure (B) and 7 days post
exposure (C) showing PI signal in the exposed sample with CB even after seven days post
treatment. Data show average ± standard deviation (SD) (n = 3).
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probably because CB is either too big to diffuse out and get cleared or there is some sort of
charge interaction (CB has a zeta potential of -21 mV) that is preventing CB from clearing
out. In either case this is concerning and needs to be taken care of in the future.
A.3 Conclusion
In this study we demonstrate uptake of PI in murine TA muscle cells when exposed to laser
at 200 mJ/cm2 for 2 minutes compared to controls. The cell still retained the PI even after
7 days post exposure. But, this process has to be further optimized to get better results
and there are several concerns: i) the lack of diffusivity of CB ii) the inability for the CB
to get cleared with time. We believe once those issues are solved, this technique would be
a viable technique for intracellular drug delivery.
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APPENDIX B
SUPPLEMETARY INFORMATION FOR PHYSICAL MECHANISMS
B.1 Calculations
B.1.1 Uniform heating of particle
1. Temperature of particle if all the heat goes to raising the temperature of the particle
Mass of nanoparticle in the solution, m =25 mg/l * 560 µl = 1.4e-08 kg
Heat capacity, Cp = 700 J/kg/K
Heat absorbed per pulse by the nanoparticles, Q = 10.15 mJ
Change in temperature, ∆T = Q/(m*Cp) = 1000◦C
2. Nanoparticle temperature rise assuming its not heat transfer limited
Rate of heat deposited on the nanoparticles = 1.015e06 W
Rate of heat removal because of heat transfer to the surrounding
= heat transfer coeff (h) * Surface Area (A) * temperature difference between bulk and
nanoparticle (∆T)
= (5.80E+06 W/m2/K)* (1.26E-13 m2) * (1000 K)
= 7.29e-04 W (for water at 25◦C)
= (5.80E+06 W/m2/K)* (1.26E-13 m2) * (1000 K)
= 2.01E-12 W (for vapor at 100◦C)
So heat removal is negligible compared to heat deposition so effectively there is no heat loss
while the particle is getting hot.
B.1.2 Vapor formation
1. If all the heat went to vaporize the water
Heat required to get 1 mol CB from 23◦C to 100◦C
= (1 mol) * (8.4 J/mol/◦C) * (100◦C -23◦C)
= 646.8 J
Heat required to get 1 mol of water from 23◦C to 100◦C
128
= (1 mol) * (75.24 J/mol/◦C) * (100◦C -23◦C)
= 5793.48 J
Heat required to vaporize 1 mol of water = 2.71e+04 J
Total heat required to vaporize 1 mol of water and keep the system at 100◦C = 3.36e04 J
Total heat supplied per pulse = 10.15 mJ
Total moles of CB consumed
=Total heat supplied/ Total heat required to consume 1 mol of CB
= 3.02e-07
Volume of water vapor = 9.07323e-09 m3
Total number of aggregates = 7.52E+09
Volume of water vapor per aggregate
=Total volume of the system = Volume of aggregate + Volume of water vapor
= 4.1866e-21 m3 + 1.21e-18 m3
= 1.21e-18 m3
Radius of the bubble assuming the system is spherical = 762 nm
2. Difference of the energy between Mie and IR measurements went to vapor formation
Difference in energy = 10.15 mJ -2.75 mJ = 7.4 mJ
Latent heat = 2.71e04 J/mol
Total volume of vapor produced = 5.45e-09 m3
Total number of nanoparticles = 7.52e09
Total volume of vapor per aggregate = 7.26e-19 m3
Total volume of vapor aggregate composite = 7.26e-19 m3
Radius of bubble assuming a spherical geometry = 645 nm
B.1.3 Reaction feasibility
1. Thermodynamics
Heat required to get 1 mol CB from 23◦C to 100◦C
= (1 mol) * (8.4 J/mol/◦C) * (100◦C -23◦C)
= 646.8 J
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Heat required to get 1 mol of water from 23◦C to 100◦C
= (1 mol) * (75.24 J/mol/◦C) * (100◦C -23◦C)
= 5793.48 J
Heat required to vaporize 1 mol of water = 2.71e+04 J
Heat of reaction for 1 mol of CB consumption = 131000 J
Total heat required for 1 mol of CB to react = 1.65e+05 J
Total heat supplied per pulse = 10.15 mJ
Total moles of CB consumed per pulse
= Total heat supplied per pulse/ Total heat required to consume 1 mol of CB
= 6.16795e-08
% of total CB consumed per pulse
= Total CB consumed per pulse/ Total moles of CB
= 5%
Moles of CO produced = 6.16795e-08
Moles of H2 produced = 6.16795e-08
Total volume of gases produced = Volume of CO + Volume of H2
= (moles of CO) * (specific Volume of CO at 100◦C) + (moles of H2)* (specific
volume of H2 at 100
◦C)
= 1.1936e-09 m3 + 1.87e-09 m3
=3.06e-09 m3
Percentage compared to vapor = 3.06e-09*100/9.07e-09=33%
2. Kinetics
Amount of gases produced per pulse = Rate of CO formation (m3 of CO/s/kg of CB)*(mass
of CB)*time(s)
= (1.72e-04 m3/kg/s)*(1.48e-08 kg)*(0.1 s)
= 2.55E-13 m3 (Note Kinetic predictions are much lower than thermodynamic calculations)
% compared to vapor = 0.0028%
Amount of CO + CO2 formed in 7 minutes (4200 pulses) = 1.07e-09 m
3
= (1.07e-09 m3)/(0.085 m3/mol) = 1.25e-08 mols
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Amount of CB used in 7 minutes = 1.25e-08 mols = 1.5078e-10kg


















   
       
Figure B.1: DLS measurement of CB nanoparticles show a mean diameter of ∼200 nm

























Figure B.2: Increase of particle temperature with time assuming first the surrounding
temperature remains at 23◦C and then once the vapor is formed, the bulk temperature goes
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Figure B.3: Characterization of the CB suspension after the exposure. First the nanoparti-
cle size was determined using DLS after either no exposure to laser till an hour of exposure
(a). The absorption spectra were characterized for CB exposed for different time periods





Figure B.4: The acoustic measurement setup which is used to characterize the acoustic
output of the system. The hydrophone can be moved in the x,y and z directions relative to





Figure B.5: Pressure output with an extended time. There is no further signal after the




C.1 Materials and Methods
C.1.1 Cell Preparation
Human ovarian cancer cells (Hey A8-F8), kindly provided by Gordon B. Mills (MD An-
derson Cancer Center, Houston, TX) and transfected with the pGL4.51[luc2/CMV/Neo]
luciferase reporter vector (Promega, Madison, WI), were used in this work (Hey A8-F8) and
maintained in RPMI-1640 medium supplemented with 10% FBS, penicillin-streptomycin-
amphotericin B and 100 µg/ml of Geneticin (GIBCO, Grand Island, NY). Silencer Select
siRNA (EGFR) (ID: s564) or Silencer Select siRNA (Negative Control #1) (Ambion, Grand
Island, NY) were dissolved in sterile nuclease-free water (Ambion) to create a 20 µM stock
solution of siRNA.
C.1.2 Nanoparticle Preparation
To prepare the CB nanoparticle solution, 20 mg of CB (Black Pearls 470, Cabot, Boston,
MA) were added to 50 ml of 0.013% (v/v) Tween 80 (Sigma-Aldrich, St. Louis, MO; added
to reduce aggregation and settling of the nanoparticles) in DI water and sonicated for at
least 15 min to obtain the final CB solution at a concentration of 400 mg/l. The size of the
individual CB nanoparticles was 25 nm, but they were aggregated into larger particles of
189.3 ± 1.5 nm (n = 3) diameter with a dispersity of 0.16 ± 0.03 (n = 3), as determined from
dynamic light scattering measurements (See Fig. 1A in main text). After making the 50
ml solution of CB nanoparticles, it was aliquoted into smaller 1.5 ml samples. Consistency
of samples was determined by measuring the absorption spectra using a spectrophotometer
(Synergy H4, BioTek, Winooski, VT) and comparing to predetermined standards.
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C.1.3 Laser Apparatus
A Nd:YAG infrared laser (Surelite III, Continuum, Santa Clara, CA) was used to apply
pulses of 1064 nm wavelength, 5 - 9 ns pulse length, and 75 - 175 mJ energy per pulse.
Pulses were applied at a repetition rate of 10 Hz (i.e., 10 pulses per second). The energy
was varied by manipulating the Q-switch timing. The beam was passed through a Faraday
isolator to prevent back reflection. The laser beam was passed through a polarizer and
quarter plate to fine tune the final output externally. The resulting 8 mm-diameter beam
was then usually diverged to 21 mm diameter using a lens to illuminate the entire cuvette
(exposure area of 4 cm2). Sham exposures were used as negative control experiments, where
solutions containing cells, dextran or siRNA (s564) and CB nanoparticles went through all
the same steps as exposed samples (see below), except that the laser was not turned on.
Another negative control involved only cells without CB nanoparticles or siRNA.
C.1.4 Laser Exposure
A suspension of 490 µl of Hey A8-F8 cells cells in RPMI-1640 medium (1.6106 cells/ml)
were combined with 50 µl siRNA (2 µM final concentration) stock solution and 37 µl of
CB nanoparticle suspension (25 mg/l final concentration) and irradiated with laser for 7
min at 18.75 mJ/cm2 or 3 min at 25 mJ/cm2 or 1 min at 44 mJ/cm2 or not exposed to
laser (sham). In some siRNA experiments, there was no CB added or anti-EGFR siRNA
was replaced with negative control (NC) siRNA. After irradiation, cell suspensions with
CB nanoparticles and dextran were either washed with 10% FBS-supplemented PBS three
times and then cover-slipped and imaged with a fluorescence microscope or transferred
to flow cytometry tubes for analysis. For siRNA experiments, cell suspensions with CB
nanoparticles and siRNA were transferred into 6-well tissue culture plates (Falcon, Franklin
Lakes, NJ) containing 2 ml of RPMI-1640 growth medium per well. Cells were incubated at
37◦C in an atmosphere of humidified air with 5% CO2 for 24 h, harvested by trypsin/EDTA
and processed for the isolation of total-cell RNA.
As a transfection control, cells were transfected with s564 siRNA and NC-siRNA using
Lipofectamine 2000 reagent (Invitrogen, Carlsbad, CA) as follows: Hey A8-F8 cells were
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plated in RPMI-1640 growth medium into 6-well tissue culture plates (105 cells in 2 ml media
per well) and incubated overnight at 37◦C in an atmosphere of humidified air with 5% CO2.
Thereafter, mixtures of 250 µl Opti-MEM (GIBCO) with 5 µl siRNA (500 nM) and 250 µl
Opti-MEM with 5 µl Lipofectamine 2000 (0.25% v/v) were combined, incubated at room
temperature for 20 min, diluted with 2 ml Opti-MEM and used to replace the medium
in each well with transfected cells. After 4 h at 37◦C in an atmosphere of humidified air
with 5% CO 2, the transfection medium was replaced with RPMI-1640 supplemented with
10% FBS (Cellgro), penicillin-streptomycin-amphotericin B; cells were then incubated for
additional 24 h and harvested by trypsin/EDTA. All transfections or control treatments
were performed in triplicate.
C.1.5 Analysis of FITC-dextran uptake
A bench-top flow cytometer (BD LSRII, BD Biosciences, San Jose, CA) was used to quantify
uptake, i.e. the number of live cells with intracellular FITC-dextran, and viability, i.e. the
number of live cells that were not necrotic or fragmented as determined by propidium iodide
staining, on a cell-by-cell basis. For quantifying necrotic death, propidium iodide staining
was analyzed using a PerCP-Cy5, 670 nm longpass filter. FITC-dextran uptake into cells
was detected using a FITC, 530/28 nm bandpass filter. A cell gate was constructed based
on forward-scattered and side-scattered light to determine the size distribution of cells in
the control. Any events lying within this gate were considered to be cells, whereas events
smaller than that were considered cell fragments or dead cells.
To determine the concentration of intact cells (and thereby account for possible cell
loss due to fragmentation), we multiplied the volumetric flow rate in the flow cytometer
by the time of analysis to determine the total volume analyzed. Dividing the number of
cells detected within the gate by the volume provided the cell concentration, which was
compared to non-exposed controls to determine cell loss due to fragmentation. The flow
cytometer was run for 90 s, which resulted in collection approximately 105 cell events per
sample (∼ 20% of the total cells present in each sample).
To account for spectral overlap between the dyes, compensation controls were run for
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each experiment. Propidium iodide-positive samples were made by incubating cells in 70%
methanol for 30 min and then washing with PBS. FITC-dextran-positive samples were made
by exposing cells with CB nanoparticles and FITC-dextran at 44 mJ/cm2 per shot for 7
min. At this condition, there was extensive cell death, but almost all cells which remained
viable had FITC-dextran uptake.
C.1.6 Isolation of RNA
Cell pellets were processed for RNA isolation using mirVana miRNA isolation kit (Ambion)
following the manufacturers protocol for total RNA isolation. Purity and concentration of
total cell RNA were determined with NanoDrop 1000 Spectrophotometer (Thermo Scien-
tific).
C.1.7 Analysis of siRNA uptake
Analysis of uptake of siRNA targeting EGFR gene (s564) was performed using TaqMan
siRNA Assay s564 asy (Applied Biosystems/Life Technologies, Carlsbad, CA). From each
treatment or control group, 10 ng of total cell RNA was denatured and reverse-transcribed
using s564 RNA-specific stem-loop RT primer and TaqMan MicroRNA Reverse Transcrip-
tion Kit in 15 µl reactions following the manufacturer’s recommendation. Subsequently,
cDNA was amplified using TaqMan Universal Master Mix II with UNG in CFX96 Real
Time PCR Detection System (BioRad, Hercules, CA) following the manufacturer’s recom-
mendation.
C.1.8 Analysis of EGFR expression
For analysis of expression of target EGFR and internal control GAPDH genes, 1.5 µg of
total cell RNA was reverse-transcribed in 20 µl reactions using High Capacity cDNA Re-
verse Transcription Kit with RNase Inhibitor (Applied Biosystems/Life Technologies). For
all transfected or control-treated cells, qPCR was performed in CFX96 Real Time PCR
Detection System (BioRad) with 10 ng of cDNA per 20 µl reactions using TaqMan assays
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Hs01076078 m1 for EGFR, Hs02758991 g1 assay for GAPDH and TaqMan Universal Mas-
ter Mix II with UNG (all from Applied Biosystems/Life Technologies) following the man-
ufacturers recommendations. All qPCR reactions were performed in triplicate. Threshold
cycles were determined using single threshold/baseline subtracted curve fit (CFX Manager
Software) and averaged across technical replicates.
C.1.9 Data analysis and statistics
A minimum of three replicates was performed for all conditions. Replicates enabled calcu-
lation of means and standard deviation. For dextran uptake studies, the null hypothesis
was that the average fraction of cells with uptake (or average fraction of viable cells) be-
tween a treated sample and a sham exposure were equal. To compare between mean values
of two data points, an unpaired Students t-test was performed (2 tails) assuming unequal
variances using GraphPad Prism 6 (GraphPad Software, La Jolla, CA). The differences
between means were considered significant for p <0.05.
For siRNA experiments, expression of EGFR gene relative to internal control GAPDH
was presented using ∆Ct method and the significance of differences between mean ∆Ct
values corresponding to experimental groups was tested using two-tailed t-test with Welch’s
correction. The differences between means were considered significant for p <0.05. The
concentration of s564 siRNA was expressed as 2-Ct, where Ct represent mean threshold cycle
values for s564 cDNA amplification across three biological replicates. Statistical significance
of differences among mean Ct values was tested with one-way ANOVA with Tukey’s post-




























Figure C.1: Light absorption by CB nanoparticle solution versus wavelength. Absorption
spectra measured using a spectrophotometer shows that CB nanoparticles absorbs across a
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Figure C.2: Expression of EGFR in Hey A8 F8 cells treated with EGFR-siRNA and NIR
laser, but no CB nanoparticles (left bar) and cells treated with CB nanoparticles, but no
siRNA or laser (right bar). In both cases, there was no significant knock-down of target
EGFR gene (2 tailed t-tests with Welchs corrections, p = 0.5). Expression presented in









Figure C.3: Brightfield (phase contrast) micrographs of Hey A8 F8 cells 24 h post treatment
with (A) CB only, (B) anti-EGFR siRNA and laser at 19 mJ/cm2 for 7 min, (C) NC-
siRNA, CB nanoparticles and laser at 19 mJ/cm2 for 7 min and (D) anti-EGFR siRNA,
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Figure C.4: Uptake of anti-EGFR (s564) siRNA and knockdown of EGFR using Lipofec-
tamine 2000 (Lipo 2000) (A) Amount of intracellular siRNA (s564) (in arbitrary units),
normalized to 10 ng of total RNA, quantified using qPCR when Hey A8-F8 cells with anti-
EFFR siRNA or scrambled siRNA treated with the manufacturers recommended amount
of Lipofectamine 2000. (B) EGFR mRNA level normalized relative to GAPDH level mea-
sured using qPCR showing knockdown when cells were treated with Lipofectamine 2000 and
anti-EGFR siRNA compared to scrambled siRNA. Asterisk symbol (*) shows statistically




C.2.1 Number of siRNA per cell
1. Number of siRNA per cell (Lipofectamine 2000)
Total number of siRNA/ Total number of cells
= molar concentration of stock siRNA * Volume of stock siRNA used
* Avogadros constant/(Cell concentration * Volume of cells used)
= (20 µM)*(5 µl)* 6.023*1e23/1e05 cells/ml) *( 2 ml)
= 3.01e08
2. Number of siRNA per cell (photoacoustic delivery)
Total number of siRNA/ Total number of cells
= molar concentration of stock siRNA * Volume of stock siRNA used
* Avogadros constant/(Cell concentration * Volume of cells used)
= (20 µM)*(50 µl)*6.023*1e23/(1.6x1e06 cells/ml)*(0.49 ml)
= 7.68e08
C.2.2 Time scales
Time scale of conduction of heat to the surrounding water of 200 nm diameter particles
= R2/4*αw
(where R is CB nanoparticle radius and αw is thermal diffusivity of water)
= (1e-07 m)2/ 4*(1.43e-07 m2/s)
= 175 ns
Time scale of conduction of heat to the surrounding water of 50 nm diameter particles
= R2/4*αw
(where R is CB nanoparticle radius and αw is thermal diffusivity of water)
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